
<html lang="en"     class="pb-page"  data-request-id="3e6ee5cd-bb80-448d-a442-417cdb3199cd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b01963;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration" /></meta><meta name="dc.Creator" content="Azzurra  Stefanucci" /></meta><meta name="dc.Creator" content="Marilisa Pia  Dimmito" /></meta><meta name="dc.Creator" content="Giorgia  Macedonio" /></meta><meta name="dc.Creator" content="Laura  Ciarlo" /></meta><meta name="dc.Creator" content="Stefano  Pieretti" /></meta><meta name="dc.Creator" content="Ettore  Novellino" /></meta><meta name="dc.Creator" content="Wei  Lei" /></meta><meta name="dc.Creator" content="Deborah  Barlow" /></meta><meta name="dc.Creator" content="Karen L.  Houseknecht" /></meta><meta name="dc.Creator" content="John M.  Streicher" /></meta><meta name="dc.Creator" content="Adriano  Mollica" /></meta><meta name="dc.Description" content="Four novel fluorinated cyclic analogues of biphalin with excellent to modest binding affinity for μ-, δ-, and κ-receptors were synthesized. The cyclic peptides have a combination of piperazine or h..." /></meta><meta name="Description" content="Four novel fluorinated cyclic analogues of biphalin with excellent to modest binding affinity for μ-, δ-, and κ-receptors were synthesized. The cyclic peptides have a combination of piperazine or h..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 13, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01963" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01963" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01963" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01963" /></link>
        
    
    

<title>Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01963" /></meta><meta property="og:title" content="Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0011.jpeg" /></meta><meta property="og:description" content="Four novel fluorinated cyclic analogues of biphalin with excellent to modest binding affinity for μ-, δ-, and κ-receptors were synthesized. The cyclic peptides have a combination of piperazine or hydrazine linker with or without a xylene bridge. Among the ligands, MACE3 demonstrated a better activity than biphalin after intravenous administration, and its corresponding analogue incorporating the hydrazine linker (MACE2) was able to induce longer lasting analgesia following subcutaneous administration. An analogue of MACE2 containing 2,6-dimethyl-l-tyrosine (MACE4) showed the best potency and in vivo antinociceptive activity of this series." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01963"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01963">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01963&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01963&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01963&amp;href=/doi/10.1021/acs.jmedchem.9b01963" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2673-2687</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01856" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02134" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Azzurra Stefanucci</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Azzurra Stefanucci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Farmacia, Università di Chieti-Pescara “G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>A.S.: e-mail, <a href="/cdn-cgi/l/email-protection#ee8fc09d9a8b888f809b8d8d87ae9b80878d86c0879a"><span class="__cf_email__" data-cfemail="2d4c035e59484b4c43584e4e446d5843444e45034459">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Azzurra++Stefanucci">Azzurra Stefanucci</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7525-2913" title="Orcid link">http://orcid.org/0000-0001-7525-2913</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marilisa Pia Dimmito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marilisa Pia Dimmito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Farmacia, Università di Chieti-Pescara “G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marilisa+Pia++Dimmito">Marilisa Pia Dimmito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giorgia Macedonio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giorgia Macedonio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Farmacia, Università di Chieti-Pescara “G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giorgia++Macedonio">Giorgia Macedonio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Ciarlo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Ciarlo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Istituto Superiore di Sanità, Centro Nazionale Ricerca e Valutazione Preclinica e Clinica dei Farmaci, Viale Regina Elena 299, 00161 Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Ciarlo">Laura Ciarlo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefano Pieretti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefano Pieretti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Istituto Superiore di Sanità, Centro Nazionale Ricerca e Valutazione Preclinica e Clinica dei Farmaci, Viale Regina Elena 299, 00161 Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Pieretti">Stefano Pieretti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5926-6194" title="Orcid link">http://orcid.org/0000-0001-5926-6194</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ettore Novellino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ettore Novellino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Farmacia, Università di Napoli “Federico II”, Via D. Montesano, 49, 80131 Naples, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ettore++Novellino">Ettore Novellino</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2181-2142" title="Orcid link">http://orcid.org/0000-0002-2181-2142</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Lei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Lei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona 85724, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Lei">Wei Lei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah Barlow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah Barlow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, Maine 04005, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Barlow">Deborah Barlow</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen L. Houseknecht</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen L. Houseknecht</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, Maine 04005, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen+L.++Houseknecht">Karen L. Houseknecht</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John M. Streicher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John M. Streicher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona 85724, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Streicher">John M. Streicher</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4173-7362" title="Orcid link">http://orcid.org/0000-0002-4173-7362</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Adriano Mollica</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adriano Mollica</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Farmacia, Università di Chieti-Pescara “G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>A.M.: e-mail, <a href="/cdn-cgi/l/email-protection#f594db989a99999c9694b5809b9c969ddb9c81"><span class="__cf_email__" data-cfemail="91f0bffcfefdfdf8f2f0d1e4fff8f2f9bff8e5">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adriano++Mollica">Adriano Mollica</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7242-4860" title="Orcid link">http://orcid.org/0000-0002-7242-4860</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01963&amp;href=/doi/10.1021%2Facs.jmedchem.9b01963" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2673–2687</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 13, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 November 2019</li><li><span class="item_label"><b>Published</b> online</span>13 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01963</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2673%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAzzurra%2BStefanucci%252C%2BMarilisa%2BPia%2BDimmito%252C%2BGiorgia%2BMacedonio%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01963%26title%3DPotent%252C%2BEfficacious%252C%2Band%2BStable%2BCyclic%2BOpioid%2BPeptides%2Bwith%2BLong%2BLasting%2BAntinociceptive%2BEffect%2Bafter%2BPeripheral%2BAdministration%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2687%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01963"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">601</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01963" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Azzurra&quot;,&quot;last_name&quot;:&quot;Stefanucci&quot;},{&quot;first_name&quot;:&quot;Marilisa&quot;,&quot;last_name&quot;:&quot;Pia Dimmito&quot;},{&quot;first_name&quot;:&quot;Giorgia&quot;,&quot;last_name&quot;:&quot;Macedonio&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Ciarlo&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Pieretti&quot;},{&quot;first_name&quot;:&quot;Ettore&quot;,&quot;last_name&quot;:&quot;Novellino&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Lei&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Barlow&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;L. Houseknecht&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Streicher&quot;},{&quot;first_name&quot;:&quot;Adriano&quot;,&quot;last_name&quot;:&quot;Mollica&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2673-2687&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01963&quot;},&quot;abstract&quot;:&quot;Four novel fluorinated cyclic analogues of biphalin with excellent to modest binding affinity for μ-, δ-, and κ-receptors were synthesized. The cyclic peptides have a combination of piperazine or hydrazine linker with or without a xylene bridge. Among the ligands, MACE3 demonstrated a better activity than biphalin after intravenous administration, and its corresponding analogue incorporating the hydrazine linker (MACE2) was able to induce longer lasting analgesia following subcutaneous administration. An analogue of MACE2 containing 2,6-dimethyl-l-tyrosine (MACE4) showed the best potency and in vivo antinociceptive activity of this series.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01963&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01963" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01963&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01963" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01963&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01963" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01963&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01963&amp;href=/doi/10.1021/acs.jmedchem.9b01963" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01963" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01963" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01963%26sid%3Dliteratum%253Aachs%26pmid%3D31834798%26genre%3Darticle%26aulast%3DStefanucci%26date%3D2020%26atitle%3DPotent%252C%2BEfficacious%252C%2Band%2BStable%2BCyclic%2BOpioid%2BPeptides%2Bwith%2BLong%2BLasting%2BAntinociceptive%2BEffect%2Bafter%2BPeripheral%2BAdministration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2673%26epage%3D2687%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (8)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292199" title="Crystallography">Crystallography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Four novel fluorinated cyclic analogues of biphalin with excellent to modest binding affinity for μ-, δ-, and κ-receptors were synthesized. The cyclic peptides have a combination of piperazine or hydrazine linker with or without a xylene bridge. Among the ligands, <b>MACE3</b> demonstrated a better activity than biphalin after intravenous administration, and its corresponding analogue incorporating the hydrazine linker (<b>MACE2</b>) was able to induce longer lasting analgesia following subcutaneous administration. An analogue of <b>MACE2</b> containing 2,6-dimethyl-<span class="smallcaps smallerCapital">l</span>-tyrosine (<b>MACE4</b>) showed the best potency and <i>in vivo</i> antinociceptive activity of this series.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The treatment of intense pain is usually based on μ-opioid receptor (MOR) agonists; however, the use of opiates is often limited by significant severe side effects. Chronic pain is a predominant pain type among patients but tends to be refractory to conventional analgesics including opioids.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The palindromic peptide biphalin is a dimer of two <span class="smallcaps smallerCapital">d</span>-Ala containing enkephalin-like portions joined by a hydrazide moiety.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> It possesses a similar affinity for MOR and DOR; however, the antinociceptive effects measured in animal models revealed higher efficacy after intracerebroventricular administration (icv) than after peripheral administration, suggesting a poor penetration of the BBB and/or a low metabolic stability.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Biphalin was recently found to produce profound analgesia in a murine skin cancer model and, unlike morphine, has less tolerance when chronically administered to the spinal cord.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">For years our laboratories have developed new biphalin analogues by introducing stepwise modifications (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In order to improve BBB penetration, different non-hydrazine linkers have been incorporated together with the pF-Phe in place of the natural Phe, resulting in a novel linear peptide named <b>AM94</b>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This analogue is characterized by high binding affinity at MOR and DOR and a greater and longer lasting efficacy than the parent compound after different administration routes such as intrathecal and subcutaneous.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The Phe residue has also been replaced with βh<sup>3</sup>-Phe resulting in a novel linear peptide with good binding properties at MOR and DOR and improved stability in human plasma.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, among the linear analogues, <b>AM94</b> was the most potent, efficacious, and long lasting <i>in vivo</i>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design of novel cyclic analogues <b>MACE1</b>–<b>4</b> of biphalin and <b>AM94</b> and their structural modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have also developed several cyclic biphalin analogues. Among the cyclic peptides, the introduction of a disulfide bridge was a step forward in revealing the active conformation at the binding pocket, leading to more potent compounds than the parent linear peptide.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Recently different cyclization strategies involved in the rational design of peptidomimetics have been applied by our research group to DPDPE and biphalin.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Another milestone in this process was the synthesis of the cyclic analogue series recently published, where the disulfide bridge was successfully substituted by a xylene bridge using CLIPS technology.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a></div><div class="NLM_p">Among these compounds, the <i>o</i>-bis(methyl)benzene bridge containing peptide exhibits good stability in human plasma and an antinociceptive effect higher than that of biphalin, after intracerebroventricular, intrathecal, and subcutaneous administrations.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These results prompted us to retain this feature in the analogues described in this paper, namely, <b>MACE1</b>–<b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), together with pF-Phe, which seemed to be related to the increase of the activity found for of <b>AM94</b>.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Constriction in the χ space is also an interesting tool to modulate the potency/affinity of opioid peptides with a modification in the conformational freedom of the aromatic side chain residues such as tyrosine, by using dimethyl tyrosine (Dmt);<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> thus, we exploited this structural feature in the novel compound <b>MACE4</b>.</div><div class="NLM_p">The choices of pharmacophore type and the correct spacer type and length are key features that lead to an optimized interaction between the bivalent analogues and the receptor binding site.<a onclick="showRef(event, 'ref3 ref12'); return false;" href="javascript:void(0);" class="ref ref3 ref12">(3,12)</a> The nature of the hydrazine moiety in biphalin is not critical for the properties of the compound; thus this moiety may be replaced by a piperazine, and the replacement of the Phe residues with a pF-phenylalanine may also be applied. These substitutions increase activity at MOR and DOR; their effects are additive and synergistic, leading to one of the best linear biphalin analogue described to date (<b>AM94</b>).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Affinity and bioactivity of mixed μ/δ-opioid receptor ligands are also potentiated by the incorporation of the Dmt structure. In a previous study the Tyr residue has been replaced by Dmt to give a novel cyclic biphalin analogue joining a -S-S- bridge with some flexible linkers at the C-terminus, with improvement in opioid agonist potency and efficacy.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The Dmt moiety promotes MOR/DOR recognition, playing the “address” portion in the “message–address” model for opioid peptides.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a></div><div class="NLM_p last">In this work we report a novel series of peptides described above (<b>MACE1</b>–<b>4</b>) designed as molecular hybrids of <b>AM94</b> and cyclic biphalins obtained by CLIPS technology. These approaches are expected to impart improvements in terms of BBB penetration and plasma stability, thus ameliorating their <i>in vivo</i> performance vs biphalin.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Our results show that novel peptides bind to both MOR and DOR to produce strong antinociception, validating our design. Furthermore, it was found that some of the novel cyclic products possess high affinity for KOR, providing additional SAR information on our approach.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">In this work, we adopted a closely related synthetic route to that previously described by Mollica et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The amino acid residues were added step by step to the piperazine/hydrazine cores in a symmetric manner (see <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Topographical control of the tyrosine side chain was applied incorporating Dmt in place of the native tyrosine in <b>MACE4</b>. Cyclic intermediates <b>3a</b>,<b>b</b> were coupled with Boc-Tyr-OH to give compound <b>6</b> or subjected to a one-pot-reduction/cyclization reaction to create the cyclic compounds <b>4a</b>,<b>b</b>. ACM side chain protection of <span class="smallcaps smallerCapital">d</span>-Cys facilitates the cyclization reaction/<i>o</i>-bis(bromomethyl)benzene incorporation, resulting in a fast and straightforward procedure for the preparation of the novel compounds, as previously described.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The cyclic peptides <b>MACE1</b>–<b>4</b> were obtained as trifluoracetic salts. The overall yields were good, and the purity was assessed to be ≥95% by RP-HPLC (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>MACE1</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA/CH<sub>2</sub>Cl<sub>2</sub> 1:1, rt (1.5 h) for <b>2a</b>,<b>b</b>, <b>6</b>, <b>MACE1</b>, <b>5a</b>–<b>c</b> or piperidine 20% in DMF, rt (15 min), then TFA, rt (30 min) for <b>MACE4</b>; (b) EDC·HCl (2.2 equiv), HOBt anhydrous (2.2 equiv), DIPEA (6.6 equiv), Boc-<span class="smallcaps smallerCapital">d</span>-Cys(ACM)-OH (2.2 equiv) in DMF at rt overnight; (c) I<sub>2</sub>, MeOH, 3 h at rt then ascorbic acid; (d) TCEP, DMF for 1 h at rt, then <i>o</i>-bis(bromomethyl)benzene at rt, overnight; (e) Boc-Tyr-OH for products <b>6</b>, <b>5a</b>,<b>b</b> or Fmoc-Dmt-OH for product <b>5c</b>, EDC·HCl, HOBt anhydrous, DIPEA, DMF, 0 °C for 20 min, then rt 24 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Opioid Receptor Binding Affinity</h3><div class="NLM_p">The affinity of <b>MACE1</b>–<b>4</b> for all three opioid receptors was evaluated using competition binding assays against the human MOR, DOR, or KOR expressed in CHO cells. The results show that all four compounds bind to the MOR and DOR with high to modest affinity (4.94–83.7 nM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). While these affinities are relatively high, they are still lower than biphalin and its linear fluorinated analogue containing the piperazine linker, <b>AM94</b>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>MACE</b> compounds bind to the opioid receptors with high to moderate affinity. (A) Competition binding curves for the <b>MACE</b> analogues and naloxone (MOR, DOR) or U50,488 (KOR) positive controls shown. All analogues were competed against a fixed concentration of <sup>3</sup>H-diprenorphine in the membranes of MOR-, DOR-, or KOR-expressing CHO cells. Summary curves shown with the mean ± SEM of each point from <i>n</i> = 3 independent experiments. (B) The <i>K</i><sub>i</sub> of each compound was calculated from the IC<sub>50</sub> of each curve using the previously established <i>K</i><sub>D</sub> of <sup>3</sup>H-diprenorphine in each cell line. Each <i>K</i><sub>i</sub> value was calculated from each independent experiment and reported here as the mean ± SEM (<i>n</i> = 3 independent experiments). Receptor selectivity ratios are also shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Interestingly the binding affinity of these compounds to the MOR is higher than that of the previously published analogue characterized by an <i>o</i>-bis(bromomethyl)benzene/hydrazine combination (<b>6a</b>),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which is probably related to the presence of the pF substitution on phenylalanine. Also, all four <b>MACE</b> compounds bind to the KOR with lower but still modest affinity (76.7–293.3 nM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Interestingly, the KOR curves are all saturated but do not fully displace the radioligand, which is consistent with mixed allosteric binding. Taken together, the data suggest high affinity and no apparent selectivity between MOR and DOR, similar to biphalin, with an acquired moderate affinity for the KOR, unlike biphalin. This led to weak to moderate selectivity for MOR/DOR over KOR.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Opioid Receptor Functional Activity</h3><div class="NLM_p">The ability of the novel analogues to activate the G-protein-coupled opioid receptors was measured using <sup>35</sup>S-GTPγS coupling with the human MOR, DOR, or KOR expressed in CHO cells as for the binding above (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Interestingly, all four <b>MACE</b> compounds displayed high potency (<0.51–7.5 nM) and high efficacy (83.6–104%) at the MOR (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B). This is in contrast to the binding affinities measured in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, particularly for <b>MACE1</b>, and implies that the novel <b>MACE</b> analogues have high intrinsic efficacy for the MOR. <b>MACE3</b> did show a highly elevated baseline in the MOR experiments, which is suggestive of ligand aggregation; including Tween80 in the reaction buffer resolved this baseline issue without significantly altering the DAMGO control (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). At the DOR, <b>MACE1</b>, -<b>3</b>, and -<b>4</b> displayed high potencies (∼4–8 nM); however, the potency of <b>MACE2</b> dropped to 142 nM. As <b>MACE2</b> had a high DOR affinity, this suggests a poor intrinsic efficacy at the DOR for <b>MACE2</b>. <b>MACE4</b> shows a subnanomolar potency at MOR as full agonist, and only a partial agonist activity at DOR and KOR. All four compounds displayed weak efficacy at the DOR (11.0–27.7%), suggesting they are weak partial agonists at the DOR, unlike biphalin and <b>AM94</b>. These results also suggest that the <b>MACE</b> compounds, as weak partial agonists, could block full agonist effects at the DOR. This was tested in antagonist mode vs 100 nM SNC80, which showed that <b>MACE1</b> had low potency (404 nM) but high efficacy (90%) antagonism, while <b>MACE2</b> had high potency (8.9 nM) but low efficacy (42%) antagonism; both <b>MACE3</b> and <b>MACE4</b> showed no detectable antagonism (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). It is not clear at this point why <b>MACE3</b>,<b>4</b> did not show antagonist activity but did show binding affinity. The explanation could encompass differences in the binding pose of diprenorphine (binding) vs SNC80 (GTPγS) or other factors. Overall though DOR antagonism should be considered in the antinociceptive mechanism of these compounds, particularly <b>MACE1</b>,<b>2</b>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>MACE</b> compounds activate the opioid receptors with variable potency and efficacy. (A) Summary agonist concentration curves for the <b>MACE</b> compounds and a positive control agonist (DAMGO for MOR; SNC80 for DOR; U50,488 for KOR) in <sup>35</sup>S-GTPγS coupling shown. All compounds were normalized to the stimulation caused by the positive control (100%) and vehicle (0%) and reported as the mean ± SEM from <i>n</i> = 3 independent experiments. (B) <b>MACE3</b> caused a highly elevated baseline under the standard conditions in (A), preventing analysis. This issue was corrected by including 0.01% Tween80 in the reaction buffer, which eliminated the baseline (presumably by breaking up ligand aggregates). A DAMGO control was also included, which did not differ significantly from (A), so the results for <b>MACE3</b> in this condition were calculated normally. (C) The compounds were tested in antagonist mode vs a fixed concentration of 100 nM SNC80. The data were normalized to the max stimulation caused by the SNC80 (100%) and vehicle (0%). (D) The potencies (<i>E</i>/IC<sub>50</sub>) and efficacies (<i>E</i>/<i>I</i><sub>Max</sub>) of each <b>MACE</b> peptide and positive control were calculated in each independent experiment (<i>n</i> = 3), then reported as the mean ± SEM. The <i>E</i><sub>Max</sub> was reported as a percent of stimulation caused by the positive control, which had a defined <i>E</i><sub>Max</sub> of 100%. The <i>I</i><sub>MAX</sub> was reported as a percent of antagonism caused by naloxone positive control, which had a defined <i>I</i><sub>MAX</sub> of 100%. The <b>MACE3</b> results at the MOR were calculated from the separate experiment in (B) and are noted by a #.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Lastly, all four compounds had high efficacy (69.3–76.0%) at the KOR, with variable potency (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). <b>MACE1</b> and <b>MACE3</b> had high potencies (9.7 and 25.9 nM, respectively), improving on their KOR binding affinity, suggesting high intrinsic efficacy. <b>MACE2</b> had a poor potency (806 nM), suggesting a poor intrinsic efficacy, although this compound also had the weakest KOR binding affinity. Overall, these results indicate that <b>MACE1</b> is nonselective between the receptors and <b>MACE3</b> has a slight selectivity for MOR/DOR over KOR (∼5-fold), suggesting both ligands will activate MOR and KOR with high efficacy and DOR with low efficacy at therapeutic doses. <b>MACE2</b> on the other hand is moderately selective for the MOR, with a ∼20-fold selectivity against the DOR and ∼100-fold selectivity against the KOR; <b>MACE4</b> is the most potent and selective for MOR. On the basis of these results, <b>MACE4</b> could selectively activate the MOR at therapeutic doses.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Antinociceptive Tests</h3><div class="NLM_p">In the hot plate test, ANOVA with Tukey’s multiple comparisons test revealed that compounds <b>MACE2</b>, <b>MACE3</b>, and <b>MACE4</b> had an antinociceptive efficacy better than the other cyclic analogue <b>MACE1</b> as well as biphalin (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Statistical analysis also revealed that compound <b>MACE4</b> showed high antinociceptive efficacy after iv administration in comparison to the <b>AM94</b> analogue (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). <b>MACE1</b> showed lower antinociceptive efficacy in comparison to the cyclic <i>o</i>-xylene analogue with hydrazine linker (<b>6a</b>) previously described,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> whereas <b>MACE2</b>, <b>MACE3</b>, and <b>MACE4</b> antinociceptive efficacy was similar to that observed after <b>6a</b> administration (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). These differences could be due to the <b>MACE</b> compounds’ selectivity profiles for the opioid receptors described in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>; alternatively, they could be due to discrepancy in BBB penetration or metabolic stability.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects induced by biphalin (B), <b>AM94</b>, <b>6a</b>, and <b>MACE1</b>–<b>4</b> in the hot plate (HP) test in mice. Compounds were administered iv 15 min before the HP test at the dose of 1.5 μmol/kg and in a volume of 5 mL/kg. Naloxone methiodide (NM) was administered ip at the dose of 2.1 μmol/kg or icv at the dose of 5 nmol/mouse 20 min before <b>MACE4</b> was administered iv at the dose of 1.5 μmol/kg. V is for iv vehicle-treated animals. ∗ is for <i>P</i> < 0.05, ∗∗ is for <i>P</i> < 0.01, ∗∗∗ is for <i>P</i> < 0.001, and ∗∗∗∗ is for <i>P</i> < 0.0001 vs B (panel A), AM94 (panel B), <b>6a</b> (panel C), or <b>MACE4</b> (panel D) for ANOVA followed by Tukey’s multiple comparisons test. <i>N</i> = 10 mice/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to investigate the site of <b>MACE4</b> action, we performed some experiments using this compound, which showed strong antinociceptive activity after iv administration in the hot plate test, in the presence of the peripherally restricted opioid antagonist naloxone methiodide. As reported in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, the intraperitoneal (ip) administration of naloxone methiodide performed 20 min before <b>MACE4</b> iv injection was able to significantly inhibit the efficacy of <b>MACE4</b> by reducing its effect below the 25% of the MPE in the hot plate test. In further experiments, naloxone methiodide was administered in the left cerebral ventricle (icv) 20 min before <b>MACE4</b> was administered iv (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). The icv pretreatment with the quaternary antagonist slightly reduced <b>MACE4</b> antinociceptive effects in the hot plate, since it was able to exert a quite comparable antinociceptive activity to that of <b>MACE4</b> administered alone for the first 30 min and from 45 to 60 min. These data may lead to the conclusion that the analgesic effect of <b>MACE4</b> is due to the stimulation of the peripheral opioid receptors rather than the central opioid receptors; this finding is also in agreement with the pharmacokinetic study performed.</div><div class="NLM_p">We also tested the antinociceptive efficacy of our compounds in the formalin test (FT) after sc administration. ANOVA followed by Tukey’s multiple comparisons test revealed that <b>MACE2</b> and <b>MACE4</b> had an antinociceptive effect better than the other cyclic analogues <b>MACE1</b>, <b>6a</b>, and <b>AM94</b> in comparison to biphalin both in the early (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A) and in the late phase (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B) of the FT. As observed in the hot plate test, <b>MACE1</b> showed lower antinociceptive efficacy in comparison to <b>6a</b> in both phases of the FT (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B) and also had lower efficacy than <b>AM94</b> in the late phase of the FT (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects induced by vehicle (V), biphalin (B), <b>AM94</b>, <b>6a</b>, and <b>MACE1</b>–<b>4</b> in the early phase (A) and in the late phase (B) of the FT in mice. Compounds were administered sc 15 min before the formalin at the dose of 0.15 μmol/mouse in a volume of 20 μL/mouse. ∗ is for <i>P</i> < 0.05, ∗∗ is for <i>P</i> < 0.01, ∗∗∗ is for <i>P</i> < 0.001, and ∗∗∗∗ is for <i>P</i> < 0.0001 vs B; °° is for <i>P</i> < 0.01 vs <b>6a</b>; # is for <i>P</i> < 0.05 vs <b>AM94</b> for ANOVA followed by Tukey’s multiple comparisons test. <i>N</i> = 10 mice/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These results are somewhat unexpected since <b>MACE1</b> and <b>MACE3</b> are both cyclic peptides incorporating a piperazine linker; <b>MACE1</b> is less potent then the linear analogue <b>AM94</b> in the HP test after intravenous administration and in the FT after subcutaneous administration, while <b>MACE3</b> containing an <i>o</i>-xylene moiety is more effective than <b>AM94</b> and <b>MACE1</b> in producing analgesia after iv administration, but it is less efficacious than <b>AM94</b> in the formalin test after sc route. Our findings indicate that the influence of the <i>o</i>-xylene linker on the <i>in vivo</i> pharmacological profile of these compounds is more pronounced than that of the piperazine linker commonly shared by <b>MACE1</b>, <b>MACE3</b>, and <b>AM94</b>. This hypothesis is also supported by the <i>in vivo</i> performance of <b>MACE2</b> and <b>MACE4</b>; these novel compounds exert strong antinociception following both sc and iv administration, higher than that of the previous described products, prompting also the possible preference of this class of compounds for the more flexible hydrazine linker present in <b>6a</b><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> over the piperazine one contained in <b>MACE1</b>,<b>3</b> and <b>AM94</b>.</div><div class="NLM_p last">These modifications were intended to improve the overall druggability of opioid peptides derived from biphalin, a goal successfully achieved as suggested by the increased efficacy of <b>MACE4</b> with sc administration (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), while iv administration of <b>6a</b> and <b>MACE2,3</b> demonstrates similar efficacy to <b>MACE4</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Alternatively, the improved efficacy of <b>MACE4</b> in sc formalin pain could be due to the enhanced selectivity of <b>MACE4</b> for the MOR (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). To investigate this effect, the BBB-PAMPA penetration and plasma stability assays for <b>MACE2</b> and <b>MACE4</b> were also carried out.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Blood–Brain Barrier PAMPA</h3><div class="NLM_p">The BBB permeability of <b>AM94</b>, <b>MACE2</b>, and <b>MACE4</b> was examined using the PAMPA (parallel artificial membrane permeability assay) assay (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>). The capability to cross the artificial membranes was interpreted following the literature,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> as Pe > 4.0 = high permeation, Pe < 2.0 = low permeation. <b>MACE2</b> exhibited the best permeability value among the biphalin analogues tested; the Pe value of <b>MACE4</b> was lower than that evaluated in the PAMPA assay of the linear fluorinated biphalin <b>AM94</b> and very close to that of the cyclic peptide Dmt-<i>c</i>[<span class="smallcaps smallerCapital">d</span>-Lys-Phe-p-CF<sub>3</sub>-Phe-Asp]NH<sub>2</sub> (<b>F18</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. BBB Permeability (PAMPA) of <b>MACE</b> Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">BBB permeability Pe (nm/s)</th><th class="colsep0 rowsep0" align="center" char=".">mean (%) mass balance</th><th class="colsep0 rowsep0" align="center">classification</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">verapamil</td><td class="colsep0 rowsep0" align="char" char=".">422.58</td><td class="colsep0 rowsep0" align="char" char=".">95.90</td><td class="colsep0 rowsep0" align="left">high permeation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">theophylline</td><td class="colsep0 rowsep0" align="char" char=".">6.85</td><td class="colsep0 rowsep0" align="char" char=".">94.49</td><td class="colsep0 rowsep0" align="left">low permeation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AM94</b></td><td class="colsep0 rowsep0" align="char" char=".">6.93</td><td class="colsep0 rowsep0" align="char" char=".">98.38</td><td class="colsep0 rowsep0" align="left">low permeation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>MACE2</b></td><td class="colsep0 rowsep0" align="char" char=".">21.57</td><td class="colsep0 rowsep0" align="char" char=".">103.00</td><td class="colsep0 rowsep0" align="left">moderate permeation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>MACE4</b></td><td class="colsep0 rowsep0" align="char" char="."><5.87</td><td class="colsep0 rowsep0" align="char" char=".">97.39</td><td class="colsep0 rowsep0" align="left">low permeation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>F18</b>: Dmt-<i>c</i>[<span class="smallcaps smallerCapital">d</span>-Lys-Phe-p-CF<sub>3</sub>-Phe-Asp]NH<sub>2</sub> <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></td><td class="colsep0 rowsep0" align="char" char="."><5.8</td><td class="colsep0 rowsep0" align="char" char=".">95.75</td><td class="colsep0 rowsep0" align="left">low permeation</td></tr></tbody></table></div></div><div class="NLM_p last">Similar to the previously reported cyclic biphalin-containing disulfide bridge analogues,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the use of a xylene moiety may improve the conformational rigidity of the peptide, resulting in a lowered ability to penetrate the membrane and exposing the hydrophobic surface composed of aromatic side chains of tyrosine and phenylalanine to the aqueous medium.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Plasma Stability</h3><div class="NLM_p">The evaluation of the stability of peptides <b>MACE2</b>,<b>4</b> was carried out by incubating the compound in plasma (human) at a defined starting dilution (i.e., 5 μM) at 37 °C. Degradation curves (for details see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>) were reported in the plot as the total amount of remaining peptide (as %) vs time (minutes), showing a good resistance to degradation for <b>MACE2</b> in human plasma (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Plasma Stability Parameters for <b>MACE2</b>, <b>MACE4</b>, and Reference Compound <b>AM94</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">unit</th><th class="colsep0 rowsep0" align="center"><b>MACE2</b></th><th class="colsep0 rowsep0" align="center"><b>MACE4</b></th><th class="colsep0 rowsep0" align="center"><b>AM94</b></th><th class="colsep0 rowsep0" align="center">eucatropine</th><th class="colsep0 rowsep0" align="center">verapamil</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h</i></td><td class="colsep0 rowsep0" align="left">1/min</td><td class="colsep0 rowsep0" align="left">0.0004</td><td class="colsep0 rowsep0" align="left">0.0005</td><td class="colsep0 rowsep0" align="left">0.0002</td><td class="colsep0 rowsep0" align="left">0.0088</td><td class="colsep0 rowsep0" align="left">0.000019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">min</td><td class="colsep0 rowsep0" align="left">>240</td><td class="colsep0 rowsep0" align="left">>240</td><td class="colsep0 rowsep0" align="left">>240</td><td class="colsep0 rowsep0" align="left">78.66</td><td class="colsep0 rowsep0" align="left">>240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% remaining compd<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">%</td><td class="colsep0 rowsep0" align="left">91.74 ± 2.14</td><td class="colsep0 rowsep0" align="left">88.12 ± 5.51</td><td class="colsep0 rowsep0" align="left">96.06 ± 1.77</td><td class="colsep0 rowsep0" align="left">12.07 ± 0.42</td><td class="colsep0 rowsep0" align="left">99.56 ± 0.07</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Measured at 240 min.</p></div></div></div><div class="NLM_p last">The human plasma half-life (<i>t</i><sub>1/2</sub>) of <b>MACE2</b> and <b>MACE4</b> was calculated by least-squares linear regression analysis of compound amount (area) vs time and was very close to the <b>AM94</b> value (>240 min) (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>). However, the percent of remaining compound in plasma for <b>MACE2,4</b> was lower than that of <b>AM94</b>, suggesting that the linear fluorinated peptide retains the best stability in human plasma. These data indicate that <b>MACE2</b> and <b>MACE4</b> exhibited a significantly long half-life with enhanced plasma stability. These data may partially explain the efficacy of <b>MACE2,4</b> compound after sc administration in mice.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vivo</i> Pharmacokinetics</h3><div class="NLM_p">We determined the concentrations of <b>MACE4</b> in plasma and brain of mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) to directly assess the impact of novel drug features on drug distribution <i>in vivo</i>. Following sc administration at 2.1 mg/kg, the same as for the formalin test above, we quantified plasma (total and free) as well as brain concentrations over a 2 h time course. Pharmacokinetic analysis indicated that maximal plasma concentrations were achieved rapidly (<i>C</i><sub>MAX</sub> = 548 nM; <i>T</i><sub>MAX</sub> = 0.083 h) with a predicted half-life of approximately 30 min (<i>T</i><sub>1/2</sub> = 0.513 h; AUC<sub>INF</sub> = 433 h·nM; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). We also determined a plasma protein binding value of 98.0% based in part on the free plasma concentration curve, which paralleled the total plasma curve with a peak value of ∼10 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Evaluation of the concentration of total drug in the brain revealed low brain exposure (∼5 ng/g) in a subset of samples, with most samples falling below the level of detection, which precluded calculation of pharmacokinetic parameters for the brain. Overall our data show a time course that roughly parallels the iv hot plate time course data (above) with low brain penetration. These observations are consistent with the PAMPA assays and with the naloxone methiodide experiments in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, which suggest that <b>MACE4</b> acts at peripheral sites to produce antinociception. These data also suggest that the structural modifications made in the <b>MACE</b> series have improved <i>in vivo</i> stability vs the earlier biphalin and <b>AM94</b> compounds.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>In vivo</i> pharmacokinetics of <b>MACE4</b> in mice. CD-1 male and female mice (<i>n</i> = 4/group) were administered with 2.1 mg/kg <b>MACE4</b> by the sc route and plasma and brains collected over a 2 h time course. <b>MACE4</b> concentrations were measured by mass spectrometry as explained in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Data are reported as the mean ± SEM. (A) Total plasma concentrations graphed with the resultant pharmacokinetic values noted in the graph. (B) Free plasma concentrations graphed with the plasma protein binding value (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) noted in the graph. (C) Total brain levels (ng/g) shown. Curve had insufficient points to calculate the PK values as for <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Docking</h3><div class="NLM_p">An <i>in silico</i> analysis was conducted to examine and compare the possible interactions of <b>MACE1</b> and <b>MACE4</b> on MOR, DOR, and KOR vs crystallographic reference ligands. The docking of the novel molecules was done on the crystallized receptor–ligand complexes of MOR (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a>), DOR (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a>), and KOR (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH">4DJH</a>) obtained from the RCSB Protein Data Bank and submitted to the Preparation Wizard module present in Maestro 10.2.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> In this preparation step of the crystallographic receptors, several errors in the raw crystal structures have been amended such as the addition of the missing residues, and all the molecules belonging to the crystallization buffer were eliminated from the files, with the only exception for the crystallographic ligand. Also, the water 1303 and water 101 for DOR, 526 and 538 for MOR, and 1303 and 1307 for KOR were kept. The included water molecules have been demonstrated to be essential to form a key water network connection between the crystallographic ligand and the histidine residue also present in the opioid receptors downloaded. Several hydrogen bonds stabilized this network by forming a web of interactions between the hydroxylic phenolic portion of the opioid ligands, the two water molecules, and His297 for MOR, His278 for DOR, and His291 for KOR, respectively. Each water network originally present in the crystal structures was first optimized for the crystallographic ligand by the Interactive H-bond Optimizer interface, featured in the Preparation Wizard application embedded in Maestro 10.2,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and then the PDB file of each crystal structure containing this network was saved and used for the docking of the new ligands <b>MACE1</b> and <b>MACE4</b>. The Interactive H-bond Optimizer interface successfully improved the water molecule orientation by finding the best possible interactions with the histidine and the ligand. This method more precisely defined the presence of the water network in the crystallized structures, since only the heavy atoms are present in the raw PDB files; the final results of the optimization are reported in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. It seems to involve also other surrounding residues like Lys233, Lys214, and Lys227 for MOR, DOR, and KOR, respectively.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Water networks found in the crystallographic complex of (A) MOR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a>), (B) DOR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a>), and (C) KOR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH">4DJH</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After this key preparation step, we proceeded with the docking experiments.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Following a previously established protocol on these targets reported by Schuster et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and by our research team,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the software Gold 6.0 was employed to perform the docking in order to study the new ligands <b>MACE1</b> and <b>MACE4</b>. As a first step, the self-docking experiment was carried out to further validate the docking procedure with GOLD 6.0, using the prepared crystallographic complex MOR/DOR/KOR. Thus, two water molecules bound to the OH phenolic moiety of the crystallographic molecules involving His297 in MOR, His278 in DOR, and His291 in KOR were also considered in the docking parameters configuration instructions of the software. GoldScore was employed as a fitness function to perform the self-docking validation process. The self-docking was set up following the procedure previously reported in the literature.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> The water molecules were fixed to “toggle and spin”; these parameters allow the software to rotate and move the water molecules within 1 Å from the original positions. Then, the docking cavity was defined as a space of 10 Å radius around the crystallographic ligand. Using these settings, the returned acceptable RMSD values are reported in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Validated docking poses superimposed to their crystallographic ones: (A) Bu72, RMSD = 1.04; (B) DIPP-NH<sub>2</sub>, RMSD = 2.05; (C) JDTic, RMSD = 0.34.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following this validation study, Gold 6.0 set with the GoldScore fitness function was employed in the <i>in silico</i> experiments on <b>MACE1</b> and <b>MACE4</b> at the receptors <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a> (DOR), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a> (MOR), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH">4DJH</a> (KOR) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> for <b>MACE4</b> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Figure S9</a> for <b>MACE1</b> reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>).</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Best binding poses of <b>MACE4</b> on MOR (A), DOR (B), KOR (C). Significant H-bond interactions with water molecules and amino acid residues are depicted in yellow dots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Docking Results</h3><div class="NLM_p"><b>MACE1</b> docked on DOR was found to interact with the same relevant key residues present in the crystallographic model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the interactions are highlighted with an asterisk (∗) in the table), specifically to Asp128 with one N-terminus, with the water 101 through the hydroxyl group of tyrosine, with π–π to Trp284 and to Leu200. Also <b>MACE1</b> was able to form further interactions to Trp114 and Arg192 also present in the docking pose of <b>MACE4</b>; however the interactions with Lys214, Phe280, and Trp207 found for <b>MACE4</b> are missing in this model.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Interactions Found for the Best Docked Pose of <b>MACE4</b> and <b>MACE1</b> (∗) (Distance in Å) on MOR, DOR, and KOR</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">interactions of the crystallographic ligands, <b>MACE1</b> (∗), and <b>MACE4</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center"><b>MACE4</b>, <b>MACE1</b> (∗)</th><th class="colsep0 rowsep0" align="center">Lig cryst_k</th><th class="colsep0 rowsep0" align="center">Lig cryst_μ</th><th class="colsep0 rowsep0" align="center">Lig cryst_δ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KOR</td><td class="colsep0 rowsep0" align="left">Asp138</td><td class="colsep0 rowsep0" align="left">2 H-bonds (3.19 and 2.30)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">1 H-bond (2.52)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Trp287</td><td class="colsep0 rowsep0" align="left">π–π (2.05)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tyr139</td><td class="colsep0 rowsep0" align="left">π–π (2.42)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Arg202</td><td class="colsep0 rowsep0" align="left">∗</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Glu297</td><td class="colsep0 rowsep0" align="left">∗</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Phe293</td><td class="colsep0 rowsep0" align="left">∗</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MOR</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (2.15)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Asp147</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (2.67)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond; 1 salt bridge</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tyr326</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (1.48)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Gln124</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (2.04)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Asn127</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (1.62)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tyr148</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π (3.0)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π-cation</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">His319</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π (2.07)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Glu229</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 salt bridge (2.99)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Lys233</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π-cation (2.55)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Trp133</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">∗</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">His297</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">∗</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOR</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (1.30)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Asp128</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (2.32)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Trp207</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">1 H-bond (2.21)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Leu200</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">2 H-bonds</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Phe280</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π (2.95)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Trp284</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π (2.98)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Trp114</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π (3.05) *</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Arg192</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π–π (2.70)*</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Lys214</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">π-cation (3.36)</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="left">/</td></tr></tbody></table></div></div><div class="NLM_p">At MOR, <b>MACE1</b> shares with the crystallographic ligand the key interactions to Asp147 with the N-terminus, to Tyr148 and the water molecule 526. Further interactions have been found with Lys233 (also present for <b>MACE4</b>), Trp133, and His197 which on the contrary are absent in the crystallographic and <b>MACE4</b> poses. Of some relevance is the direct π–π stack to His297 which has been recognized to be involved in the water network discussed above. Interestingly, the 2,6-dimethyl substitution present on the Dmt residue is able to orient the plane of the aromatic ring (the one interacting with the water network) of the side chain parallel to the <i>o</i>-xylene bridge, thus forming a π–π stack between the two aromatic moieties. This intramolecular stabilization could be advantageous to stabilize the correct overall three-dimensional structure of the molecule. It is worth noting that only in the MOR docking pose has this interaction been found.</div><div class="NLM_p"><b>MACE1</b> docked at KOR shows the same relevant key residues present in the crystallographic model <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH">4DJH</a>, specifically Asp138 interacting with one N-terminus, and the water molecule 1303 with the hydroxyl group of tyrosine. <b>MACE1</b> was able to form further interactions with Arg202, Glu297, and Phe293, which are not present in the crystallographic and <b>MACE4</b> poses. On the contrary the two π–π stacks to Trp287 and Tyr139 present in the <b>MACE4</b> pose are missing.</div><div class="NLM_p"><b>MACE4</b> docked on DOR establishes to the receptor cavity with one arm the same relevant interactions of the crystallographic ligand, such as the key interaction with the Asp127, the water network as above-discussed, and a π–π stack to Trp284. Additional interactions are three π–π stacks respectively to Phe280, Trp114, Arg192, and a π–cation interaction with Lys214. The hydrogen bond to Leu200 present in the crystallographic pose is absent here. At the MOR, <b>MACE4</b> binds to the key Asp147 docking water network as well. Also <b>MACE4</b> shares with the crystallographic ligand one π–π interaction to Tyr148. Other relevant hydrogen bonds are present between <b>MACE4</b> and Tyr326, Gln124, Asn127, one π–π stack to His319, one salt bridge to Glu229, and a π–cation interaction to Lys233.</div><div class="NLM_p"><b>MACE4</b> binds at the KOR by establishing two interactions with Asp138 and forming the water network as the crystallographic ligand; two additional π–π stacks are present involving Tyr287 and Tyr139. Both <b>MACE1</b> and <b>MACE4</b> conserve the ability to form the water network and the other typical interaction found in the crystallographic models. In order to better compare the best poses of compounds docked on the three receptors, the method MM-GBSA embedded in Maestro 10.2 was employed to calculate the Δ<i>G</i> free binding energy.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The calculation returned with the free binding energy for <b>MACE1</b> docked to DOR (−93.244 kcal/mol) > MOR (−80.619 kcal/mol) > KOR (−66.732 kcal/mol) and on the other hand the Δ<i>G</i> binding energy for <b>MACE4</b> docked to DOR (−77.360 kcal/mol) > MOR (−74.313 kcal/mol) > KOR (−47.803 kcal/mol). Although these results show the high stability of both compounds at the target receptors, they should be not directly compared with the binding values. However, the Δ<i>G</i> free binding values follow the same pattern of binding affinity rank found by the <i>in vitro</i> assays reported in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, in which <b>MACE1</b> and <b>MACE4</b> have shown a preference for DOR, followed by a similar but lower affinity for MOR and a sensibly less affinity for KOR.</div><div class="NLM_p last">Considering the <i>in vitro</i> relative binding affinities vs G-protein stimulation of <b>MACE4</b>, this novel ligand showed binding affinity following this scale: DOR > MOR > KOR as the MM-GBSA scale. In the <i>in silico</i> experiments, the docking pose on KOR was comparable to the binding results, being less stabilized than those found for DOR and MOR. Also further interactions to Lys233 and Lys214 are present in the best poses of MOR and DOR respectively, and may have a pivotal role in the stimulation of the opioid receptors. However, the relative maximal efficacy followed the order MOR > KOR > DOR; thus this compound should be considered a full agonist at MOR and a partial agonist of DOR and KOR, with some MOR/DOR selectivity vs KOR.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chronic pain treatment still represents an unmet goal for modern medicinal chemistry, as it is often untreated or undermanaged due to a lack of long-term tolerable and efficacious medications. Opiate therapy is one of the most commonly adopted treatments for the management of chronic pain; however, opiates can have limited efficacy in certain pain types and are also accompanied by tolerance, addiction, and other serious drawbacks.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The prolonged use of opioid ligands with peripherally restricted activity for the management of inflammatory pain could be devoid of peripheral tolerance,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> which is an important aspect to be considered in the management of chronic arthritis, neuropathic, postoperative pain, and tumor related pain.</div><div class="NLM_p">In this context it is worthwhile to mention the small molecule DiPOA, a selective μ-opioid receptor agonist administered systemically, that is restricted to the periphery; this small molecule is nonsedating and antihyperalgesic in inflammatory and postsurgical pain states.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In addition, the μ-opioid receptor agonist HS-731 described by Bileviciute-Ljungar et al. is able to induce a long lasting antinociceptive effect after sc and oral administration in a rat model of inflammation, which permits the determination of the primary interaction of this molecule with MOR located at the periphery.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">The scope of our research encompasses the development and discovery of new opioid peptides with strong antinociception after peripheral administration. Our findings suggest that the novel molecule <b>MACE4</b> presented in this work may exert its antinociceptive activity via peripheral sites of action. The attachment of an <i>o</i>-xylene moiety was reported to yield compounds with improved bioavailability, stability, and plasma half-life,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> whereas the use of piperazine linkers together with the pF-phenylalanine in position 4,4′ has been demonstrated to confer κ affinity without loss of affinity toward δ- and μ-receptors. We have optimized the structure of <b>MACE2</b> by using the Dmt residue in place of the native Tyr with the aim to control the tyrosine side chain’s rotation. The interaction of <b>MACE4</b> with MOR was improved by dimethylation of the phenol ring, probably through a proper orientation of the tyrosine aromatic ring driven by the methyl groups,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> as demonstrated by molecular modeling studies in which, as discussed above, the aromatic ring of Dmt is able to form an intramolecular π–π stack to the <i>o</i>-xylene bridge in the MOR best pose.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">The new analogue <b>MACE4</b> possesses an improved KOR affinity in respect to <b>MACE2</b> and subnanomolar activity at MOR. Its ability to bind to multiple opioid receptors with good affinity could be a desirable feature, since the selective μ-opioid receptor agonist DAMGO produces respiratory depression and constipation. Highly selective KOR agonists reported in literature induce more side effects than some mixed KOR/MOR agonists,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and the mixed MOR-agonist/DOR-antagonist MDAN-21 is 50 times more potent than morphine.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, the strategy to develop nonselective analogues as new analgesics may lead to compounds that maintain a more favorable profile.</div><div class="NLM_p last">The novel designed entities <b>MACE2</b>, <b>MACE3</b>, and <b>MACE4</b> show enhanced antinociceptive effects in hot plate and formalin pain states after peripheral administration in comparison to biphalin and the established analogues like <b>AM94</b>. This enhanced antinociception could be due to the selectivity profiles of these compounds vs the nonselective <b>MACE1</b>; alternatively, compounds <b>MACE2</b>, <b>MACE4</b>, and <b>AM94</b> showed scarce BBB penetration properties, measured by a BBB-PAMPA model with an excellent plasma stability which may provide for a better, longer lasting analgesic effect. These results were confirmed and extended for <b>MACE4</b> in a pharmacokinetic study in mice, suggesting that <b>MACE4</b> preferentially stimulates peripheral opioid receptors. Indeed, <b>MACE4</b> injected by the iv route was tested in the hot plate test, following pretreatment with naloxone methiodide (NM), which cannot cross the blood–brain barrier, administered by ip or by icv. The test clearly showed that NM was able to substantially revert the antinociceptive effect of <b>MACE4</b> only if administered peripherally, thus demonstrating that this compound is able to act by stimulating the peripheral opioid receptors. This is also consistent with the low BBB passage found in the PAMPA study and supported by the low concentration of the peptide detected in the brain after ip administration in the PK study. Overall the combined approaches used in the design of these novel compounds conferred high efficacy and antinociceptive properties after peripheral administration.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedures</h3><div class="NLM_p">The synthesis of the novel cyclic peptides was performed by standard solution phase coupling/deprotection procedures (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref10 ref15'); return false;" href="javascript:void(0);" class="ref ref10 ref15">(10,15)</a> Starting products <b>1a</b>,<b>b</b> have been previously described in literature.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The reference compounds <b>AM94</b> and <b>6a</b> were prepared for biological purposes following the procedures reported by our research group.<a onclick="showRef(event, 'ref5 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref10">(5,10)</a> Purification of the final products <b>MACE1</b>–<b>4</b> was accomplished by reverse phase HPLC using a Waters XBridgeTM Prep BEH C18, 130 Å, 5.0 μm, i.d. 19 mm × 250 mm length, 19 mm × 10 mm column, HPLC solvent A, 0.1% TFA in water; solvent B, ACN; gradient 5–95% B in A over 32 min, flow rate 7.0 mL/min. The identity of <i>N</i><sup>α</sup>-Boc-protected and Fmoc-protected intermediates was tested by LRMS and <sup>1</sup>H NMR analysis (for further details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>). The purity and the retention time (<i>t</i><sub>R</sub>) of the final TFA salts were assessed by analytical RP-HPLC (C18-bonded 4.6 mm × 150 mm); flow rate of 1 mL·min<sup>–1</sup>; gradient of H<sub>2</sub>O/ACN 0.1% TFA ranging from 10% ACN to 90% ACN in 32 min, ≥95% purity (UV detection at 214 nm). The cyclic peptides <b>MACE1</b>–<b>4</b> were obtained as trifluoracetic acid salts in good overall yield and ≥95% purity following RP-HPLC purification.</div><div class="NLM_p">For peptides <b>MACE1</b>–<b>3</b>, RP-UPLC (C18-bonded 4.6 mm × 150 mm) analysis has also been performed, using the following parameters: flow rate of 1 mL·min<sup>–1</sup>; linear gradient of Water/ACN 0.1% TFA starting from 10% ACN to 90% ACN in 20 min (λ 214 nm).</div><div class="NLM_p last">The final structures were confirmed by <sup>1</sup>H/<sup>13</sup>C NMR spectra (Varian Mercury 300 MHz) and mass spectrometry ESI-HRMS (for details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (Boc-<span class="smallcaps smallerCapital">d</span>-Cys(ACM)-Gly-pF-Phe)<sub>2</sub>-hydrazine (<b>2a</b>)</h3><div class="NLM_p last">The intermediate <b>2a</b> was prepared starting from BocGly-pFPhe-NHNH-pFPhe-GlyBoc (0.36 g, 0.53 mmol), after removal of the <i>N</i><sup>α</sup>-Boc protecting group, following the standard procedure of coupling reaction/deprotection in solution (71% yield, for further details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>). <i>R</i><sub><i>f</i></sub> = 0.12 (AcOEt/CH<sub>3</sub>OH 9:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.21 (d, 2H, N<i>H</i>-N<i>H</i>), 8.49 (t, 2H, Acm N<i>H</i>), 8.21 (d, 2H, Phe N<i>H</i>), 7.93 (t, 2H, Gly N<i>H</i>), 7.29–7.01 (m, 8H, aromatics), 6.97 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 4.57 (m, 2H, Phe α-CH), 4.22 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.99–3.73 (dd, 4H, Acm CH<sub>2</sub>), 3.75–3.55 (m, 4H, Gly α-CH), 3.02–2.55 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 1.79 (s, 6H, Acm 2 × CH<sub>3</sub>), 1.35 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>44</sub>H<sub>62</sub>F<sub>2</sub>N<sub>10</sub>O<sub>12</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1024.4; found 1025.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (Boc-<span class="smallcaps smallerCapital">d</span>-Cys(ACM)-Gly-pF-Phe)<sub>2</sub>-piperazine (<b>2b</b>)</h3><div class="NLM_p last">Intermediate <b>2b</b> was obtained after removal of the <i>N</i><sup>α</sup>-Boc protecting group and coupling reaction with Boc-<span class="smallcaps smallerCapital">d</span>-Cys(ACM)-OH, following the procedures reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a> (78% yield); <i>R</i><sub><i>f</i></sub> = 0.16 (AcOEt/CH<sub>3</sub>OH 9:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.46 (t, 2H, Acm N<i>H</i>), 8.25 (d, 2H, Phe N<i>H</i>), 8.01 (t, 2H, Gly N<i>H</i>), 7.21–7.05 (m, 8H, aromatics), 6.95 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 4.87 (m, 2H, Phe α-CH), 4.28–4.15 (m, 4H, Acm CH<sub>2</sub> + 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.74–3.54 (m, 4H, Gly α-CH), 3.42–3.11 (m, 8H, -CH<sub>2</sub>-CH<sub>2</sub>-), 2.92–2.56 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 1.81 (s, 6H, Acm 2 × CH<sub>3</sub>), 1.35 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>48</sub>H<sub>68</sub>F<sub>2</sub>N<sub>10</sub>O<sub>12</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1078.4; found 1079.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>c</i>(Boc-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-hydrazine (<b>3a</b>)</h3><div class="NLM_p last">The cyclic intermediate <b>3a</b> was obtained in 72% yield after reaction workup, following the procedure reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>. <i>R</i><sub><i>f</i></sub> = 0.74 (EtOAc/MeOH 9.5:0.5). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.02 (d, 2H, N<i>H</i>-N<i>H</i>), 8.51 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 7.76 (d, 2H, Phe N<i>H</i>), 7.18 (t, 2H, Gly N<i>H</i>), 7.16–7.02 (m, 8H, aromatics), 4.54 (m, 2H, Phe α-CH), 4.21 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.92–3.87 (m, 4H, Gly α-CH), 3.02–2.71 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 1.35 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>38</sub>H<sub>50</sub>F<sub>2</sub>N<sub>8</sub>O<sub>10</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 880.3; found 903.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>c</i>(Boc-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-piperazine (<b>3b</b>)</h3><div class="NLM_p last">Intermediate <b>3b</b> was synthesized starting from <b>2b</b>, following the procedure reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>; the desired product was obtained in 57% yield, after reaction workup. <i>R</i><sub><i>f</i></sub> = 0.8 (EtOAc/MeOH 9.5:0.5). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.28 (d, 2H, Phe N<i>H</i>), 8.06 (t, 2H, Gly N<i>H</i>), 7.23–7.01 (m, 8H, aromatics +2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 4.84 (m, 2H, Phe α-CH), 4.16 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.74–3.54 (m, 4H, Gly α-CH), 3.46–3.13 (m, 8H, -CH<sub>2</sub>-CH<sub>2</sub>-), 2.92–2.56 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 1.36 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>42</sub>H<sub>56</sub>F<sub>2</sub>N<sub>8</sub>O<sub>10</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 934.3; found 957.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>c</i>(Boc-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-hydrazine <i>o</i>-Xylene (<b>4a</b>)</h3><div class="NLM_p last">Cyclic peptide <b>4a</b> was prepared following the procedure described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>; the desired compound was obtained in 92% yield after reaction workup, as a crude solid product. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.31 (d, 2H, N<i>H</i>-N<i>H</i>), 8.44 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 8.11 (d, 2H, Phe N<i>H</i>), 6.98 (t, 2H, Gly N<i>H</i>), 7.24–7.02 (m, 12H, aromatics), 4.68 (m, 2H, Phe α-CH), 4.34 (d, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.87–2.84 (m, 4H, Gly α-CH), 3.02–2.71 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 2.52–2.39 (s, 4H, 2 × CH<sub>2</sub>), 1.35 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>46</sub>H<sub>58</sub>F<sub>2</sub>N<sub>8</sub>O<sub>10</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 984.3; found 1007.5 [M + Na]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>c</i>(Boc-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-piperazine <i>o-</i>Xylene (<b>4b</b>)</h3><div class="NLM_p last">Cyclic peptide <b>4b</b> was prepared following the same reaction procedure described above (for further details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>), the final compound was obtained in 90% yield after reaction workup, as a crude solid product. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.33 (d, 2H, Phe N<i>H</i>), 7.65 (t, 2H, Gly N<i>H</i>), 7.49–7.04 (m, 12H, aromatics + 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 4.84 (m, 2H, Phe α-CH), 4.22 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.81–3.61 (m, 4H, Gly α-CH), 3.47–3.15 (m, 8H, -CH<sub>2</sub>-CH<sub>2</sub>-), 2.98–2.69 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 2.47 (s, 4H, 2 × CH<sub>2</sub>), 1.36 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>50</sub>H<sub>64</sub>F<sub>2</sub>N<sub>8</sub>O<sub>10</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1038.4; found 1061.6 [M + Na]<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>c</i>(BocTyr-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-hydrazine <i>o</i>-Xylene (<b>5a</b>)</h3><div class="NLM_p last">Intermediate <b>4a</b> was deprotected by treatment with TFA/DCM mixture at rt and coupled with Boc-Tyr-OH following the procedure reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>. The final compound <b>5a</b> was obtained in 88% yield after reaction workup, as a pure white solid. <i>R</i><sub><i>f</i></sub> = 0.12 (AcOEt/CH<sub>3</sub>OH 9:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.26 (d, 2H, N<i>H</i>-N<i>H</i>), 9.13 (s, 2H, Tyr OH), 8.76 (br, 2H, <span class="smallcaps smallerCapital">d</span>-Cys NH), 8.42 (br, 2H, Tyr NH), 8.28 (d, 2H, Phe N<i>H</i>), 8.06 (t, 2H, Gly N<i>H</i>), 7.23–7.01 (m, 12H, aromatics), 6.77–6.59 (dd, 8H, Tyr aromatics), 4.81–4.66 (m, 2H, Phe α-CH + m, 2H, Tyr α-CH), 4.11 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.43–3.26 (m, 4H, Gly α-CH), 3.08–2.79 (m, 4H, Tyr β-CH<sub>2</sub>), 2.82–2.41 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 2.47 (s, 4H, 2 × CH<sub>2</sub>), 1.35 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>64</sub>H<sub>76</sub>F<sub>2</sub>N<sub>10</sub>O<sub>14</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1310.5; found 1333.7 [M + Na]<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>c</i>(BocTyr-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-piperazine <i>o</i>-Xylene (<b>5b</b>)</h3><div class="NLM_p last">Intermediate <b>4b</b> was deprotected by treatment with TFA/DCM mixture at rt, then coupled to Boc-Tyr-OH following the procedure reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>. The final cyclic peptide <b>5b</b> was obtained in 94% yield after reaction workup, as a pure white solid. <i>R</i><sub><i>f</i></sub> = 0.16 (AcOEt/CH<sub>3</sub>OH 9:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.13 (s, 2H, Tyr OH), 8.56 (br, 2H, <span class="smallcaps smallerCapital">d</span>-Cys NH), 8.42 (br, 2H, Tyr N<i>H</i>), 8.30 (d, 2H, Phe N<i>H</i>), 8.21 (t, 2H, Gly N<i>H</i>), 7.38–6.96 (m, 12H, aromatics), 6.71–6.59 (dd, 8H, Tyr aromatics), 4.88 (m, 2H, Phe α-CH), 4.48 (m, 2H, Tyr α-CH), 4.16 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 4.08–3.76 (m, 4H, Tyr β-CH<sub>2</sub>), 3.81–3.61 (m, 4H, Gly α-CH), 3.47–3.15 (m, 8H, -CH<sub>2</sub>-CH<sub>2</sub>-), 3.12–2.76 (m, 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 2.47 (s, 4H, 2 × CH<sub>2</sub>), 1.35 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>68</sub>H<sub>82</sub>F<sub>2</sub>N<sub>10</sub>O<sub>14</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1364.5; found 1387.7 [M + Na]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>c</i>(Fmoc-Dmt-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-hydrazine <i>o</i>-Xylene (<b>5c</b>)</h3><div class="NLM_p last">The <i>N</i><sup>α</sup>-Boc protecting group was removed from intermediate compound <b>4a</b> and coupled to Fmoc-Dmt-OH as reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>. The final product <b>5c</b> was obtained in 88% yield after reaction workup, as a pure white solid. <i>R</i><sub><i>f</i></sub> = 0.15 (AcOEt/CH<sub>3</sub>OH 9:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.23 (d, 2H, N<i>H</i>-N<i>H</i>), 8.90 (s, 2H, Dmt OH), 8.77 (br, 2H, <span class="smallcaps smallerCapital">d</span>-Cys NH), 8.10 (d, 2H, Dmt NH), 7.99 (d, 2H, Phe N<i>H</i>), 7.87–7.84 (d, 4H, Phe aromatics), 7.65 (t, 4H, Dmt aromatics), 7.40–6.96 (m, 20H, Fmoc aromatics, <i>o</i>-xylene aromatics), 6.31 (s, 4H, 2 × CH<sub>2</sub>), 4.72 (m, 2H, Phe α-CH + m, 2H, Dmt α-CH), 4.15 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.87 (dd, 4H, Gly α-CH), 3.07–2.54 (m, 8H, Dmt β-CH<sub>2</sub>, Phe β-CH<sub>2</sub>), 2.41–2.06 (m, 20H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>, Fmoc -CH<sub>2</sub>-, 4 × CH<sub>3</sub>). LRMS calcd for C<sub>88</sub>H<sub>88</sub>F<sub>2</sub>N<sub>10</sub>O<sub>14</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1610.5; found 1611.6 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>c</i>(BocTyr-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-piperazine (<b>6</b>)</h3><div class="NLM_p last">The desired peptide <b>6</b> was obtained after removal of the <i>N</i><sup>α</sup>-Boc protecting group and Boc-Tyr-OH coupling reaction (for further details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>), with 76% yield after standard workup, as a crude white product. <i>R</i><sub><i>f</i></sub> = 0.20 (AcOEt/MeOH 9:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.12 (s, 2H, Tyr OH), 8.34 (d, 2H, Phe N<i>H</i>), 8.06 (t, 2H, Gly N<i>H</i>), 7.21–6.58 (m, 16H, aromatics +2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 4.85 (m, 2H, Phe α-CH), 4.55 (m, 2H, Tyr α-CH), 4.03 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.76–3.54 (m, 4H, Gly α-CH), 3.48–3.26 (m, 8H, -CH<sub>2</sub>-CH<sub>2</sub>-), 2.87–2.41 (m, 8H, Phe, Tyr β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 1.34 (s, 18H, 2 × (CH<sub>3</sub>)<sub>3</sub>-). LRMS calcd for C<sub>60</sub>H<sub>74</sub>F<sub>2</sub>N<sub>10</sub>O<sub>14</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1260.4; found 1261.3 [M + H]<sup>+</sup>.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2TFA·<i>c</i>(Tyr-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-piperazine (<b>MACE1</b>)</h3><div class="NLM_p last"><i>N</i><sup>α</sup>-Boc protecting group of <b>6</b> was removed by treatment with TFA/DCM = 1:1 mixture at rt for 1.5 h; the crude product was purified on RP-HPLC to afford <b>MACE1</b> in 68% overall yield. <i>t</i><sub>R</sub> (UPLC) = 4.48 min. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.33 (s, 2H, Tyr OH), 8.92 (d, <i>J</i> = 8.1 Hz, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 8.73 (br, 6H, Tyr NH<sub>3</sub><sup><i>+</i></sup>), 8.53 (br, 2H, Phe N<i>H</i>), 8.18 (t, 2H, Gly N<i>H</i>), 7.22–7.01 (m, 12H, Phe, TyrArH), 6.66 (d, <i>J</i> = 8.4 Hz, 4H, TyrArH), 4.85 (q, <i>J</i> = 6.9 Hz, 2H, Phe α-CH), 4.72 (m, 2H, Tyr α-CH), 3.89 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH), 3.76–3.54 (m, 4H, Gly α-CH), 3.48–3.26 (m, 8H, -CH<sub>2</sub>-CH<sub>2</sub>-), 2.88–2.45 (m, 8H, Phe, Tyr β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>). <sup>13</sup>C NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 36.60, 37.04, 38.29, 41.89, 42.99, 44.99, 49.84, 51.41, 54.46, 115.05, 115.32, 115.79, 125.10, 131.01, 131.66, 131.77, 133.90, 157.06, 158.60, 159.03, 159.85, 168.24, 169.07, 169.52, 170.81. HRMS calcd for C<sub>50</sub>H<sub>58</sub>N<sub>10</sub>O<sub>10</sub>S<sub>2</sub>F<sub>2</sub> (<i>m</i>/<i>z</i>): 1061.3825; found 1061.3788.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2TFA·<i>c</i>(Tyr-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-hydrazine <i>o</i>-Xylene (<b>MACE2</b>)</h3><div class="NLM_p last">The Boc-protected peptide <b>5a</b> was treated with a mixture of TFA/DCM = 1:1 at rt for 1.5 h. The desired final product <b>MACE2</b> was obtained in 80% overall yield after RP-HPLC purification. <i>t</i><sub>R</sub> (UPLC) = 4.22 min. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.30 (d, 2H, N<i>H</i>-N<i>H</i>), 9.36 (s, 2H, Tyr OH), 8.93 (t, 2H, Gly N<i>H</i>), 8.83 (d, <i>J</i> = 8.4 Hz, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 8.16 (br, 6H, Tyr NH<sub>3</sub><sup>+</sup>), 8.06 (d, <i>J</i> = 9.3 Hz, 2H, Phe N<i>H</i>), 7.32–6.98 (m, 16H, PheArH, TyrArH and xylene ArH), 6.59 (d, <i>J</i> = 8.7 Hz, 4H, TyrArH), 4.81–4.66 (q, <i>J</i> = 6.9 Hz, 2H, Phe α-CH + m, <i>J</i> = 4.2 Hz, 2H, Tyr α-CH), 3.99–3.86 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH + 4H, Gly α-CH), 3.09–2.64 (m, 8H, Tyr β-CH<sub>2</sub> + Phe β-CH<sub>2</sub>), 2.48 (s, 4H, 2 × CH<sub>2</sub>), 2.28 (m, 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>). <sup>13</sup>C NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 31.40, 32.78, 36.91, 38.07, 42.80, 51.33, 52.73, 53.83, 115.01, 115.29, 115.62, 125.07, 127.46, 130.90, 131.02, 131.54, 131.64, 133.85 133.89, 136.94, 156.96, 159.86, 163.07, 168.25, 168.30, 169.66, 170.32. HRMS calcd for C<sub>54</sub>H<sub>60</sub>N<sub>10</sub>O<sub>10</sub>S<sub>2</sub>F<sub>2</sub> (<i>m</i>/<i>z</i>): 1111.3982; found 1111.4036.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2TFA·<i>c</i>(Tyr-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-piperazine <i>o</i>-Xylene (<b>MACE3</b>)</h3><div class="NLM_p last">Product <b>5b</b> was deprotected with a cocktail of TFA/DCM = 1:1 at rt for 1.5 h; after reaction workup, the crude product was purified on RP-HPLC to afford <b>MACE3</b> in 80% overall yield. <i>t</i><sub>R</sub> (UPLC) = 4.66 min. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.13 (s, 2H, Tyr OH), 8.77 (d, <i>J</i> = 8.1 Hz, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 8.64 (t, 2H, Gly N<i>H</i>), 8.43 (d, <i>J</i> = 7.5 Hz, 2H, Phe N<i>H</i>), 8.08 (br, 6H, Tyr NH<sub>3</sub><sup>+</sup>), 8.08–6.67 (m, 10H, Phe, Tyr and xylene ArH), 6.63 (d, <i>J</i> = 8.4 Hz, 4H, Tyr aromatics), 4.87 (m, 2H, Phe α-CH), 4.73 (q, 2H, Tyr α-CH), 3.96–3.78 (m, 4H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH + Gly α-CH), 3.44–2.74 (m, 4H, Tyr β-CH2 + 8H, -CH<sub>2</sub>-CH<sub>2</sub>- + 4H, Phe β-CH<sub>2</sub> + 4H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 2.48 (s, 4H, 2 × CH<sub>2</sub>). <sup>13</sup>C NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 32.31, 33.87, 37.00, 42.11, 42.24, 45.16, 50.15, 51.67, 54.01, 115.05, 115.34, 115.69, 125.13, 127.49, 130.85, 130.99, 131.72, 131.83, 133.70, 136.72, 156.98, 158.28, 158.71, 159.90, 163.10, 168.12, 168.43, 169.66, 170.21. HRMS calcd for C<sub>58</sub>H<sub>66</sub>N<sub>10</sub>O<sub>10</sub>S<sub>2</sub>F<sub>2</sub> (<i>m</i>/<i>z</i>): 1165.4451; found 1165.4421.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2TFA·<i>c</i>(Dmt-<span class="smallcaps smallerCapital">d</span>-Cys-Gly-pF-Phe)<sub>2</sub>-hydrazine <i>o</i>-Xylene (<b>MACE4</b>)</h3><div class="NLM_p last">Product <b>5c</b> was deprotected with a mixture of piperidine 20% in DMF at rt for 1.5 h. The reaction mixture was treated with TFA for 15 min, then it was evaporated in rotavapor washing with DCM repetitively. The crude product was purified by RP-HPLC to afford pure <b>MACE4</b> in 64% overall yield. <i>t</i><sub>R</sub> (HPLC) = 15.83 min. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.21 (d, 2H, N<i>H</i>-N<i>H</i>), 9.08 (s, 2H, Dmt OH), 8.54 (d, <i>J</i> = 7.8 Hz, 2H, <span class="smallcaps smallerCapital">d</span>-Cys N<i>H</i>), 8.42 (br, 6H, Dmt NH<sub>3</sub><sup>+</sup>), 7.92 (d, <i>J</i> = 9.3 Hz, 2H, Phe N<i>H</i>), 7.36 (d, 2H, Dmt aromatics), 7.27 (d, 2H, Dmt aromatics), 7.14 (t, 4H, PheArH), 6.95 (t, 4H, PheArH), 6.34 (s, 4H, 2 × CH<sub>2</sub>), 4.79–4.71 (m, 4H, Phe α-CH + Dmt α-CH), 3.98–3.79 (m, 7H, <span class="smallcaps smallerCapital">d</span>-Cys α-CH, Gly α-CH, Dmt β-CH), 3.09–3.01 (m, 5H, Dmt β-CH, Phe β-CH<sub>2</sub>), 2.83 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>) 2.61 (m, 2H, <span class="smallcaps smallerCapital">d</span>-Cys β-CH<sub>2</sub>), 2.14 (s, 12H, 4 × CH<sub>3</sub>). <sup>13</sup>C NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 20.60, 30.72, 30.97, 31.25, 38,32, 43.05, 51.53, 52.59, 114.93, 115.20, 122.36, 127.45, 131.05, 131.55, 131.65, 133.80, 133.84, 137.06, 138.80, 156.16, 158.36, 158.80, 159.82, 163.02, 168.10, 168.82, 169.93, 170.14. HRMS calcd for C<sub>58</sub>H<sub>68</sub>F<sub>2</sub>N<sub>10</sub>O<sub>10</sub>S<sub>2</sub> (<i>m</i>/<i>z</i>): 1167.4608; found 1167.4645.</div></div><div id="sec4_15_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>In Vitro</i> Analysis. Cell Lines and Cell Culture</h3><div class="NLM_p last">The details for cell lines and culture preparation, previously reported by Stefanucci et al.,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_15_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Competition Radioligand Binding</h3><div class="NLM_p last">The binding assay procedure has been previously described by Stefanucci et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_15_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <sup>35</sup>S-GTPγS Coupling Assay</h3><div class="NLM_p last">The GTPγS assay procedure was previously described by Stefanucci et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and reported in detail in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_16_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Nociception Tests. Animals and Ethical Statement</h3><div class="NLM_p last">Animals were managed according to the research protocol and the ARRIVE guidelines (for details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a></div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Hot Plate Test</h3><div class="NLM_p last">The HP test equipment and procedure are reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_16_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Formalin Test (FT)</h3><div class="NLM_p last">The formalin test was conducted on mice after sc administration to evaluate nociceptive behavioral effects;<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> for details see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_16_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Data Analysis and Statistics</h3><div class="NLM_p last">The data and statistical analysis have been performed according to the guidelines in pharmacology.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Experimental data were expressed as the mean ± sem. Area under the time–effect curve was calculated using GraphPad Prism 6.03 software. Significant differences among the groups were evaluated with an analysis of variance (ANOVA) followed by Tukey’s post hoc comparison using GraphPad Prism 6.03 software. Statistical significance was set at <i>P</i> < 0.05.</div></div><div id="sec4_16_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> PAMPA Assay Method</h3><div class="NLM_p last">The working solutions have been prepared as donor and acceptor solutions of <b>MACE2</b>,<b>4</b> and reference compounds following the procedure reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_16_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Plasma Stability Method</h3><div class="NLM_p last">Plasma stability of <b>MACE2</b>,<b>4</b> and <b>AM94</b> was evaluated at well-defined concentrations following the procedure described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_16_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>In Vivo</i> Pharmacokinetics</h3><div class="NLM_p last">Male and female CD-1 mice, 4–6 weeks old in age-matched cohorts, were dosed by the sc route at 2.1 mg/kg with <b>MACE4</b>, and plasma and brains were collected over a 2 h time course. The animals were euthanized by rapid cervical dislocation. Blood was collected by a heart stick with a tuberculin syringe and 30g needle; whole blood was collected into EDTA-treated plasma tubes and plasma collected by centrifugation, followed by snap freezing in liquid nitrogen. Whole brains were dissected out, rinsed with saline, and snap frozen on liquid nitrogen. The tissue was processed, and <b>MACE4</b> was measured using LC/MS/MS with an Agilent 1200 and Agilent 6460 as described by McLane et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Noncompartmental analysis of total plasma concentrations was used to calculate PK parameters, and plasma protein binding was also determined.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec4_17_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Molecular Modeling. Protein Preparation</h3><div class="NLM_p last">The X-ray structure of μ-receptor cocrystallized with Bu72 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a>);<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> the X-ray structure of δ-receptor cocrystallized with H-Dmt-Tic-Phe-Phe-NH<sub>2</sub> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a>);<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> the X-ray structure of the κ-receptor cocrystallized with JDTic (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH">4DJH</a>) were taken online from the RCSB Protein Data Base.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The receptors were prepared for molecular docking by separating the crystallographic ligand from the other small molecules eventually found in the PDB files. Then the proteins were processed with the Protein Wizard Preparation suite embedded in Maestro 10.2, which fixes automatically all the errors in the crystal, and also a minimization of the hydrogens was achieved by OPLS-3 force field.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> After the optimization of the water network in each crystal structure, the receptors were separated from the respective ligand and used for docking. The proteins were submitted to molecular modeling without any further modifications. Ligand preparation and molecular docking calculations were performed following the procedures reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">Supporting Information</a>.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39−42)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01963" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01963?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01963</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR spectra of final compounds, analytical RP-HPLC traces, UPLC traces, HRMS, plasma stability curves, BBB-PAMPA procedure (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_008.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_001.pdb">jm9b01963_si_001.pdb (360.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_002.pdb">jm9b01963_si_002.pdb (352.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_003.pdb">jm9b01963_si_003.pdb (362.59 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_004.pdb">jm9b01963_si_004.pdb (356.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_005.pdb">jm9b01963_si_005.pdb (355.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_006.pdb">jm9b01963_si_006.pdb (363.01 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf">jm9b01963_si_007.pdf (1.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_008.csv">jm9b01963_si_008.csv (2.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01963" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Azzurra Stefanucci</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Chieti-Pescara
“G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7525-2913" title="Orcid link">http://orcid.org/0000-0001-7525-2913</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e687c89592838087889385858fa693888f858ec88f92"><span class="__cf_email__" data-cfemail="89e8a7fafdecefe8e7fceaeae0c9fce7e0eae1a7e0fd">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adriano Mollica</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Chieti-Pescara
“G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7242-4860" title="Orcid link">http://orcid.org/0000-0002-7242-4860</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dcbdf2b1b3b0b0b5bfbd9ca9b2b5bfb4f2b5a8"><span class="__cf_email__" data-cfemail="35541b585a59595c565475405b5c565d1b5c41">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marilisa Pia Dimmito</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Chieti-Pescara
“G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgia Macedonio</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Chieti-Pescara
“G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Ciarlo</span> - <span class="hlFld-Affiliation affiliation">Istituto
Superiore di Sanità, Centro Nazionale Ricerca e Valutazione
Preclinica e Clinica dei Farmaci, Viale Regina Elena 299, 00161 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Pieretti</span> - <span class="hlFld-Affiliation affiliation">Istituto
Superiore di Sanità, Centro Nazionale Ricerca e Valutazione
Preclinica e Clinica dei Farmaci, Viale Regina Elena 299, 00161 Rome, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5926-6194" title="Orcid link">http://orcid.org/0000-0001-5926-6194</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ettore Novellino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Napoli
“Federico II”, Via D. Montesano, 49, 80131 Naples, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2181-2142" title="Orcid link">http://orcid.org/0000-0002-2181-2142</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Lei</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, College of Medicine, University
of Arizona, Tucson, Arizona 85724, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Barlow</span> - <span class="hlFld-Affiliation affiliation">Department
of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, Maine 04005, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen L. Houseknecht</span> - <span class="hlFld-Affiliation affiliation">Department
of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, Maine 04005, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Streicher</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, College of Medicine, University
of Arizona, Tucson, Arizona 85724, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4173-7362" title="Orcid link">http://orcid.org/0000-0002-4173-7362</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors contributed to the writing of the manuscript and gave approval to the final version.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The <i>in vitro</i> analysis was carried out using institutional funds from the University of Arizona. We thank Gabriela Molnar of the University of Arizona for considerable technical assistance in the performance of the <i>in vitro</i> assays.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">MOR</td><td class="NLM_def"><p class="first last">μ-opioid receptor</p></td></tr><tr><td class="NLM_term">DOR</td><td class="NLM_def"><p class="first last">δ-opioid receptor</p></td></tr><tr><td class="NLM_term">KOR</td><td class="NLM_def"><p class="first last">κ-opioid receptor</p></td></tr><tr><td class="NLM_term">CLIPS</td><td class="NLM_def"><p class="first last">chemical linkage of peptides onto scaffolds</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">ACM</td><td class="NLM_def"><p class="first last">acetamidomethyl</p></td></tr><tr><td class="NLM_term">DAMGO</td><td class="NLM_def"><p class="first last">[DAla(2), N-Me-Phe-(4), Gly-ol(5)] enkephalin</p></td></tr><tr><td class="NLM_term">DPDPE</td><td class="NLM_def"><p class="first last">D-Pen2,D-Pen5-enkephalin</p></td></tr><tr><td class="NLM_term">Dmt</td><td class="NLM_def"><p class="first last">2,6-dimethyl-<span class="smallcaps smallerCapital">l</span>-tyrosine</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">icv</td><td class="NLM_def"><p class="first last">intracerebroventricular</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">D-Pen</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-penicillamine</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">i.t.</td><td class="NLM_def"><p class="first last">intrathecal</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethilendiamine</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">JDTic</td><td class="NLM_def"><p class="first last">(3<i>R</i>)-1,2,3,4-tetrahydro-7-hydroxy-<i>N</i>-[(1<i>S</i>)-1-[[(3<i>R</i>,4<i>R</i>)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reversed phase high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">FT</td><td class="NLM_def"><p class="first last">formalin test</p></td></tr><tr><td class="NLM_term">HP</td><td class="NLM_def"><p class="first last">hot plate</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">NM</td><td class="NLM_def"><p class="first last">naloxone methiodide</p></td></tr><tr><td class="NLM_term">MM-GBSA</td><td class="NLM_def"><p class="first last">molecular mechanics Poisson–Boltzmann surface area</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">RMSD</td><td class="NLM_def"><p class="first last">root-mean-square deviation</p></td></tr><tr><td class="NLM_term">DIPP-NH<sub>2</sub></td><td class="NLM_def"><p class="first last">H-Dmt-Ticψ[CH<sub>2</sub>-NH]Phe-Phe-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">GI</td><td class="NLM_def"><p class="first last">gastrointestinal</p></td></tr><tr><td class="NLM_term">DMEM/F12</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium/nutrient mixture F-12</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">PPBL</td><td class="NLM_def"><p class="first last">permeability of the aqueous boundary layer around a dissolving drug particle</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darnell, L.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic interventions for pain management</span>. <i>Crit Care Nurs Clin North Am.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1016/j.cnc.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2Fj.cnc.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=29107306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BC1M7otFyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2017&pages=427-447&author=F.+C.+Farrarauthor=D.+Whiteauthor=L.+Darnell&title=Pharmacologic+interventions+for+pain+management&doi=10.1016%2Fj.cnc.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Interventions for Pain Management</span></div><div class="casAuthors">Farrar Francisca Cisneros; White Danielle; Darnell Linda</div><div class="citationInfo"><span class="NLM_cas:title">Critical care nursing clinics of North America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">427-447</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Serious life-threatening respiratory depression may occur with pharmacologic pain intervention.  The nurse has an ethical and legal duty to provide safe, quality, and accountable pain management.  The nurse must acquire self-efficacy for the administration of pain medications for critically ill patients to prevent serious side effects and adverse reactions.  This article presents a clinical toolkit for acute pain pharmacologic management by presenting professional guidelines, evidence-based pain assessment tools, common pain medication therapy, and focused monitoring specific to the drug.  Medical adjustments owing to special populations is also discussed.  Case reports demonstrate application of clinical reasoning skills needed for pain management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoIFV7ArpQPP6BottYdIAWfW6udTcc2eZpkIGJsZ5VK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7otFyjsQ%253D%253D&md5=2fb01422c43aaac0f7343d022d4fcef2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cnc.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cnc.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DFarrar%26aufirst%3DF.%2BC.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DDarnell%26aufirst%3DL.%26atitle%3DPharmacologic%2520interventions%2520for%2520pain%2520management%26jtitle%3DCrit%2520Care%2520Nurs%2520Clin%2520North%2520Am.%26date%3D2017%26volume%3D29%26spage%3D427%26epage%3D447%26doi%3D10.1016%2Fj.cnc.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsky, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malatynska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleyard, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaninova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive profile of biphalin, a dimeric encephalin analog</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">1446</span>– <span class="NLM_lpage">1454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=8389867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2ns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1993&pages=1446-1454&author=P.+J.+Horanauthor=A.+Mattiaauthor=E.+J.+Bilskyauthor=S.+Weberauthor=T.+P.+Davisauthor=H.+I.+Yamamuraauthor=E.+Malatynskaauthor=S.+M.+Appleyardauthor=J.+Slaninovaauthor=A.+Misickaauthor=A.+W.+Lipkowskiauthor=V.+J.+Hrubyauthor=F.+Porreca&title=Antinociceptive+profile+of+biphalin%2C+a+dimeric+encephalin+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive profile of biphalin, a dimeric enkephalin analog</span></div><div class="casAuthors">Horan, Peter J.; Mattia, Antonia; Bilsky, Edward J.; Weber, Steven; Davis, Thomas P.; Yamamura, Henry I.; Malatynska, Ewa; Appleyard, Suzanne M.; Slaninova, Jirina; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1446-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The dimeric enkephalin biphalin (Tyr-D-Ala-Gly-Phe-NH)2 was evaluated in mice using antinociceptive, gastrointestinal and phys. dependence paradigms and compared with that of morphine (ref. μ agonist) and etorphine (ultrapotent opioid agonist).  Intracerebroventricular biphalin was 6.7- and 257-fold more potent than etorphine or morphine in eliciting antinociception.  When administered i.t., biphalin produced only a 60% maximal antinociceptive effect in the tail-flick test even when given at doses up to 3 orders of magnitude higher than those effective i.c.v.; morphine was equipotent in this assay when given i.c.v. or i.t.  Both morphine and biphalin were equipotent after i.p. administration.  In spite of its antinociceptive effectiveness after i.p. administration, only a small fraction of [125I]biphalin penetrated to the brain (0.051%, at 20 min).  After i.c.v. administration, biphalin antinociception was antagonized by receptor selective doses of β-funaltrexamine (μ antagonist), naloxonazine (μ1 antagonist), ICI 174,864 (δ antagonist) and [D-Ala2,Cys4]deltorphin (δ2 antagonist), but not by [D-Ala2,Leu5,Cys6]enkephalin (δ1 antagonist) or nor-binaltorphimine (κ antagonist), whereas etorphine antinociception was antagonized only by β-funaltrexamine and naloxonazine.  Intracerebroventricular biphalin inhibited gastrointestinal propulsion at doses 8-fold higher than those producing i.c.v. antinociception; i.c.v. morphine showed a similar antinociceptive and gastrointestinal propulsion A50.  I.p. biphalin, but not i.p. morphine, showed little, if any, phys. dependence, but both biphalin and morphine produced phys. dependence when equiantinociceptive doses were infused i.c.v.  These results demonstrate an unusual profile for biphalin which suggests a potentially novel mechanism which may involve, in part, the putative opioid receptor complex of phys. or functionally interacting μ and δ2 opioid receptors.  Biphalin may thus represent the first in a series of such compds. which may lead to therapeutic advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA7Qt9LGJN_bVg90H21EOLACvtfcHk0li-kCOuTOtx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2ns7Y%253D&md5=6a4f697df154c0059e847bdef01e2d84</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DP.%2BJ.%26aulast%3DMattia%26aufirst%3DA.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DMalatynska%26aufirst%3DE.%26aulast%3DAppleyard%26aufirst%3DS.%2BM.%26aulast%3DSlaninova%26aufirst%3DJ.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DAntinociceptive%2520profile%2520of%2520biphalin%252C%2520a%2520dimeric%2520encephalin%2520analog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D265%26spage%3D1446%26epage%3D1454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feliciani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciatore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.2174/1389557511307010011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.2174%2F1389557511307010011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=11-33&author=F.+Felicianiauthor=F.+Pinnenauthor=A.+Stefanucciauthor=R.+Costanteauthor=I.+Cacciatoreauthor=G.+Lucenteauthor=A.+Mollica&title=Structure-activity+relationships+of+biphalin+analogs+and+their+biological+evaluation+on+opioid+receptors&doi=10.2174%2F1389557511307010011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1389557511307010011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511307010011%26sid%3Dliteratum%253Aachs%26aulast%3DFeliciani%26aufirst%3DF.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DCacciatore%26aufirst%3DI.%26aulast%3DLucente%26aufirst%3DG.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DStructure-activity%2520relationships%2520of%2520biphalin%2520analogs%2520and%2520their%2520biological%2520evaluation%2520on%2520opioid%2520receptors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D13%26spage%3D11%26epage%3D33%26doi%3D10.2174%2F1389557511307010011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochynska-Czyz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacharczuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujalska-Zadrozny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain-A comparison with morphine</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2016.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2Fj.ejps.2016.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=27094782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVyjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=39-49&author=A.+Lesniakauthor=M.+Bochynska-Czyzauthor=M.+Sacharczukauthor=S.+Benhyeauthor=A.+Misickaauthor=M.+Bujalska-Zadroznyauthor=A.+W.+Lipkowski&title=Biphalin+preferentially+recruits+peripheral+opioid+receptors+to+facilitate+analgesia+in+a+mouse+model+of+cancer+pain-A+comparison+with+morphine&doi=10.1016%2Fj.ejps.2016.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine</span></div><div class="casAuthors">Lesniak, Anna; Bochynska-Czyz, Marta; Sacharczuk, Mariusz; Benhye, Sandor; Misicka, Aleksandra; Bujalska-Zadrozny, Magdalena; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-49</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The search for new drugs for cancer pain management has been a long-standing goal in basic and clin. research.  Classical opioid drugs exert their primary antinociceptive effect upon activating opioid receptors located in the central nervous system.  A substantial body of evidence points to the relevance of peripheral opioid receptors as potential targets for cancer pain treatment.  Peptides showing limited blood-brain-barrier permeability promote peripheral analgesia in many pain models.  In the present study we examd. the peripheral and central analgesic effect of i.v. administered biphalin - a dimeric opioid peptide in a mouse skin cancer pain model, developed by an intraplantar inoculation of B16F0 melanoma cells.  The effect of biphalin was compared with morphine - a golden std. in cancer pain management.  Biphalin produced profound, dose-dependent and naloxone sensitive spinal analgesia.  Addnl., the effect in the tumor-bearing paw was largely mediated by peripheral opioid receptors, as it was readily attenuated by the blood-brain-barrier-restricted opioid receptor antagonist - naloxone methiodide.  On the contrary, morphine facilitated its analgesic effect primarily by activating spinal opioid receptors.  Both drugs induced tolerance in B16F0 - implanted paws after chronic treatment, however biphalin as opposed to morphine, showed little decrease in its activity at the spinal level.  Our results indicate that biphalin may be considered a future alternative drug in cancer pain treatment due to an enhanced local analgesic activity as well as lower tolerance liability compared with morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_k0xLyMzrIbVg90H21EOLACvtfcHk0li-kCOuTOtx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVyjsLo%253D&md5=5b6b588dda0ffac74b9b388864b85630</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DLesniak%26aufirst%3DA.%26aulast%3DBochynska-Czyz%26aufirst%3DM.%26aulast%3DSacharczuk%26aufirst%3DM.%26aulast%3DBenhye%26aufirst%3DS.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DBujalska-Zadrozny%26aufirst%3DM.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DBiphalin%2520preferentially%2520recruits%2520peripheral%2520opioid%2520receptors%2520to%2520facilitate%2520analgesia%2520in%2520a%2520mouse%2520model%2520of%2520cancer%2520pain-A%2520comparison%2520with%2520morphine%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D89%26spage%3D39%26epage%3D49%26doi%3D10.1016%2Fj.ejps.2016.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1002/psc.2465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fpsc.2465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=23136069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eiurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=233-239&author=A.+Mollicaauthor=R.+Costanteauthor=A.+Stefanucciauthor=F.+Pinnenauthor=G.+Lucenteauthor=S.+Fidanzaauthor=S.+Pieretti&title=Antinociceptive+profile+of+potent+opioid+peptide+AM94%2C+a+fluorinated+analogue+of+biphalin+with+non-hydrazine+linker&doi=10.1002%2Fpsc.2465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker</span></div><div class="casAuthors">Mollica, Adriano; Costante, Roberto; Stefanucci, Azzurra; Pinnen, Francesco; Lucente, Gino; Fidanza, Stefano; Pieretti, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">233-239</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">AM94 is a fluorinated analog of biphalin with non-hydrazine linker that has an in vitro affinity for μ-opioid and δ-opioid receptors tenfold higher than biphalin.  Furthermore, in vivo evaluation in rats showed that AM94 has in hot plate test - after both intracerebroventricular and i.v. administrations - a greater and more durable efficacy than biphalin.  Here, the antinociceptive profile of AM94 is further evaluated by following two different administration routes, intrathecal and s.c., and two different animal species, rats and mice.  The analgesic potency of AM94 is compared with that of both the parent peptide biphalin and morphine.  Results show that in rats (tail flick test) and in mice (formalin test), AM94 has a higher and more durable analgesic effect than biphalin after intrathecal and s.c. administrations.  Conformational properties of biphalin and AM94 were also investigated by variable-temp. 1H NMR and energy minimization.  Copyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsduIHCd6H1rVg90H21EOLACvtfcHk0lgtLmV3mrLsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eiurzF&md5=6cdaa54fc8146f4b246e66a0dfcf8296</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fpsc.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.2465%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DLucente%26aufirst%3DG.%26aulast%3DFidanza%26aufirst%3DS.%26aulast%3DPieretti%26aufirst%3DS.%26atitle%3DAntinociceptive%2520profile%2520of%2520potent%2520opioid%2520peptide%2520AM94%252C%2520a%2520fluorinated%2520analogue%2520of%2520biphalin%2520with%2520non-hydrazine%2520linker%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2013%26volume%3D19%26spage%3D233%26epage%3D239%26doi%3D10.1002%2Fpsc.2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Potent biphalin analogs with μ/δ mixed opioid activity: <i>In vivo</i> and <i>In vitro</i> biological evaluation</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1002/ardp.201300380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fardp.201300380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=24798820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislChtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2014&pages=305-312&author=R.+Costanteauthor=A.+Stefanucciauthor=F.+Pinnenauthor=A.+Mollica&title=Potent+biphalin+analogs+with+%CE%BC%2F%CE%B4+mixed+opioid+activity%3A+In+vivo+and+In+vitro+biological+evaluation&doi=10.1002%2Fardp.201300380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Biphalin Analogs with μ/δ Mixed Opioid Activity: In Vivo and In Vitro Biological Evaluation</span></div><div class="casAuthors">Costante, Roberto; Pinnen, Francesco; Stefanucci, Azzurra; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Biphalin [(Tyr-Ala-Gly-Phe-NH-)2] is an octapeptide with mixed μ/δ opioid activity.  Its structure is based on two identical enkephalin-like portions linked "tail-to-tail" by a hydrazine bridge.  This study presents the synthesis and in vitro and in vivo bioassays of two biphalin analogs that do not present the toxicity connected with the presence of the hydrazine moiety and are able to elicit a higher antinociceptive effect than biphalin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTI0RkfV53rVg90H21EOLACvtfcHk0lgtLmV3mrLsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislChtrk%253D&md5=8d7622542dbbf79a07e4bc7f9ac39b03</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fardp.201300380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201300380%26sid%3Dliteratum%253Aachs%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DPotent%2520biphalin%2520analogs%2520with%2520%25CE%25BC%252F%25CE%25B4%2520mixed%2520opioid%2520activity%253A%2520In%2520vivo%2520and%2520In%2520vitro%2520biological%2520evaluation%26jtitle%3DArch.%2520Pharm.%26date%3D2014%26volume%3D347%26spage%3D305%26epage%3D312%26doi%3D10.1002%2Fardp.201300380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Biological active analogues of the opioid peptide biphalin: Mixed hM<sup>3</sup>-peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3419</span>– <span class="NLM_lpage">3423</span>, <span class="refDoi"> DOI: 10.1021/jm301456c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301456c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2ntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3419-3423&author=A.+Mollicaauthor=F.+Pinnenauthor=R.+Costanteauthor=M.+Locatelliauthor=A.+Stefanucciauthor=S.+Pierettiauthor=P.+Davisauthor=J.+Laiauthor=D.+Rankinauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Biological+active+analogues+of+the+opioid+peptide+biphalin%3A+Mixed+hM3-peptides&doi=10.1021%2Fjm301456c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Active Analogues of the Opioid Peptide Biphalin: Mixed α/β3-Peptides</span></div><div class="casAuthors">Mollica, Adriano; Pinnen, Francesco; Costante, Roberto; Locatelli, Marcello; Stefanucci, Azzurra; Pieretti, Stefano; Davis, Peg; Lai, Josephine; Rankin, David; Porreca, Frank; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3419-3423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural residues of the dimeric opioid peptide biphalin [(H-Tyr-D-Ala-Gly-Phe-NH)2-] were replaced by the corresponding homo-β3-amino acids.  Peptide 1 [(H-Tyr-D-Ala-Gly-hβ3Phe-NH)2-] contg. hβ3Phe in place of Phe showed good μ- and δ-receptor affinities (Kiδ = 0.72 nM; Kiμ = 1.1 nM) and antinociceptive activity in vivo together with an increased enzymic stability in human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6k4wr1xOsrVg90H21EOLACvtfcHk0lgtLmV3mrLsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2ntLs%253D&md5=a06ba74ccf8759ec7115af5bebf4dfba</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm301456c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301456c%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DLocatelli%26aufirst%3DM.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DRankin%26aufirst%3DD.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DBiological%2520active%2520analogues%2520of%2520the%2520opioid%2520peptide%2520biphalin%253A%2520Mixed%2520hM3-peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3419%26epage%3D3423%26doi%3D10.1021%2Fjm301456c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotenuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limatola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsodi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samavati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zador, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyhe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Novel cyclic biphalin analogue with improved antinociceptive properties</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1021/ml500241n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500241n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1032-1036&author=A.+Mollicaauthor=A.+Carotenutoauthor=E.+Novellinoauthor=A.+Limatolaauthor=R.+Costanteauthor=F.+Pinnenauthor=A.+Stefanucciauthor=S.+Pierettiauthor=A.+Borsodiauthor=R.+Samavatiauthor=F.+Zadorauthor=S.+Benyheauthor=P.+Davisauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Novel+cyclic+biphalin+analogue+with+improved+antinociceptive+properties&doi=10.1021%2Fml500241n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cyclic Biphalin Analogue with Improved Antinociceptive Properties</span></div><div class="casAuthors">Mollica, Adriano; Carotenuto, Alfonso; Novellino, Ettore; Limatola, Antonio; Costante, Roberto; Pinnen, Francesco; Stefanucci, Azzurra; Pieretti, Stefano; Borsodi, Anna; Samavati, Reza; Zador, Ferenc; Benyhe, Sandor; Davis, Peg; Porreca, Frank; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1032-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel opioid analogs have been designed by substituting the native D-Ala residues in position 2,2' of biphalin with two residues of D-penicillamine or L-penicillamine and by forming a disulfide bond between the thiol groups.  The so-obtained compd. 9 contg. D-penicillamines showed excellent μ/δ mixed receptor affinities (K i δ = 5.2 nM; K i μ = 1.9 nM), together with an efficacious capacity to trigger the second messenger and a very good in vivo antinociceptive activity, whereas product 10 was scarcely active.  An explanation of the two different pharmacol. behaviors of products 9 and 10 was found by studying their conformational properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcpAB9Zk-1bVg90H21EOLACvtfcHk0ljrjecvJSXyQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ&md5=5bb0b213b04bddfed5f835c4cf307f5b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fml500241n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500241n%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLimatola%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DSamavati%26aufirst%3DR.%26aulast%3DZador%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DNovel%2520cyclic%2520biphalin%2520analogue%2520with%2520improved%2520antinociceptive%2520properties%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1032%26epage%3D1036%26doi%3D10.1021%2Fml500241n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minosi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szűcs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdei, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zádor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyhe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Opioid receptor activity and analgesic potency of DPDPE peptide analogues containing a xylene bridge</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Oiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=449-454&author=A.+Stefanucciauthor=E.+Novellinoauthor=S.+Mirzaieauthor=G.+Macedonioauthor=S.+Pierettiauthor=P.+Minosiauthor=E.+Sz%C5%B1csauthor=A.+I.+Erdeiauthor=F.+Z%C3%A1dorauthor=S.+Benyheauthor=A.+Mollica&title=Opioid+receptor+activity+and+analgesic+potency+of+DPDPE+peptide+analogues+containing+a+xylene+bridge&doi=10.1021%2Facsmedchemlett.7b00044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge</span></div><div class="casAuthors">Stefanucci, Azzurra; Novellino, Ettore; Mirzaie, Sako; Macedonio, Giorgia; Pieretti, Stefano; Minosi, Paola; Szucs, Edina; Erdei, Anna I.; Zador, Ferenc; Benyhe, Sandor; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-454</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abstr.: D-Pen2,D-Pen5 enkephalin (DPDPE) is one of the most selective synthetic peptide agonist targeting the δ-opioid receptor.  Three cyclic analogs of DPDPE contg. a xylene bridge in place of disulfide bond have been synthesized and fully characterized as opioid receptors agonists.  The in vitro activity was investigated showing a good affinity of 7a-c for μ and δ-receptors.  In vivo biol. assays revealed that 7b is the most potent analog with the ability to maintain high level of analgesia from 15 to 60 min following intracerebroventricular (i.c.v.) administration, whereas DPDPE was slight-ly active until 45 min. 7b induced long lasting analgesia also after s.c. administration, whereas DPDPE was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCwJGizEcNCbVg90H21EOLACvtfcHk0ljrjecvJSXyQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Oiu70%253D&md5=8c4e70edc7248eb226dc41d63043cf57</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00044%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMirzaie%26aufirst%3DS.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DMinosi%26aufirst%3DP.%26aulast%3DSz%25C5%25B1cs%26aufirst%3DE.%26aulast%3DErdei%26aufirst%3DA.%2BI.%26aulast%3DZ%25C3%25A1dor%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DOpioid%2520receptor%2520activity%2520and%2520analgesic%2520potency%2520of%2520DPDPE%2520peptide%2520analogues%2520containing%2520a%2520xylene%2520bridge%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D449%26epage%3D454%26doi%3D10.1021%2Facsmedchemlett.7b00044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotenuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzoli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szűcs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdei, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zádor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyhe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Cyclic biphalin analogues incorporating a xylene bridge: Synthesis, characterization, and biological profile</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">858</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00210</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00210" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFGitbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=858-863&author=A.+Stefanucciauthor=A.+Carotenutoauthor=G.+Macedonioauthor=E.+Novellinoauthor=S.+Pierettiauthor=F.+Marzoliauthor=E.+Sz%C5%B1csauthor=A.+I.+Erdeiauthor=F.+Z%C3%A1dorauthor=S.+Benyheauthor=A.+Mollica&title=Cyclic+biphalin+analogues+incorporating+a+xylene+bridge%3A+Synthesis%2C+characterization%2C+and+biological+profile&doi=10.1021%2Facsmedchemlett.7b00210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile</span></div><div class="casAuthors">Stefanucci, Azzurra; Carotenuto, Alfonso; Macedonio, Giorgia; Novellino, Ettore; Pieretti, Stefano; Marzoli, Francesca; Szucs, Edina; Erdei, Anna I.; Zador, Ferenc; Benyhe, Sandor; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">858-863</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work we enhanced the ring lipophilicity of biphalin introducing a xylene moiety, thus obtaining three cyclic regioisomers.  Novel compds. have similar in vitro activity as the parent compd. but one of these (I) shows a remarkable increase of in vivo antinociceptive effect.  Nociception tests have disclosed its significant high potency and the more prolonged effect in eliciting analgesia, higher than that of biphalin and of the disulfide bridge contg. analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRoFOSqF5Z3LVg90H21EOLACvtfcHk0lgSCTKh00NKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFGitbvF&md5=c7d2183ccc9f22920e8b915ebb449ca6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00210%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DMarzoli%26aufirst%3DF.%26aulast%3DSz%25C5%25B1cs%26aufirst%3DE.%26aulast%3DErdei%26aufirst%3DA.%2BI.%26aulast%3DZ%25C3%25A1dor%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DCyclic%2520biphalin%2520analogues%2520incorporating%2520a%2520xylene%2520bridge%253A%2520Synthesis%252C%2520characterization%252C%2520and%2520biological%2520profile%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D858%26epage%3D863%26doi%3D10.1021%2Facsmedchemlett.7b00210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luisi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.4155%2Ffmc-2016-0232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=28635314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=859-869&author=A.+Stefanucciauthor=W.+Leiauthor=V.+J.+Hrubyauthor=G.+Macedonioauthor=G.+Luisiauthor=S.+Carradoriauthor=J.+M.+Streicherauthor=A.+Mollica&title=Fluorescent-labeled+bioconjugates+of+the+opioid+peptides+biphalin+and+DPDPE+incorporating+fluorescein-maleimide+linkers&doi=10.4155%2Ffmc-2016-0232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers</span></div><div class="casAuthors">Stefanucci, Azzurra; Lei, Wei; Hruby, Victor J.; Macedonio, Giorgia; Luisi, Grazia; Carradori, Simone; Streicher, John M.; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">859-869</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: The conjugation of fluorescent labels to opioid peptides is an extremely challenging task, which needs to be overcome to create new classes of probes for biol. assays.  Materials & methods: Three opioid peptide analogs of biphalin and [D-Pen2,5]-Enkephalin (DPDPE) contg. a fluorescein-maleimide motif were synthesized.  Results & discussion: The biphalin analog 17 binds to opioid receptors with Ki μ = 530 ± 90 nM and Ki δ = 69.8 ± 16.4 nM.  We then tested the ability of the compds. to stimulate G-protein-coupling, 17 activated μ-receptor expressing cells (EC50 = 16.7 ± 6.7 nM, EMax = 76 ± 4%) as well as δ-receptor expressing cells (EC50 = 42 ± 10 nM, EMax = 34 ± 8%).  However, 17 was not able to fluorescently label receptor in live or fixed cells.  Conclusion: Our data suggest that the biphalin scaffold could be employed to develop fluorescent ligands with the appropriate fluorescent motif, and suggest a means for further probe development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAcsYO_SWLObVg90H21EOLACvtfcHk0lgSCTKh00NKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7%252FL&md5=1144fc9a420750b948faaf38ca2d9845</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0232%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DLuisi%26aufirst%3DG.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DFluorescent-labeled%2520bioconjugates%2520of%2520the%2520opioid%2520peptides%2520biphalin%2520and%2520DPDPE%2520incorporating%2520fluorescein-maleimide%2520linkers%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D859%26epage%3D869%26doi%3D10.4155%2Ffmc-2016-0232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remesic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic Opioid Peptides</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1303</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160427123005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.2174%2F0929867323666160427123005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=27117332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFags7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1288-1303&author=M.+Remesicauthor=Y.+S.+Leeauthor=V.+J.+Hruby&title=Cyclic+Opioid+Peptides&doi=10.2174%2F0929867323666160427123005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Opioid Peptides</span></div><div class="casAuthors">Remesic, Michael; Lee, Yeon Sun; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1288-1303</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">For decades the opioid receptors have been an attractive therapeutic target for the treatment of pain.  Since the first discovery of enkephalin, approx. a dozen endogenous opioid peptides have been known to produce opioid activity and analgesia, but their therapeutics have been limited mainly due to low blood brain barrier penetration and poor resistance to proteolytic degrdn.  One versatile approach to overcome these drawbacks is the cyclization of linear peptides to cyclic peptides with constrained topog. structure.  Compared to their linear parents, cyclic analogs exhibit better metabolic stability, lower offtarget toxicity, and improved bioavailability.  Extensive structure-activity relationship studies have uncovered promising compds. for the treatment of pain as well as further elucidate structural elements required for selective opioid receptor activity.  The benefits that come with employing cyclization can be further enhanced through the generation of polycyclic derivs.  Opioid ligands generally have a short peptide chain and thus the realm of polycyclic peptides has yet to be explored.  In this review, a brief history of designing ligands for the opioid receptors, including classic linear and cyclic ligands, is discussed along with recent approaches and successes of cyclic peptide ligands for the receptors.  Various scaffolds and approaches to improve bioavailability are elaborated and concluded with a discourse towards polycyclic peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqRd2N_Fx-LVg90H21EOLACvtfcHk0lgSCTKh00NKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFags7w%253D&md5=3a1df6a45b331fa5d7c78f0c34eccfe9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160427123005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160427123005%26sid%3Dliteratum%253Aachs%26aulast%3DRemesic%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DCyclic%2520Opioid%2520Peptides%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1288%26epage%3D1303%26doi%3D10.2174%2F0929867323666160427123005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">The opioid peptide analogue biphalin induces less physical dependence than morphine</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S0024-3205(01)01194-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2FS0024-3205%2801%2901194-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=11508644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFans7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1023-1028&author=M.+Yamazakiauthor=T.+Suzukiauthor=M.+Naritaauthor=A.+W.+Lipkowski&title=The+opioid+peptide+analogue+biphalin+induces+less+physical+dependence+than+morphine&doi=10.1016%2FS0024-3205%2801%2901194-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The opioid peptide analogue biphalin induces less physical dependence than morphine</span></div><div class="casAuthors">Yamazaki, Mitsuaki; Suzuki, Tsutomu; Narita, Minoru; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1023-1028</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We compared the phys. dependence liability of biphalin, a dimeric enkephalin analog that possesses high antinociceptive activity, with that of morphine in equipotent i.v. doses.  Naloxone challenge produced severe withdrawal signs after a 5-day infusion of morphine but only minor withdrawal signs after a 5-day biphalin infusion.  In a cross-dependence study, biphalin did not suppress body wt. loss after morphine withdrawal, but successfully suppressed wt. loss after pentazocine withdrawal.  These data support consideration of biphalin as a new analgesic with a novel pharmacol. profile and min. dependence liability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0NwvUOb7iu7Vg90H21EOLACvtfcHk0lggpfvLToeH-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFans7c%253D&md5=70d0faa9a611991665243355e0dedbe6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2801%2901194-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252801%252901194-8%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DThe%2520opioid%2520peptide%2520analogue%2520biphalin%2520induces%2520less%2520physical%2520dependence%2520than%2520morphine%26jtitle%3DLife%2520Sci.%26date%3D2001%26volume%3D69%26spage%3D1023%26epage%3D1028%26doi%3D10.1016%2FS0024-3205%2801%2901194-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbotham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1093/bja/aep129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1093%2Fbja%2Faep129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=19474215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVKjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2009&pages=38-49&author=N.+Dietisauthor=R.+Guerriniauthor=G.+Caloauthor=S.+Salvadoriauthor=D.+J.+Rowbothamauthor=D.+G.+Lambert&title=Simultaneous+targeting+of+multiple+opioid+receptors%3A+a+strategy+to+improve+side-effect+profile&doi=10.1093%2Fbja%2Faep129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile</span></div><div class="casAuthors">Dietis, N.; Guerrini, R.; Calo, G.; Salvadori, S.; Rowbotham, D. J.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-49</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">0007-0912</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Opioid receptors are currently classified as μ (mu: mOP), δ (delta: dOP), κ (kappa: kOP) with a fourth related non-classical opioid receptor for nociceptin/orphainin FQ, NOP.  Morphine is the current gold std. analgesic acting at MOP receptors but produces a range of variably troublesome side-effects, in particular tolerance.  There is now good lab. evidence to suggest that blocking DOP while activating MOP produces analgesia (or antinociception) without the development of tolerance.  Simultaneous targeting of MOP and DOP can be accomplished by: (i) co-administering two selective drugs, (ii) administering one non-selective drug, or (iii) designing a single drug that specifically targets both receptors; a bivalent ligand.  Bivalent ligands generally contain two active centers or pharmacophores that are variably sepd. by a chem. spacer and there are several interesting examples in the literature.  For example linking the MOP agonist oxymorphone to the DOP antagonist naltrindole produces a MOP/DOP bivalent ligand that should produce analgesia with reduced tolerance.  The type of response/selectivity produced depends on the pharmacophore combination (e.g. oxymorphone and naltrindole as above) and the space between them.  Prodn. and evaluation of bivalent ligands is an emerging field in drug design and for anesthesia, analgesics that are designed not to be highly selective morphine-like (MOP) ligands represents a new avenue for the prodn. of useful drugs for chronic (and in particular cancer) pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirDRA_J_oBbVg90H21EOLACvtfcHk0lggpfvLToeH-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVKjsrw%253D&md5=11a940d3394458c4d4894a2b6149e3b4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbja%2Faep129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252Faep129%26sid%3Dliteratum%253Aachs%26aulast%3DDietis%26aufirst%3DN.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRowbotham%26aufirst%3DD.%2BJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DSimultaneous%2520targeting%2520of%2520multiple%2520opioid%2520receptors%253A%2520a%2520strategy%2520to%2520improve%2520side-effect%2520profile%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2009%26volume%3D103%26spage%3D38%26epage%3D49%26doi%3D10.1093%2Fbja%2Faep129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliciani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">New potent biphalin analogues containing <i>p</i>-fluoro-L-phenylalanine at the 4,4’ positions and non-hydrazine linker</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1503</span>– <span class="NLM_lpage">1511</span>, <span class="refDoi"> DOI: 10.1007/s00726-010-0760-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1007%2Fs00726-010-0760-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=20924622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFWqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=1503-1511&author=A.+Mollicaauthor=F.+Pinnenauthor=F.+Felicianiauthor=A.+Stefanucciauthor=G.+Lucenteauthor=P.+Davisauthor=F.+Porrecaauthor=S.+W.+Maauthor=J.+Laiauthor=V.+J.+Hruby&title=New+potent+biphalin+analogues+containing+p-fluoro-L-phenylalanine+at+the+4%2C4%E2%80%99+positions+and+non-hydrazine+linker&doi=10.1007%2Fs00726-010-0760-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New potent biphalin analogues containing p-fluoro-L-phenylalanine at the 4,4' positions and non-hydrazine linkers</span></div><div class="casAuthors">Mollica, Adriano; Pinnen, Francesco; Feliciani, Federica; Stefanucci, Azzurra; Lucente, Gino; Davis, Peg; Porreca, Frank; Ma, Shou-Wu; Lai, Josephine; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1503-1511</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">The authors report the synthesis and the biol. evaluation of two new analogs of the potent dimeric opioid peptide biphalin.  The performed modification is based on the replacement of two key structural elements of the native biphalin, namely: the hydrazine bridge which joins the two palindromic moieties and the phenylalanine residues at 4 and 4' positions of the backbone.  The two new analogs contain 1,2-phenylenediamine and piperazine, resp., in place of the hydrazidic linker and p-fluoro-l-phenylalanine residues at 4 and 4' positions.  Binding values are Kiμ = 0.51 nM and Kiδ 12.8 nM for the phenylenediamine analog; Kiμ = 0.09 nM and Kiμ = 0.11 nM for the piperazine analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEPaPuQD717Vg90H21EOLACvtfcHk0lggpfvLToeH-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFWqtro%253D&md5=091d91c83ce439e96ec7ca78feb42904</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00726-010-0760-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-010-0760-7%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DFeliciani%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DLucente%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DNew%2520potent%2520biphalin%2520analogues%2520containing%2520p-fluoro-L-phenylalanine%2520at%2520the%25204%252C4%25E2%2580%2599%2520positions%2520and%2520non-hydrazine%2520linker%26jtitle%3DAmino%2520Acids%26date%3D2011%26volume%3D40%26spage%3D1503%26epage%3D1511%26doi%3D10.1007%2Fs00726-010-0760-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughtput artificial membrane permeability assay for blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughtput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0licf0Yz6gn_eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughtput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piekielna-Ciesielska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymaszkiewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielińska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecka, A.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF<sub>3</sub>-Phe-Asp]NH<sub>2</sub></span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1441839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1080%2F14756366.2018.1441839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=29513114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2nsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=560-566&author=J.+Piekielna-Ciesielskaauthor=A.+Mollicaauthor=S.+Pierettiauthor=J.+Fichnaauthor=A.+Szymaszkiewiczauthor=M.+Zieli%C5%84skaauthor=R.+Kordekauthor=A.+Janecka&title=Antinociceptive+potency+of+a+fluorinated+cyclopeptide+Dmt-c%5BD-Lys-Phe-p-CF3-Phe-Asp%5DNH2&doi=10.1080%2F14756366.2018.1441839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2</span></div><div class="casAuthors">Piekielna-Ciesielska, Justyna; Mollica, Adriano; Pieretti, Stefano; Fichna, Jakub; Szymaszkiewicz, Agata; Zielinska, Marta; Kordek, Radzislaw; Janecka, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">560-566</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Opioid peptides and opiate drugs such as morphine, mediate their analgesic effects, but also undesired side effects, mostly through activation of the mu opioid receptor.  However, delta- and kappa-opioid receptors can also contribute to the analgesic effects of opioids.  Recent findings showed that simultaneous activation of multiple opioid receptors may result in addnl. analgesia with fewer side effects.  Here, the authors evaluated the pharmacol. profile of the authors' formerly developed mixed mu/kappa-opioid receptor ligands, Dmt-c[D-Lys-Phe-Phe-Asp]NH2 (C-36) and Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2 (F-81).  The ability of these peptides to cross the blood-brain barrier was tested in the parallel artificial membrane permeability (PAMPA) assay.  On the basis of the hot-plate test in mice after central and peripheral administration, analog F-81 was selected for the anti-nociceptive and anti-inflammatory activity assessment after peripheral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoeyREwmweIrVg90H21EOLACvtfcHk0licf0Yz6gn_eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2nsrs%253D&md5=fc70836e8087830bf9adeef2069c96e6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1441839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1441839%26sid%3Dliteratum%253Aachs%26aulast%3DPiekielna-Ciesielska%26aufirst%3DJ.%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DFichna%26aufirst%3DJ.%26aulast%3DSzymaszkiewicz%26aufirst%3DA.%26aulast%3DZieli%25C5%2584ska%26aufirst%3DM.%26aulast%3DKordek%26aufirst%3DR.%26aulast%3DJanecka%26aufirst%3DA.%26atitle%3DAntinociceptive%2520potency%2520of%2520a%2520fluorinated%2520cyclopeptide%2520Dmt-c%255BD-Lys-Phe-p-CF3-Phe-Asp%255DNH2%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D560%26epage%3D566%26doi%3D10.1080%2F14756366.2018.1441839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinberg, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into t-opioid receptor activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nature14886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fnature14886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=26245379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=315-321&author=W.+Huangauthor=A.+Manglikauthor=A.+J.+Venkatakrishnanauthor=T.+Laeremansauthor=E.+N.+Feinbergauthor=A.+L.+Sanbornauthor=H.+E.+Katoauthor=K.+E.+Livingstonauthor=T.+S.+Thorsenauthor=R.+C.+Klingauthor=S.+Granierauthor=P.+Gmeinerauthor=S.+M.+Husbandsauthor=J.+R.+Traynorauthor=W.+I.+Weisauthor=J.+Steyaertauthor=R.+O.+Drorauthor=B.+K.+Kobilka&title=Structural+insights+into+t-opioid+receptor+activation&doi=10.1038%2Fnature14886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into μ-opioid receptor activation</span></div><div class="casAuthors">Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics.  To shed light on the structural basis for μOR activation, here we report a 2.1 Å X-ray crystal structure of the murine μOR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment Nb39 (nanobody 39).  The BU72-stabilized changes in the μOR binding pocket are subtle and differ from those obsd. for agonist-bound structures of the β2-adrenergic receptor (β2AR) and the M2 muscarinic receptor (M2R).  Comparison with active β2AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the μOR, and mol. dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad.  Addnl., an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFUN1wheV07Vg90H21EOLACvtfcHk0licf0Yz6gn_eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM&md5=b9af3e1351b04539379532c127c02651</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature14886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14886%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DFeinberg%26aufirst%3DE.%2BN.%26aulast%3DSanborn%26aufirst%3DA.%2BL.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DLivingston%26aufirst%3DK.%2BE.%26aulast%3DThorsen%26aufirst%3DT.%2BS.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructural%2520insights%2520into%2520t-opioid%2520receptor%2520activation%26jtitle%3DNature%26date%3D2015%26volume%3D524%26spage%3D315%26epage%3D321%26doi%3D10.1038%2Fnature14886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemyn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yefanov, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberthuer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tourwe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">Structural basis for bifunctional peptide recognition at human e-opioid receptor</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fnsmb.2965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=25686086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=265-268&author=G.+Fenaltiauthor=N.+A.+Zatsepinauthor=C.+Bettiauthor=P.+Giguereauthor=G.+W.+Hanauthor=A.+Ishchenkoauthor=W.+Liuauthor=K.+Guillemynauthor=H.+Zhangauthor=D.+Jamesauthor=D.+Wangauthor=U.+Weierstallauthor=J.+C.+Spenceauthor=S.+Boutetauthor=M.+Messerschmidtauthor=G.+J.+Williamsauthor=C.+Gatiauthor=O.+M.+Yefanovauthor=T.+A.+Whiteauthor=D.+Oberthuerauthor=M.+Metzauthor=C.+H.+Yoonauthor=A.+Bartyauthor=H.+N.+Chapmanauthor=S.+Basuauthor=J.+Coeauthor=C.+E.+Conradauthor=R.+Frommeauthor=P.+Frommeauthor=D.+Tourweauthor=P.+W.+Schillerauthor=B.+L.+Rothauthor=S.+Balletauthor=V.+Katritchauthor=R.+C.+Stevensauthor=V.+Cherezov&title=Structural+basis+for+bifunctional+peptide+recognition+at+human+e-opioid+receptor&doi=10.1038%2Fnsmb.2965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for bifunctional peptide recognition at human δ-opioid receptor</span></div><div class="casAuthors">Fenalti, Gustavo; Zatsepin, Nadia A.; Betti, Cecilia; Giguere, Patrick; Han, Gye Won; Ishchenko, Andrii; Liu, Wei; Guillemyn, Karel; Zhang, Haitao; James, Daniel; Wang, Dingjie; Weierstall, Uwe; Spence, John C. H.; Boutet, Sebastien; Messerschmidt, Marc; Williams, Garth J.; Gati, Cornelius; Yefanov, Oleksandr M.; White, Thomas A.; Oberthuer, Dominik; Metz, Markus; Yoon, Chun Hong; Barty, Anton; Chapman, Henry N.; Basu, Shibom; Coe, Jesse; Conrad, Chelsie E.; Fromme, Raimund; Fromme, Petra; Tourwe, Dirk; Schiller, Peter W.; Roth, Bryan L.; Ballet, Steven; Katritch, Vsevolod; Stevens, Raymond C.; Cherezov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-268</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bifunctional μ- and δ-opioid receptor (OR) ligands are potential therapeutic alternatives, with diminished side effects, to alkaloid opiate analgesics.  We solved the structure of human δ-OR bound to the bifunctional δ-OR antagonist and μ-OR agonist tetrapeptide H-Dmt-Tic-Phe-Phe-NH2 (DIPP-NH2) by serial femtosecond crystallog., revealing a cis-peptide bond between H-Dmt and Tic.  The obsd. receptor-peptide interactions are crit. for understanding of the pharmacol. profiles of opioid peptides and for development of improved analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG47AjtGIDCbVg90H21EOLACvtfcHk0lh8tbkbL8IHyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSitLg%253D&md5=e16eca5584731b26d7176c6a5f5e099d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2965%26sid%3Dliteratum%253Aachs%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DGiguere%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGuillemyn%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DSpence%26aufirst%3DJ.%2BC.%26aulast%3DBoutet%26aufirst%3DS.%26aulast%3DMesserschmidt%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DYefanov%26aufirst%3DO.%2BM.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DOberthuer%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DM.%26aulast%3DYoon%26aufirst%3DC.%2BH.%26aulast%3DBarty%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DH.%2BN.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DConrad%26aufirst%3DC.%2BE.%26aulast%3DFromme%26aufirst%3DR.%26aulast%3DFromme%26aufirst%3DP.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DStructural%2520basis%2520for%2520bifunctional%2520peptide%2520recognition%2520at%2520human%2520e-opioid%2520receptor%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D265%26epage%3D268%26doi%3D10.1038%2Fnsmb.2965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span> <i>Schrödinger
Release 2015-2</i>; <span class="NLM_publisher-name">Glide, Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New
York, NY</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%0ARelease+2015-2%3B+Glide%2C+Schr%C3%B6dinger%2C%0ALLC%3A+New%0AYork%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%250ARelease%25202015-2%26pub%3DGlide%252C%2520Schr%25C3%25B6dinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+Glide%3A+Docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lh8tbkbL8IHyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520Glide%253A%2520Docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaserer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidhammer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spetea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D.</span></span> <span> </span><span class="NLM_article-title">μ Opioid receptor: novel antagonists and structural modeling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21548</span>, <span class="refDoi"> DOI: 10.1038/srep21548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fsrep21548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=26888328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21548&author=T.+Kasererauthor=A.+Lanteroauthor=H.+Schmidhammerauthor=M.+Speteaauthor=D.+Schuster&title=%CE%BC+Opioid+receptor%3A+novel+antagonists+and+structural+modeling&doi=10.1038%2Fsrep21548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">μ Opioid receptor: novel antagonists and structural modeling</span></div><div class="casAuthors">Kaserer, Teresa; Lantero, Aquilino; Schmidhammer, Helmut; Spetea, Mariana; Schuster, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21548</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The μ opioid receptor (MOR) is a prominent member of the G protein-coupled receptor family and the mol. target of morphine and other opioid drugs.  Despite the long tradition of MOR-targeting drugs, still little is known about the ligand-receptor interactions and structure-function relationships underlying the distinct biol. effects upon receptor activation or inhibition.  With the resolved crystal structure of the β-funaltrexamine-MOR complex, we aimed at the discovery of novel agonists and antagonists using virtual screening tools, i.e. docking, pharmacophore- and shape-based modeling.  We suggest important mol. interactions, which active mols. share and distinguish agonists and antagonists.  These results allowed for the generation of theor. validated in silico workflows that were employed for prospective virtual screening.  Out of 18 virtual hits evaluated in in vitro pharmacol. assays, three displayed antagonist activity and the most active compd. significantly inhibited morphine-induced antinociception.  The new identified chemotypes hold promise for further development into neurochem. tools for studying the MOR or as potential therapeutic lead candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCoqM4r8HMKrVg90H21EOLACvtfcHk0lgXJ_xHC9S0HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislylu7w%253D&md5=0820b4d11e21168641444e8b77b02dbd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsrep21548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21548%26sid%3Dliteratum%253Aachs%26aulast%3DKaserer%26aufirst%3DT.%26aulast%3DLantero%26aufirst%3DA.%26aulast%3DSchmidhammer%26aufirst%3DH.%26aulast%3DSpetea%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DD.%26atitle%3D%25CE%25BC%2520Opioid%2520receptor%253A%2520novel%2520antagonists%2520and%2520structural%2520modeling%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21548%26doi%3D10.1038%2Fsrep21548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmito, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzoli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">5771</span>– <span class="NLM_lpage">5783</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-42289-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fs41598-019-42289-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=30962495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252Fjt1Wnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=5771-5783&author=A.+Stefanucciauthor=W.+Leiauthor=S.+Pierettiauthor=E.+Novellinoauthor=M.+P.+Dimmitoauthor=F.+Marzoliauthor=J.+M.+Streicherauthor=A.+Mollica&title=On+resin+click-chemistry-mediated+synthesis+of+novel+enkephalin+analogues+with+potent+anti-nociceptive+activity&doi=10.1038%2Fs41598-019-42289-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity</span></div><div class="casAuthors">Stefanucci Azzurra; Dimmito Marilisa Pia; Mollica Adriano; Lei Wei; Streicher John M; Pieretti Stefano; Marzoli Francesca; Novellino Ettore</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5771</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Here, we report the chemical synthesis of two DPDPE analogues 7a (NOVA1) and 7b (NOVA2).  This entailed the solid-phase synthesis of two enkephalin precursor chains followed by a Cu(I)-catalyzed azide-alkyne cycloaddition, with the aim of improving in vivo analgesic efficacy versus DPDPE.  NOVA2 showed good affinity and selectivity for the μ-opioid receptor (KI of 59.2 nM, EC50 of 12.9 nM, EMax of 87.3%), and long lasting anti-nociceptive effects in mice when compared to DPDPE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiJMLWBMvsfhJ5E29YNGvQfW6udTcc2eaKY67umGqlMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252Fjt1Wnsw%253D%253D&md5=d6f22ae834eaba9b192af48b9747316b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-42289-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-42289-5%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDimmito%26aufirst%3DM.%2BP.%26aulast%3DMarzoli%26aufirst%3DF.%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DOn%2520resin%2520click-chemistry-mediated%2520synthesis%2520of%2520novel%2520enkephalin%2520analogues%2520with%2520potent%2520anti-nociceptive%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D5771%26epage%3D5783%26doi%3D10.1038%2Fs41598-019-42289-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wardhan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2074</span>, <span class="refDoi"> DOI: 10.12688/f1000research.12286.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.12688%2Ff1000research.12286.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=29225793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BC1MzgtVSisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=2065-2074&author=R.+Wardhanauthor=J.+Chelly&title=Recent+advances+in+acute+pain+management%3A+understanding+the+mechanisms+of+acute+pain%2C+the+prescription+of+opioids%2C+and+the+role+of+multimodal+pain+therapy&doi=10.12688%2Ff1000research.12286.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy</span></div><div class="casAuthors">Wardhan Richa; Chelly Jacques</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2065</span>
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    </div><div class="casAbstract">In this review, we discuss advances in acute pain management, including the recent report of the joint American Pain Society and American Academy of Pain Medicine task force on the classification of acute pain, the role of psychosocial factors, multimodal pain management, new non-opioid therapy, and the effect of the "opioid epidemic".  In this regard, we propose that a fundamental principle in acute pain management is identifying patients who are most at risk and providing an "opioid free anesthesia and postoperative analgesia".  This can be achieved by using a multimodal approach that includes regional anesthesia and minimizing the dose and the duration of opioid prescription.  This allows prescribing medications that work through different mechanisms.  We shall also look at the recent pharmacologic and treatment advances made in acute pain and regional anesthesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtqHpTbtJBjBcr74wzj5o5fW6udTcc2eaQUt9CEJuMyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzgtVSisg%253D%253D&md5=e7144b119d651c7dd5d7a4de73eddf37</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.12286.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.12286.1%26sid%3Dliteratum%253Aachs%26aulast%3DWardhan%26aufirst%3DR.%26aulast%3DChelly%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520acute%2520pain%2520management%253A%2520understanding%2520the%2520mechanisms%2520of%2520acute%2520pain%252C%2520the%2520prescription%2520of%2520opioids%252C%2520and%2520the%2520role%2520of%2520multimodal%2520pain%2520therapy%26jtitle%3DF1000Research%26date%3D2017%26volume%3D6%26spage%3D2065%26epage%3D2074%26doi%3D10.12688%2Ff1000research.12286.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwaszkiewicz, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span> <span> </span><span class="NLM_article-title">Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.3389/fphar.2013.00132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.3389%2Ffphar.2013.00132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=24167491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BC2c7gs1Grsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=132-138&author=K.+S.+Iwaszkiewiczauthor=J.+J.+Schneiderauthor=S.+Hua&title=Targeting+peripheral+opioid+receptors+to+promote+analgesic+and+anti-inflammatory+actions&doi=10.3389%2Ffphar.2013.00132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions</span></div><div class="casAuthors">Iwaszkiewicz Katerina S; Schneider Jennifer J; Hua Susan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Mechanisms of endogenous pain control are significant.  Increasing studies have clearly produced evidence for the clinical usefulness of opioids in peripheral analgesia.  The immune system uses mechanisms of cell migration not only to fight pathogens but also to control pain and inflammation within injured tissue.  It has been demonstrated that peripheral inflammatory pain can be effectively controlled by an interaction of immune cell-derived opioid peptides with opioid receptors on peripheral sensory nerve terminals.  Experimental and clinical studies have clearly shown that activation of peripheral opioid receptors with exogenous opioid agonists and endogenous opioid peptides are able to produce significant analgesic and anti-inflammatory effects, without central opioid mediated side effects (e.g., respiratory depression, sedation, tolerance, dependence).  This article will focus on the role of opioids in peripheral inflammatory conditions and the clinical implications of targeting peripheral opioid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCrlFIPUywuzAyhZbj3lKdfW6udTcc2eaQUt9CEJuMyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7gs1Grsg%253D%253D&md5=09f11622b05d78facc2643a4fb880f99</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00132%26sid%3Dliteratum%253Aachs%26aulast%3DIwaszkiewicz%26aufirst%3DK.%2BS.%26aulast%3DSchneider%26aufirst%3DJ.%2BJ.%26aulast%3DHua%26aufirst%3DS.%26atitle%3DTargeting%2520peripheral%2520opioid%2520receptors%2520to%2520promote%2520analgesic%2520and%2520anti-inflammatory%2520actions%26jtitle%3DFront.%2520Pharmacol.%26date%3D2013%26volume%3D4%26spage%3D132%26epage%3D138%26doi%3D10.3389%2Ffphar.2013.00132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotshteyn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turchin, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomonis, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broglè, K. C.</span></span> <span> </span><span class="NLM_article-title">DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.063560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1124%2Fjpet.103.063560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=15054116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVykt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=793-799&author=G.+T.+Whitesideauthor=J.+E.+Harrisonauthor=M.+S.+Pearsonauthor=Z.+Chenauthor=Y.+Rotshteynauthor=P.+I.+Turchinauthor=J.+D.+Pomonisauthor=L.+Markauthor=K.+Walkerauthor=K.+C.+Brogl%C3%A8&title=DiPOA+%28%5B8-%283%2C3-Diphenyl-propyl%29-4-oxo-1-phenyl-1%2C3%2C8-triazaspiro%5B4.5%5Ddec-3-yl%5D-acetic+Acid%29%2C+a+novel%2C+systemically+available%2C+and+peripherally+restricted+mu+opioid+agonist+with+antihyperalgesic+activity%3A+II.+In+vivo+pharmacological+characterization+in+the+rat&doi=10.1124%2Fjpet.103.063560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">DiPOA ([8-(3,3-diphenylpropyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat</span></div><div class="casAuthors">Whiteside, Garth T.; Harrison, James E.; Pearson, Michelle S.; Chen, Zhengming; Rotshteyn, Yakov; Turchin, Paul I.; Pomonis, James D.; Mark, Lilly; Walker, Katharine; Brogle, Kevin C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">793-799</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Mu opioid receptors are expressed throughout the central and peripheral nervous systems.  Peripheral inflammation leads to an increase in mu receptor present on the peripheral terminals of primary sensory neurons.  Activation of peripheral mu receptors produces potent antihyperalgesic effects in both humans and animals.  Here, we describe the in vivo pharmacol. properties of the structurally novel, highly potent, systemically available yet peripherally restricted mu opioid agonist, [8-(3,3-diphenylpropyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid (DiPOA).  DiPOA administered i.p. produced naltrexone-sensitive, dose-dependent reversal of Freund's complete adjuvant-induced inflammatory mech. hyperalgesia (1-10 mg/kg).  Maximum percent reversal (67%) was seen 1 h postadministration at 10 mg/kg (the highest dose studied).  DiPOA also proved antihyperalgesic in a model of postsurgical pain with a max. percent reversal of 85% 1 h postadministration at 30 mg/kg i.p. (the highest dose studied).  DiPOA administered i.p. had no effect in the tail flick assay of acute pain (0.1-10 mg/kg), produced no ataxia as measured by latency to fall from an accelerating rotarod (3-30 mg/kg), and was not antihyperalgesic in the Seltzer model of neuropathic pain (1-10 mg/kg).  This is the first report of a peripherally restricted, small-mol. mu opioid agonist that is nonsedating, antihyperalgesic, and effective against inflammatory and postsurgical pain when administered systemically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCIgpGdUguarVg90H21EOLACvtfcHk0lhSoQHn0c41Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVykt74%253D&md5=c366a0425c235549967f4d86da17f586</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.063560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.063560%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DHarrison%26aufirst%3DJ.%2BE.%26aulast%3DPearson%26aufirst%3DM.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DRotshteyn%26aufirst%3DY.%26aulast%3DTurchin%26aufirst%3DP.%2BI.%26aulast%3DPomonis%26aufirst%3DJ.%2BD.%26aulast%3DMark%26aufirst%3DL.%26aulast%3DWalker%26aufirst%3DK.%26aulast%3DBrogl%25C3%25A8%26aufirst%3DK.%2BC.%26atitle%3DDiPOA%2520%2528%255B8-%25283%252C3-Diphenyl-propyl%2529-4-oxo-1-phenyl-1%252C3%252C8-triazaspiro%255B4.5%255Ddec-3-yl%255D-acetic%2520Acid%2529%252C%2520a%2520novel%252C%2520systemically%2520available%252C%2520and%2520peripherally%2520restricted%2520mu%2520opioid%2520agonist%2520with%2520antihyperalgesic%2520activity%253A%2520II.%2520In%2520vivo%2520pharmacological%2520characterization%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D793%26epage%3D799%26doi%3D10.1124%2Fjpet.103.063560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bileviciute-Ljungar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spetea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windisch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidhammer, H.</span></span> <span> </span><span class="NLM_article-title">Peripherally mediated antinociception of the m-opioid receptor agonist 2-[(4,5g-Epoxy-3-hydroxy-14βmethoxy-17-methylmorphinan-6βyl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.096032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1124%2Fjpet.105.096032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=16339394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVWmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=220-227&author=I.+Bileviciute-Ljungarauthor=M.+Speteaauthor=Y.+Guoauthor=J.+Sch%C3%BCtzauthor=P.+Windischauthor=H.+Schmidhammer&title=Peripherally+mediated+antinociception+of+the+m-opioid+receptor+agonist+2-%5B%284%2C5g-Epoxy-3-hydroxy-14%CE%B2methoxy-17-methylmorphinan-6%CE%B2yl%29amino%5Dacetic+acid+%28HS-731%29+after+subcutaneous+and+oral+administration+in+rats+with+carrageenan-induced+hindpaw+inflammation&doi=10.1124%2Fjpet.105.096032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally mediated antinociception of the μ-opioid receptor agonist 2-[(4,5α-epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation</span></div><div class="casAuthors">Bileviciute-Ljungar, Indre; Spetea, Mariana; Guo, Yan; Schutz, Johannes; Windisch, Petra; Schmidhammer, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Opioids induce analgesia by activating opioid receptors not only within the central nervous system but also on peripheral sensory neurons.  This study investigated peripherally mediated antinociception produced by the μ-opioid receptor agonist 2-[(4,5α-epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic acid (HS-731) after s.c. and oral administration in rats with carrageenan-induced hindpaw inflammation.  Antinociceptive effects after s.c. administration were assessed 3 h after intraplantar carrageenan injection and compared with those of centrally acting μ-opioid agonists 14-methoxymetopon and morphine.  Opioid agonists caused dose-dependent increases in inflamed paw withdrawal latencies to mech. and thermal stimulation.  The time course of action was different, in that HS-731 (20 μg/kg s.c.) produced significant long-lasting effects up to 4 h after administration, whereas 14-methoxymetopon (20 μg/kg) and morphine (2 mg/kg) reached their peak of action at 10 to 30 min, and their effect declined rapidly thereafter.  S.c. administration of the peripherally selective opioid antagonist naloxone methiodide inhibited antinociception elicited by HS-731 (20 μg/kg s.c.), whereas it was ineffective against 14-methoxymetopon (20 μg/kg s.c.).  Moreover, the antinociception produced by 100 μg/kg s.c. HS-731 was dose-dependently reversed by s.c. naloxone methiodide.  This indicates that HS-731 preferentially activates peripheral opioid receptors, whereas 14-methoxymetopon mediates analgesia via central mechanisms.  Orally administered HS-731 significantly reduced hyperalgesia in the inflamed paw induced by carrageenan, which was reversible by s.c. administered naloxone methiodide.  These results show that systemic (s.c. and oral) treatment with the μ-opioid agonist HS-731 produces potent and long-lasting antinociception through peripheral mechanisms in rats with carrageenan-induced hindpaw inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlV0UnJMuSLVg90H21EOLACvtfcHk0lhSoQHn0c41Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVWmt7c%253D&md5=ed14cf0f039457fa728595cbdaa178f6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.096032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.096032%26sid%3Dliteratum%253Aachs%26aulast%3DBileviciute-Ljungar%26aufirst%3DI.%26aulast%3DSpetea%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DJ.%26aulast%3DWindisch%26aufirst%3DP.%26aulast%3DSchmidhammer%26aufirst%3DH.%26atitle%3DPeripherally%2520mediated%2520antinociception%2520of%2520the%2520m-opioid%2520receptor%2520agonist%25202-%255B%25284%252C5g-Epoxy-3-hydroxy-14%25CE%25B2methoxy-17-methylmorphinan-6%25CE%25B2yl%2529amino%255Dacetic%2520acid%2520%2528HS-731%2529%2520after%2520subcutaneous%2520and%2520oral%2520administration%2520in%2520rats%2520with%2520carrageenan-induced%2520hindpaw%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D220%26epage%3D227%26doi%3D10.1124%2Fjpet.105.096032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span> <span> </span><span class="NLM_article-title">Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1506</span>– <span class="NLM_lpage">1509</span>, <span class="refDoi"> DOI: 10.1248/cpb.47.1506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1248%2Fcpb.47.1506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10553648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK1MXmslCqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1999&pages=1506-1509&author=Y.+Sasakiauthor=T.+Sutoauthor=A.+Amboauthor=H.+Ouchiauthor=Y.+Yamamoto&title=Biological+properties+of+opioid+peptides+replacing+Tyr+at+position+1+by+2%2C6-dimethyl-Tyr&doi=10.1248%2Fcpb.47.1506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-tyrosine</span></div><div class="casAuthors">Sasaki, Yusuke; Suto, Takuya; Ambo, Akihiro; Ouchi, Hidekazu; Yamamoto, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1506-1509</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">To understand the effect of the replacement of Tyr residue at position 1 in opioid peptides by 2,6-dimethyl-Tyr (Dmt) on the biol. property, chiral (D or L) Dmt1 analogs of Leu-enkephalin (Enk) and Tyr-D-Arg-Phe-βAla-NH2 (YRFB) were synthesized and their enzymic stabilities, in vitro bioactivities and receptor binding affinities compared with those of parent peptides.  [L-Dmt1]Enk (1) exhibited 4-fold higher stability against aminopeptidase-M and possessed dramatically increased activities in guinea pig ileum (GPI) (187-fold) and mouse vas deferens (MVD) (131-fold) assays, and in rat brain receptor binding assays (356-fold at μ receptor and 46-fold at δ receptor) as compared to Enk.  [L-Dmt1]YRFB (3) also exhibited increased activities in GPI (46-fold) and MVD (177-fold) assays, and in the binding assays (69-fold at μ receptor and 341-fold at δ receptor) as compared to the parent peptide.  [D-Dmt1]Enk (2) and [D-Dmt1]YRFB (4) exhibited activities with diminished or lesser potency than the parent peptide in all assays.  These results indicate that there is a tendency for μ affinity to be enhanced more than δ affinity with introduction of L-Dmt into δ ligand peptide (Enk), and for δ affinity to be enhanced more than μ affinity in case of μ ligand peptide (YRFB), resulting in reduced receptor selectivities at the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkokfMI34avLVg90H21EOLACvtfcHk0lhSoQHn0c41Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslCqt7s%253D&md5=4d6d864805d50ae7a56d8afed20ed4d7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1248%2Fcpb.47.1506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.47.1506%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DSuto%26aufirst%3DT.%26aulast%3DAmbo%26aufirst%3DA.%26aulast%3DOuchi%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26atitle%3DBiological%2520properties%2520of%2520opioid%2520peptides%2520replacing%2520Tyr%2520at%2520position%25201%2520by%25202%252C6-dimethyl-Tyr%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1999%26volume%3D47%26spage%3D1506%26epage%3D1509%26doi%3D10.1248%2Fcpb.47.1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pogozheva, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomize, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosberg, H. I.</span></span> <span> </span><span class="NLM_article-title">Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">612</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/S0006-3495(98)77552-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2FS0006-3495%2898%2977552-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=9675164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK1cXltFyitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=612-634&author=I.+D.+Pogozhevaauthor=A.+L.+Lomizeauthor=H.+I.+Mosberg&title=Opioid+receptor+three-dimensional+structures+from+distance+geometry+calculations+with+hydrogen+bonding+constraints&doi=10.1016%2FS0006-3495%2898%2977552-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints</span></div><div class="casAuthors">Pogozheva, Irina D.; Lomize, Andrei L.; Mosberg, Henry I.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">612-634</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">Three-dimensional structures of the transmembrane, seven α-helical domains and extracellular loops of δ, μ, and κ opioid receptors, were calcd. using the distance geometry algorithm, with hydrogen bonding constraints based on the previously developed general model of the transmembrane α-bundle for rhodopsin-like G-protein coupled receptors (Biophys. J. 1997. 70:1963).  Each calcd. opioid receptor structure has an extensive network of interhelical hydrogen bonds and a ligand-binding crevice that is partially covered by a β-hairpin formed by the second extracellular loop.  The binding cavities consist of an inner "conserved region" composed of 18 residues that are identical in δ, μ, and κ opioid receptors, and a peripheral "variable region," composed of 19 residues that are different in δ, μ, and κ subtypes and are responsible for the subtype specificity of various ligands.  Sixteen δ-, μ-, or κ-selective, conformationally constrained peptide and nonpeptide opioid agonists and antagonists and affinity labels were fit into the binding pockets of the opioid receptors.  All ligands considered have a similar spatial arrangement in the receptors, with the tyramine moiety of alkaloids or Tyr1 of opioid peptides interacting with conserved residues in the bottom of the pocket and the tyramine N+ and OH groups forming ionic interactions or H-bonds with a conserved aspartate from helix III and a conserved histidine from helix VI, resp.  The central, conformationally constrained fragments of the opioids (the disulfide-bridged cycles of the peptides and various ring structures in the nonpeptide ligands) are oriented approx. perpendicular to the tyramine and directed toward the extracellular surface.  The results obtained are qual. consistent with ligand affinities, crosslinking studies, and mutagenesis data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomsqriUZlUkLVg90H21EOLACvtfcHk0liQhbLFUQUUqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFyitr4%253D&md5=d676d455db7c5e99247284e4315c2a04</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977552-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977552-6%26sid%3Dliteratum%253Aachs%26aulast%3DPogozheva%26aufirst%3DI.%2BD.%26aulast%3DLomize%26aufirst%3DA.%2BL.%26aulast%3DMosberg%26aufirst%3DH.%2BI.%26atitle%3DOpioid%2520receptor%2520three-dimensional%2520structures%2520from%2520distance%2520geometry%2520calculations%2520with%2520hydrogen%2520bonding%2520constraints%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D75%26spage%3D612%26epage%3D634%26doi%3D10.1016%2FS0006-3495%2898%2977552-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidlack, J. M.</span></span> <span> </span><span class="NLM_article-title">Cyclazocine revisited</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1007/BF02532378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1007%2FBF02532378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=8947927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1Okurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=1369-1373&author=S.+Archerauthor=S.+D.+Glickauthor=J.+M.+Bidlack&title=Cyclazocine+revisited&doi=10.1007%2FBF02532378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclazocine revisited</span></div><div class="casAuthors">Archer, Sydney; Glick, Stanley D.; Bidlack, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1369-1373</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">Recently synthesized compds. which have long-term mu antagonist activity and short-term kappa agonist effects prevent self-administration of cocaine and morphine in rats.  Cyclazocine, a compd. synthesized in 1962 and studied in animals and man in the 1960's and in the early 1970's is a mu antagonist in rats and man and is a potent kappa agonist in both species.  It also prevents self-administration of cocaine and morphine in rats.  Although it produces unpleasant side effects in man, subjects become tolerant to these side effects but not to the antagonistic actions of the drug after prolonged administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLCN_lEZbabVg90H21EOLACvtfcHk0liQhbLFUQUUqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1Okurg%253D&md5=3006d809a84276b480ebfc9247424a46</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02532378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02532378%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DGlick%26aufirst%3DS.%2BD.%26aulast%3DBidlack%26aufirst%3DJ.%2BM.%26atitle%3DCyclazocine%2520revisited%26jtitle%3DNeurochem.%2520Res.%26date%3D1996%26volume%3D21%26spage%3D1369%26epage%3D1373%26doi%3D10.1007%2FBF02532378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenard, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roerig, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portoghese, P. S.</span></span> <span> </span><span class="NLM_article-title">Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">19208</span>– <span class="NLM_lpage">19213</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506627102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1073%2Fpnas.0506627102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=16365317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XivV2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=19208-19213&author=D.+J.+Danielsauthor=N.+R.+Lenardauthor=C.+L.+Etienneauthor=P.+Y.+Lawauthor=S.+C.+Roerigauthor=P.+S.+Portoghese&title=Opioid-induced+tolerance+and+dependence+in+mice+is+modulated+by+the+distance+between+pharmacophores+in+a+bivalent+ligand+series&doi=10.1073%2Fpnas.0506627102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series</span></div><div class="casAuthors">Daniels, David J.; Lenard, Natalie R.; Etienne, Chris L.; Law, Ping-Yee; Roerig, Sandra C.; Portoghese, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">19208-19213</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Given the mounting evidence for involvement of δ opioid receptors in the tolerance and phys. dependence of μ opioid receptor agonists, the authors have investigated the possible phys. interaction between μ and δ opioid receptors by using bivalent ligands.  Based on reports of suppression of antinociceptive tolerance by the δ antagonist naltrindole (NTI), bivalent ligands [μ-δ agonist-antagonist (MDAN) series] that contain different length spacers, and pharmacophores derived from NTI and the μ agonist oxymorphone, have been synthesized and evaluated by intracerebroventricular (i.c.v.) administration in the tail-flick test in mice.  In acute i.c.v. studies, the bivalent ligands functioned as agonists with potencies ranging from 1.6- to 45-fold greater than morphine.  In contrast, the monovalent μ agonist analogs were substantially more potent than the MDAN congeners and were essentially equipotent with one another and oxymorphone.  Pretreatment with NTI decreased the ED50 values for MDAN-19 to a greater degree than for MDAN-16 but had no effect on MDAN-21.  Chronic i.c.v. studies revealed that MDAN ligands whose spacer was 16 atoms or longer produced less dependence than either morphine or μ monovalent control MA-19.  On the other hand, both phys. dependence and tolerance were suppressed at MDAN spacer lengths of 19 atoms or greater.  These data suggest that phys. interaction between the μ and δ opioid receptors modulates μ-mediated tolerance and dependence.  Because MDAN-21 was found to be 50-fold more potent than morphine by the i.v. route (i.v.), it offers a previously uncharacterized approach for the development of analgesics devoid of tolerance and dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonz5CFnYjrYrVg90H21EOLACvtfcHk0liQhbLFUQUUqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivV2nuw%253D%253D&md5=eaa04a16db78abe66a01eb1c16756c21</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506627102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506627102%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DD.%2BJ.%26aulast%3DLenard%26aufirst%3DN.%2BR.%26aulast%3DEtienne%26aufirst%3DC.%2BL.%26aulast%3DLaw%26aufirst%3DP.%2BY.%26aulast%3DRoerig%26aufirst%3DS.%2BC.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DOpioid-induced%2520tolerance%2520and%2520dependence%2520in%2520mice%2520is%2520modulated%2520by%2520the%2520distance%2520between%2520pharmacophores%2520in%2520a%2520bivalent%2520ligand%2520series%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D19208%26epage%3D19213%26doi%3D10.1073%2Fpnas.0506627102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilkenny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthill, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, D. G.</span></span> <span> </span><span class="NLM_article-title">Animal research: reporting in vivo experiments: the ARRIVE guidelines</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1579</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00872.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1111%2Fj.1476-5381.2010.00872.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=20649561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1577-1579&author=C.+Kilkennyauthor=W.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Animal+research%3A+reporting+in+vivo+experiments%3A+the+ARRIVE+guidelines&doi=10.1111%2Fj.1476-5381.2010.00872.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Animal research: Reporting in vivo experiments: the arrive guidelines</span></div><div class="casAuthors">Kilkenny, Carol; Browne, William; Cuthill, Innes C.; Emerson, Michael; Altman, Douglas G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1577-1579</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWTuV0uX4LbVg90H21EOLACvtfcHk0ljjZLawPrsLLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSqtLk%253D&md5=2812fe0670e4f613a0b0aa3da03e5e7c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00872.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00872.x%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DAnimal%2520research%253A%2520reporting%2520in%2520vivo%2520experiments%253A%2520the%2520ARRIVE%2520guidelines%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26spage%3D1577%26epage%3D1579%26doi%3D10.1111%2Fj.1476-5381.2010.00872.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilley, E.</span></span> <span> </span><span class="NLM_article-title">Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">3189</span>– <span class="NLM_lpage">3193</span>, <span class="refDoi"> DOI: 10.1111/bph.12955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1111%2Fbph.12955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=25964986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3189-3193&author=J.+C.+McGrathauthor=E.+Lilley&title=Implementing+guidelines+on+reporting+research+using+animals+%28ARRIVE+etc.%29%3A+new+requirements+for+publication+in+BJP&doi=10.1111%2Fbph.12955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP</span></div><div class="casAuthors">McGrath, John C.; Lilley, Elliot</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3189-3193</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The ARRIVE guidelines have been implemented in BJP for 4 years with the aim of increasing transparency in reporting expts. involving animals.  BJP has assessed our success in implementing them and concluded that we could do better.  This editorial discusses the issues and explains how we are changing our requirements for authors to report their findings in expts. involving animals.  This is one of a series of discussing updates to the BJP Linked Editorials : This Editorial is part of a series.  To view the other Editorials in this series, visit: ; ; and .  Video : To view the video on the ARRIVE guidelines, visit:.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-Be_pTHIX1rVg90H21EOLACvtfcHk0ljjZLawPrsLLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rO&md5=8525b931d44bd6640a6649ad2f43f733</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fbph.12955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12955%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DJ.%2BC.%26aulast%3DLilley%26aufirst%3DE.%26atitle%3DImplementing%2520guidelines%2520on%2520reporting%2520research%2520using%2520animals%2520%2528ARRIVE%2520etc.%2529%253A%2520new%2520requirements%2520for%2520publication%2520in%2520BJP%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3189%26epage%3D3193%26doi%3D10.1111%2Fbph.12955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen A; Berge O G; Hunskaar S; Rosland J H; Hole K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eY9YV8wTUOzv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giembycz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacEwan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonnacott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, J. C.</span></span> <span> </span><span class="NLM_article-title">Experimental design and analysis and their reporting: new guidance for publication in BJP</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">3461</span>– <span class="NLM_lpage">3471</span>, <span class="refDoi"> DOI: 10.1111/bph.12856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1111%2Fbph.12856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=26114403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3461-3471&author=M.+J.+Curtisauthor=R.+A.+Bondauthor=D.+Spinaauthor=A.+Ahluwaliaauthor=S.+P.+Alexanderauthor=M.+A.+Giembyczauthor=A.+Gilchristauthor=D.+Hoyerauthor=P.+A.+Inselauthor=A.+A.+Izzoauthor=A.+J.+Lawrenceauthor=D.+J.+MacEwanauthor=L.+D.+Moonauthor=S.+Wonnacottauthor=A.+H.+Westonauthor=J.+C.+McGrath&title=Experimental+design+and+analysis+and+their+reporting%3A+new+guidance+for+publication+in+BJP&doi=10.1111%2Fbph.12856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental design and analysis and their reporting: new guidance for publication in BJP</span></div><div class="casAuthors">Curtis, Michael J.; Bond, Richard A.; Spina, Domenico; Ahluwalia, Amrita; Alexander, Stephen P. A.; Giembycz, Mark A.; Gilchrist, Annette; Hoyer, Daniel; Insel, Paul A.; Izzo, Angelo A.; Lawrence, Andrew J.; MacEwan, David J.; Moon, Lawrence D. F.; Wonnacott, Sue; Weston, Arthur H.; McGrath, John C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3461-3471</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Linked Editorials : This Editorial is part of a series.  To view the other Editorials in this series, visit: ; ; and.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Jd_c_V1H0rVg90H21EOLACvtfcHk0lghmI_QjYvZNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurrJ&md5=766587bc5c1f7142ab57bf8f276fe12b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fbph.12856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12856%26sid%3Dliteratum%253Aachs%26aulast%3DCurtis%26aufirst%3DM.%2BJ.%26aulast%3DBond%26aufirst%3DR.%2BA.%26aulast%3DSpina%26aufirst%3DD.%26aulast%3DAhluwalia%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DS.%2BP.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26aulast%3DGilchrist%26aufirst%3DA.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DInsel%26aufirst%3DP.%2BA.%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DLawrence%26aufirst%3DA.%2BJ.%26aulast%3DMacEwan%26aufirst%3DD.%2BJ.%26aulast%3DMoon%26aufirst%3DL.%2BD.%26aulast%3DWonnacott%26aufirst%3DS.%26aulast%3DWeston%26aufirst%3DA.%2BH.%26aulast%3DMcGrath%26aufirst%3DJ.%2BC.%26atitle%3DExperimental%2520design%2520and%2520analysis%2520and%2520their%2520reporting%253A%2520new%2520guidance%2520for%2520publication%2520in%2520BJP%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3461%26epage%3D3471%26doi%3D10.1111%2Fbph.12856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLane, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergquist, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cormier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsky, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span> <span> </span><span class="NLM_article-title">Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2Fj.lfs.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=28723417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WqsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2017&pages=1-7&author=V.+D.+McLaneauthor=I.+Bergquistauthor=J.+Cormierauthor=D.+J.+Barlowauthor=K.+L.+Houseknechtauthor=E.+J.+Bilskyauthor=L.+Cao&title=Long-term+morphine+delivery+via+slow+release+morphine+pellets+or+osmotic+pumps%3A+Plasma+concentration%2C+analgesia%2C+and+naloxone-precipitated+withdrawal&doi=10.1016%2Fj.lfs.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal</span></div><div class="casAuthors">McLane, Virginia D.; Bergquist, Ivy; Cormier, James; Barlow, Deborah J.; Houseknecht, Karen L.; Bilsky, Edward J.; Cao, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Slow-release morphine sulfate pellets and osmotic pumps are common routes of chronic morphine delivery in mouse models, but direct comparisons of these drug delivery systems are lacking.  In this study, we assessed the efficacy of slow-release pellets vs. osmotic pumps in delivering morphine to adult mice.  Male C57BL/6NCr mice (8 wk old) were implanted s.c. with slow-release pellets (25 mg morphine sulfate) or osmotic pumps (64 mg/mL, 1.0 μL/h).  Plasma morphine concns. were quantified via LC-MS/MS, analgesic efficacy was detd. by tail flick assay, and dependence was assessed with naloxone-pptd. withdrawal behaviors (jumping) and physiol. effects (excretion, wt. loss).  Morphine pellets delivered significantly higher plasma drug concns. compared to osmotic pumps, which were limited by the soly. of the morphine sulfate and pump vol./flow rate.  Within 96 h post-implantation, plasma morphine concns. were indistinguishable in pellet vs. pump-treated samples.  While osmotic pump did not have an antinociceptive effect in the tail flick assay, pumps and pellets induced comparable dependence symptoms (naloxone-pptd. jumping behavior) from 24-72 h post-implantation.  In this study, we compared slow-release morphine pellets to osmotic minipumps for morphine delivery in mice.  We found that osmotic pumps and s.c. morphine sulfate pellets yielded significantly different pharmacokinetics over a 7-day period, and as a result significantly different antinociceptive efficacy.  Nonetheless, both delivery methods induced dependence as measured by naloxone-pptd. withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMVEKRpARU77Vg90H21EOLACvtfcHk0lghmI_QjYvZNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WqsrrP&md5=8211027f5149fc9ce0eb659c4856d4f3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DMcLane%26aufirst%3DV.%2BD.%26aulast%3DBergquist%26aufirst%3DI.%26aulast%3DCormier%26aufirst%3DJ.%26aulast%3DBarlow%26aufirst%3DD.%2BJ.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DCao%26aufirst%3DL.%26atitle%3DLong-term%2520morphine%2520delivery%2520via%2520slow%2520release%2520morphine%2520pellets%2520or%2520osmotic%2520pumps%253A%2520Plasma%2520concentration%252C%2520analgesia%252C%2520and%2520naloxone-precipitated%2520withdrawal%26jtitle%3DLife%2520Sci.%26date%3D2017%26volume%3D185%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.lfs.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascarella, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westkaemper, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human kappa-opioid receptor in complex with JDTic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1038/nature10939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fnature10939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=22437504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVegt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=327-332&author=H.+Wuauthor=D.+Wackerauthor=M.+Mileniauthor=V.+Katritchauthor=G.+W.+Hanauthor=E.+Vardyauthor=W.+Liuauthor=A.+A.+Thompsonauthor=X.+P.+Huangauthor=F.+I.+Carrollauthor=S.+W.+Mascarellaauthor=R.+B.+Westkaemperauthor=P.+D.+Mosierauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+kappa-opioid+receptor+in+complex+with+JDTic&doi=10.1038%2Fnature10939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human κ-opioid receptor in complex with JDTic</span></div><div class="casAuthors">Wu, Huixian; Wacker, Daniel; Mileni, Mauro; Katritch, Vsevolod; Han, Gye Won; Vardy, Eyal; Liu, Wei; Thompson, Aaron A.; Huang, Xi-Ping; Carroll, F. Ivy; Mascarella, S. Wayne; Westkaemper, Richard B.; Mosier, Philip D.; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">327-332</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiol. processes, including the regulation of pain, respiratory drive, mood, and -in the case of κ-opioid receptor (κ-OR)- dysphoria and psychotomimesis.  Here we report the crystal structure of the human κ-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 Å resoln.  The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human κ-OR.  Modeling of other important κ-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5'-guanidinonaltrindole, and the diterpene agonist salvinorin A analog RB-64, reveals both common and distinct features for binding these diverse chemotypes.  Anal. of site-directed mutagenesis and ligand structure-activity relationships confirms the interactions obsd. in the crystal structure, thereby providing a mol. explanation for κ-OR subtype selectivity, and essential insights for the design of compds. with new pharmacol. properties targeting the human κ-OR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpARTr4eE_zZbVg90H21EOLACvtfcHk0lghmI_QjYvZNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVegt7k%253D&md5=c54dd24df9065ed3b1a51420e74e2542</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnature10939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10939%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DWestkaemper%26aufirst%3DR.%2BB.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520kappa-opioid%2520receptor%2520in%2520complex%2520with%2520JDTic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D327%26epage%3D332%26doi%3D10.1038%2Fnature10939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A force field providing broad coverage of drug-like small molecules and proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lh3NNPUlHKhSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, N.</span></span> <span> </span><span class="NLM_article-title">ChemDraw Ultra 10.0</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">13649</span>– <span class="NLM_lpage">13650</span>, <span class="refDoi"> DOI: 10.1021/ja0697875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0697875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=13649-13650&author=N.+Mills&title=ChemDraw+Ultra+10.0&doi=10.1021%2Fja0697875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">ChemDraw Ultra 10.0</span></div><div class="casAuthors">Mills, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13649-13650</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSDwZrNGK3c7Vg90H21EOLACvtfcHk0lh3NNPUlHKhSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFequr8%253D&md5=994150d3069bed3f48d411c429b54a78</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja0697875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0697875%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DN.%26atitle%3DChemDraw%2520Ultra%252010.0%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D13649%26epage%3D13650%26doi%3D10.1021%2Fja0697875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">2794</span>– <span class="NLM_lpage">2812</span>, <span class="refDoi"> DOI: 10.1002/prot.23106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fprot.23106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=21905107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFehsLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=2794-2812&author=J.+Liauthor=R.+Abelauthor=K.+Zhuauthor=Y.+Caoauthor=S.+Zhaoauthor=R.+A.+Friesner&title=The+VSGB+2.0+model%3A+a+next+generation+energy+model+for+high+resolution+protein+structure+modeling&doi=10.1002%2Fprot.23106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling</span></div><div class="casAuthors">Li, Jianing; Abel, Robert; Zhu, Kai; Cao, Yixiang; Zhao, Suwen; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2794-2812</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A novel energy model (VSGB 2.0) for high resoln. protein structure modeling is described, which features an optimized implicit solvent model as well as physics-based corrections for hydrogen bonding, π-π interactions, self-contact interactions, and hydrophobic interactions.  Parameters of the VSGB 2.0 model were fit to a crystallog. database of 2239 single side chain and 100 11-13 residue loop predictions.  Combined with an advanced method of sampling and a robust algorithm for protonation state assignment, the VSGB 2.0 model was validated by predicting 115 super long loops up to 20 residues.  Despite the dramatically increasing difficulty in reconstructing longer loops, a high accuracy was achieved: all of the lowest energy conformations have global backbone RMSDs better than 2.0 Å from the native conformations.  Av. global backbone RMSDs of the predictions are 0.51, 0.63, 0.70, 0.62, 0.80, 1.41, and 1.59 Å for 14, 15, 16, 17, 18, 19, and 20 residue loop predictions, resp.  When these results are cor. for possible statistical bias as explained in the text, the av. global backbone RMSDs are 0.61, 0.71, 0.86, 0.62, 1.06, 1.67, and 1.59 Å.  Given the precision and robustness of the calcns., the authors believe that the VSGB 2.0 model is suitable to tackle "real" problems, such as biol. function modeling and structure-based drug discovery.  Proteins 2011; © 2011 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXSQ9URQR6obVg90H21EOLACvtfcHk0lhfnWJq8Q3UCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFehsLfK&md5=cb63aef455d13520c8ed94b99eae2287</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fprot.23106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.23106%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DThe%2520VSGB%25202.0%2520model%253A%2520a%2520next%2520generation%2520energy%2520model%2520for%2520high%2520resolution%2520protein%2520structure%2520modeling%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2011%26volume%3D79%26spage%3D2794%26epage%3D2812%26doi%3D10.1002%2Fprot.23106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span> <span> </span><span class="NLM_article-title">Accurate prediction of the relative potencies of members of a series of kinase inhibitors using Molecular Docking and MM-GBSA Scoring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4808</span>, <span class="refDoi"> DOI: 10.1021/jm060522a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060522a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4805-4808&author=P.+D.+Lyneauthor=M.+L.+Lambauthor=J.+C.+Saeh&title=Accurate+prediction+of+the+relative+potencies+of+members+of+a+series+of+kinase+inhibitors+using+Molecular+Docking+and+MM-GBSA+Scoring&doi=10.1021%2Fjm060522a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA Scoring</span></div><div class="casAuthors">Lyne, Paul D.; Lamb, Michelle L.; Saeh, Jamal C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4805-4808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability of mol. docking, using the program Glide and an MM-GBSA postdocking scoring protocol, to correctly rank a no. of congeneric kinase inhibitors was assessed.  The approach was successful for the cases considered and suggests that this may be useful for the design of inhibitors in the lead optimization phase of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVyYUu0E1ua7Vg90H21EOLACvtfcHk0lhfnWJq8Q3UCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFGjs7s%253D&md5=ea44ed5036a1569d191481bf10c74889</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060522a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060522a%26sid%3Dliteratum%253Aachs%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26atitle%3DAccurate%2520prediction%2520of%2520the%2520relative%2520potencies%2520of%2520members%2520of%2520a%2520series%2520of%2520kinase%2520inhibitors%2520using%2520Molecular%2520Docking%2520and%2520MM-GBSA%2520Scoring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4805%26epage%3D4808%26doi%3D10.1021%2Fjm060522a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ucurum, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotiadis, D.</span></span> <span> </span><span class="NLM_article-title">Engineering a chemical switch into the light-driven proton pump proteorhodopsin by cysteine mutagenesis and thiol modification</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8846</span>– <span class="NLM_lpage">8849</span>, <span class="refDoi"> DOI: 10.1002/anie.201601537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fanie.201601537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=8846-8849&author=D.+Harderauthor=S.+Hirschiauthor=Z.+Ucurumauthor=R.+Goersauthor=W.+Meierauthor=D.+J.+M%C3%BCllerauthor=D.+Fotiadis&title=Engineering+a+chemical+switch+into+the+light-driven+proton+pump+proteorhodopsin+by+cysteine+mutagenesis+and+thiol+modification&doi=10.1002%2Fanie.201601537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering a Chemical Switch into the Light-driven Proton Pump Proteorhodopsin by Cysteine Mutagenesis and Thiol Modification</span></div><div class="casAuthors">Harder, Daniel; Hirschi, Stephan; Ucurum, Zoehre; Goers, Roland; Meier, Wolfgang; Mueller, Daniel J.; Fotiadis, Dimitrios</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">8846-8849</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">For applications in synthetic biol., for example, the bottom-up assembly of biomol. nanofactories, modules of specific and controllable functionalities are essential.  Of fundamental importance in such systems are energizing modules, which are able to establish an electrochem. gradient across a vesicular membrane as an energy source for powering other modules.  Light-driven proton pumps like proteorhodopsin (PR) are excellent candidates for efficient energy conversion.  We have extended the versatility of PR by implementing an on/off switch based on reversible chem. modification of a site-specifically introduced cysteine residue.  The position of this cysteine residue in PR was identified by structure-based cysteine mutagenesis combined with a proton-pumping assay using E. coli cells overexpressing PR and PR proteoliposomes.  The identified PR mutant represents the first light-driven proton pump that can be chem. switched on/off depending on the requirements of the mol. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqghhyONGTbPrVg90H21EOLACvtfcHk0lhfnWJq8Q3UCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWrs74%253D&md5=cfe0be5674fdb2d9a8be029bccf0dddb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601537%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DD.%26aulast%3DHirschi%26aufirst%3DS.%26aulast%3DUcurum%26aufirst%3DZ.%26aulast%3DGoers%26aufirst%3DR.%26aulast%3DMeier%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BJ.%26aulast%3DFotiadis%26aufirst%3DD.%26atitle%3DEngineering%2520a%2520chemical%2520switch%2520into%2520the%2520light-driven%2520proton%2520pump%2520proteorhodopsin%2520by%2520cysteine%2520mutagenesis%2520and%2520thiol%2520modification%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D8846%26epage%3D8849%26doi%3D10.1002%2Fanie.201601537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Salvatore Pacifico, Valentina Albanese, Davide Illuminati, Erika Marzola, Martina Fabbri, Federica Ferrari, Victor A.D. Holanda, Chiara Sturaro, Davide Malfacini, Chiara Ruzza, Claudio Trapella, Delia Preti, Ettore Lo Cascio, Alessandro Arcovito, Stefano Della Longa, Martina Marangoni, Davide Fattori, Romina Nassini, Girolamo Calò, <span class="NLM_string-name hlFld-ContribAuthor">Remo Guerrini</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Mixed NOP/Opioid Receptor Peptide Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6656-6669. <a href="https://doi.org/10.1021/acs.jmedchem.0c02062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02062%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BMixed%252BNOP%25252FOpioid%252BReceptor%252BPeptide%252BAgonists%26aulast%3DPacifico%26aufirst%3DSalvatore%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27112020%26date%3D17052021%26volume%3D64%26issue%3D10%26spage%3D6656%26epage%3D6669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Danni Cao, Peng Huang, Yi-Ting Chiu, Chongguang Chen, Huiqun Wang, Mengchu Li, Yi Zheng, Frederick J. Ehlert, Yan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Lee-Yuan Liu-Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (19)
                                     , 3036-3050. <a href="https://doi.org/10.1021/acschemneuro.0c00407" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00407%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DComparison%252Bof%252BPharmacological%252BProperties%252Bbetween%252Bthe%252BKappa%252BOpioid%252BReceptor%252BAgonist%252BNalfurafine%252Band%252B42B%25252C%252BIts%252B3-Dehydroxy%252BAnalogue%25253A%252BDisconnect%252Bbetween%252Bin%252BVitro%252BAgonist%252BBias%252Band%252Bin%252BVivo%252BPharmacological%252BEffects%26aulast%3DCao%26aufirst%3DDanni%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01072020%26date%3D08092020%26date%3D24092020%26date%3D08092020%26volume%3D11%26issue%3D19%26spage%3D3036%26epage%3D3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zhuang</span>, <span class="hlFld-ContribAuthor ">Jiaying  Xiong</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Hao</span>, <span class="hlFld-ContribAuthor ">Wei  Du</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Bifeng  Liu</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced side effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113658. <a href="https://doi.org/10.1016/j.ejmech.2021.113658" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113658%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252B%2525CE%2525BC%252Bopioid%252Band%252B%2525CF%2525831%252Breceptor%252Bligands%252Bas%252Bnovel%252Banalgesics%252Bwith%252Breduced%252Bside%252Beffects%26aulast%3DZhuang%26aufirst%3DTao%26date%3D2021%26volume%3D223%26spage%3D113658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  Della Valle</span>, <span class="hlFld-ContribAuthor ">Azzurra  Stefanucci</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Scioli</span>, <span class="hlFld-ContribAuthor ">Edina  Szűcs</span>, <span class="hlFld-ContribAuthor ">Sándor  Benyhe</span>, <span class="hlFld-ContribAuthor ">Stefano  Pieretti</span>, <span class="hlFld-ContribAuthor ">Paola  Minosi</span>, <span class="hlFld-ContribAuthor ">Chiara  Sturaro</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calò</span>, <span class="hlFld-ContribAuthor ">Gokhan  Zengin</span>, <span class="hlFld-ContribAuthor ">Adriano  Mollica</span>. </span><span class="cited-content_cbyCitation_article-title">Selective MOR activity of DAPEA and Endomorphin-2 analogues containing a (R)-γ-Freidinger lactam in position two. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>115 </em>, 105219. <a href="https://doi.org/10.1016/j.bioorg.2021.105219" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105219%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSelective%252BMOR%252Bactivity%252Bof%252BDAPEA%252Band%252BEndomorphin-2%252Banalogues%252Bcontaining%252Ba%252B%252528R%252529-%2525CE%2525B3-Freidinger%252Blactam%252Bin%252Bposition%252Btwo%26aulast%3DDella%2BValle%26aufirst%3DAlice%26date%3D2021%26volume%3D115%26spage%3D105219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Rama  Gunta</span>, <span class="hlFld-ContribAuthor ">Huiqun  Wang</span>, <span class="hlFld-ContribAuthor ">Mengchu  Li</span>, <span class="hlFld-ContribAuthor ">Danni  Cao</span>, <span class="hlFld-ContribAuthor ">Rolando E.  Mendez</span>, <span class="hlFld-ContribAuthor ">James C.  Gillespie</span>, <span class="hlFld-ContribAuthor ">Chongguang  Chen</span>, <span class="hlFld-ContribAuthor ">Lan-Hsuan M.  Huang</span>, <span class="hlFld-ContribAuthor ">Lee-Yuan  Liu-Chen</span>, <span class="hlFld-ContribAuthor ">Dana E.  Selley</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4′-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104702. <a href="https://doi.org/10.1016/j.bioorg.2021.104702" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104702%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DVerifying%252Bthe%252Brole%252Bof%252B3-hydroxy%252Bof%252B17-cyclopropylmethyl-4%25252C5%2525CE%2525B1-epoxy-3%25252C14%2525CE%2525B2-dihydroxy-6%2525CE%2525B2-%25255B%2525284%2525E2%252580%2525B2-pyridyl%252529%252Bcarboxamido%25255Dmorphinan%252Bderivatives%252Bvia%252Btheir%252Bbinding%252Baffinity%252Band%252Bselectivity%252Bprofiles%252Bon%252Bopioid%252Breceptors%26aulast%3DHuang%26aufirst%3DBoshi%26date%3D2021%26volume%3D109%26spage%3D104702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azzurra  Stefanucci</span>, <span class="hlFld-ContribAuthor ">Marilisa Pia  Dimmito</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Tenore</span>, <span class="hlFld-ContribAuthor ">Stefano  Pieretti</span>, <span class="hlFld-ContribAuthor ">Paola  Minosi</span>, <span class="hlFld-ContribAuthor ">Gokhan  Zengin</span>, <span class="hlFld-ContribAuthor ">Chiara  Sturaro</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calò</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Angelo  Cichelli</span>, <span class="hlFld-ContribAuthor ">Adriano  Mollica</span>. </span><span class="cited-content_cbyCitation_article-title">Plant-derived peptides rubiscolin-6, soymorphin-6 and their c-terminal amide derivatives: Pharmacokinetic properties and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2020,</strong> <em>73 </em>, 104154. <a href="https://doi.org/10.1016/j.jff.2020.104154" title="DOI URL">https://doi.org/10.1016/j.jff.2020.104154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2020.104154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2020.104154%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DPlant-derived%252Bpeptides%252Brubiscolin-6%25252C%252Bsoymorphin-6%252Band%252Btheir%252Bc-terminal%252Bamide%252Bderivatives%25253A%252BPharmacokinetic%252Bproperties%252Band%252Bbiological%252Bactivity%26aulast%3DStefanucci%26aufirst%3DAzzurra%26date%3D2020%26volume%3D73%26spage%3D104154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design of novel cyclic analogues <b>MACE1</b>–<b>4</b> of biphalin and <b>AM94</b> and their structural modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>MACE1</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA/CH<sub>2</sub>Cl<sub>2</sub> 1:1, rt (1.5 h) for <b>2a</b>,<b>b</b>, <b>6</b>, <b>MACE1</b>, <b>5a</b>–<b>c</b> or piperidine 20% in DMF, rt (15 min), then TFA, rt (30 min) for <b>MACE4</b>; (b) EDC·HCl (2.2 equiv), HOBt anhydrous (2.2 equiv), DIPEA (6.6 equiv), Boc-<span class="smallcaps smallerCapital">d</span>-Cys(ACM)-OH (2.2 equiv) in DMF at rt overnight; (c) I<sub>2</sub>, MeOH, 3 h at rt then ascorbic acid; (d) TCEP, DMF for 1 h at rt, then <i>o</i>-bis(bromomethyl)benzene at rt, overnight; (e) Boc-Tyr-OH for products <b>6</b>, <b>5a</b>,<b>b</b> or Fmoc-Dmt-OH for product <b>5c</b>, EDC·HCl, HOBt anhydrous, DIPEA, DMF, 0 °C for 20 min, then rt 24 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>MACE</b> compounds bind to the opioid receptors with high to moderate affinity. (A) Competition binding curves for the <b>MACE</b> analogues and naloxone (MOR, DOR) or U50,488 (KOR) positive controls shown. All analogues were competed against a fixed concentration of <sup>3</sup>H-diprenorphine in the membranes of MOR-, DOR-, or KOR-expressing CHO cells. Summary curves shown with the mean ± SEM of each point from <i>n</i> = 3 independent experiments. (B) The <i>K</i><sub>i</sub> of each compound was calculated from the IC<sub>50</sub> of each curve using the previously established <i>K</i><sub>D</sub> of <sup>3</sup>H-diprenorphine in each cell line. Each <i>K</i><sub>i</sub> value was calculated from each independent experiment and reported here as the mean ± SEM (<i>n</i> = 3 independent experiments). Receptor selectivity ratios are also shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>MACE</b> compounds activate the opioid receptors with variable potency and efficacy. (A) Summary agonist concentration curves for the <b>MACE</b> compounds and a positive control agonist (DAMGO for MOR; SNC80 for DOR; U50,488 for KOR) in <sup>35</sup>S-GTPγS coupling shown. All compounds were normalized to the stimulation caused by the positive control (100%) and vehicle (0%) and reported as the mean ± SEM from <i>n</i> = 3 independent experiments. (B) <b>MACE3</b> caused a highly elevated baseline under the standard conditions in (A), preventing analysis. This issue was corrected by including 0.01% Tween80 in the reaction buffer, which eliminated the baseline (presumably by breaking up ligand aggregates). A DAMGO control was also included, which did not differ significantly from (A), so the results for <b>MACE3</b> in this condition were calculated normally. (C) The compounds were tested in antagonist mode vs a fixed concentration of 100 nM SNC80. The data were normalized to the max stimulation caused by the SNC80 (100%) and vehicle (0%). (D) The potencies (<i>E</i>/IC<sub>50</sub>) and efficacies (<i>E</i>/<i>I</i><sub>Max</sub>) of each <b>MACE</b> peptide and positive control were calculated in each independent experiment (<i>n</i> = 3), then reported as the mean ± SEM. The <i>E</i><sub>Max</sub> was reported as a percent of stimulation caused by the positive control, which had a defined <i>E</i><sub>Max</sub> of 100%. The <i>I</i><sub>MAX</sub> was reported as a percent of antagonism caused by naloxone positive control, which had a defined <i>I</i><sub>MAX</sub> of 100%. The <b>MACE3</b> results at the MOR were calculated from the separate experiment in (B) and are noted by a #.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects induced by biphalin (B), <b>AM94</b>, <b>6a</b>, and <b>MACE1</b>–<b>4</b> in the hot plate (HP) test in mice. Compounds were administered iv 15 min before the HP test at the dose of 1.5 μmol/kg and in a volume of 5 mL/kg. Naloxone methiodide (NM) was administered ip at the dose of 2.1 μmol/kg or icv at the dose of 5 nmol/mouse 20 min before <b>MACE4</b> was administered iv at the dose of 1.5 μmol/kg. V is for iv vehicle-treated animals. ∗ is for <i>P</i> < 0.05, ∗∗ is for <i>P</i> < 0.01, ∗∗∗ is for <i>P</i> < 0.001, and ∗∗∗∗ is for <i>P</i> < 0.0001 vs B (panel A), AM94 (panel B), <b>6a</b> (panel C), or <b>MACE4</b> (panel D) for ANOVA followed by Tukey’s multiple comparisons test. <i>N</i> = 10 mice/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects induced by vehicle (V), biphalin (B), <b>AM94</b>, <b>6a</b>, and <b>MACE1</b>–<b>4</b> in the early phase (A) and in the late phase (B) of the FT in mice. Compounds were administered sc 15 min before the formalin at the dose of 0.15 μmol/mouse in a volume of 20 μL/mouse. ∗ is for <i>P</i> < 0.05, ∗∗ is for <i>P</i> < 0.01, ∗∗∗ is for <i>P</i> < 0.001, and ∗∗∗∗ is for <i>P</i> < 0.0001 vs B; °° is for <i>P</i> < 0.01 vs <b>6a</b>; # is for <i>P</i> < 0.05 vs <b>AM94</b> for ANOVA followed by Tukey’s multiple comparisons test. <i>N</i> = 10 mice/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>In vivo</i> pharmacokinetics of <b>MACE4</b> in mice. CD-1 male and female mice (<i>n</i> = 4/group) were administered with 2.1 mg/kg <b>MACE4</b> by the sc route and plasma and brains collected over a 2 h time course. <b>MACE4</b> concentrations were measured by mass spectrometry as explained in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Data are reported as the mean ± SEM. (A) Total plasma concentrations graphed with the resultant pharmacokinetic values noted in the graph. (B) Free plasma concentrations graphed with the plasma protein binding value (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) noted in the graph. (C) Total brain levels (ng/g) shown. Curve had insufficient points to calculate the PK values as for <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Water networks found in the crystallographic complex of (A) MOR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a>), (B) DOR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD">4RWD</a>), and (C) KOR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH">4DJH</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Validated docking poses superimposed to their crystallographic ones: (A) Bu72, RMSD = 1.04; (B) DIPP-NH<sub>2</sub>, RMSD = 2.05; (C) JDTic, RMSD = 0.34.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/medium/jm9b01963_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Best binding poses of <b>MACE4</b> on MOR (A), DOR (B), KOR (C). Significant H-bond interactions with water molecules and amino acid residues are depicted in yellow dots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01963/20200306/images/large/jm9b01963_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01963&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darnell, L.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic interventions for pain management</span>. <i>Crit Care Nurs Clin North Am.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1016/j.cnc.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2Fj.cnc.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=29107306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BC1M7otFyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2017&pages=427-447&author=F.+C.+Farrarauthor=D.+Whiteauthor=L.+Darnell&title=Pharmacologic+interventions+for+pain+management&doi=10.1016%2Fj.cnc.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Interventions for Pain Management</span></div><div class="casAuthors">Farrar Francisca Cisneros; White Danielle; Darnell Linda</div><div class="citationInfo"><span class="NLM_cas:title">Critical care nursing clinics of North America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">427-447</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Serious life-threatening respiratory depression may occur with pharmacologic pain intervention.  The nurse has an ethical and legal duty to provide safe, quality, and accountable pain management.  The nurse must acquire self-efficacy for the administration of pain medications for critically ill patients to prevent serious side effects and adverse reactions.  This article presents a clinical toolkit for acute pain pharmacologic management by presenting professional guidelines, evidence-based pain assessment tools, common pain medication therapy, and focused monitoring specific to the drug.  Medical adjustments owing to special populations is also discussed.  Case reports demonstrate application of clinical reasoning skills needed for pain management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoIFV7ArpQPP6BottYdIAWfW6udTcc2eY2N7gowdA-Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7otFyjsQ%253D%253D&md5=2fb01422c43aaac0f7343d022d4fcef2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cnc.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cnc.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DFarrar%26aufirst%3DF.%2BC.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DDarnell%26aufirst%3DL.%26atitle%3DPharmacologic%2520interventions%2520for%2520pain%2520management%26jtitle%3DCrit%2520Care%2520Nurs%2520Clin%2520North%2520Am.%26date%3D2017%26volume%3D29%26spage%3D427%26epage%3D447%26doi%3D10.1016%2Fj.cnc.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsky, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malatynska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleyard, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaninova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive profile of biphalin, a dimeric encephalin analog</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">1446</span>– <span class="NLM_lpage">1454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=8389867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2ns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1993&pages=1446-1454&author=P.+J.+Horanauthor=A.+Mattiaauthor=E.+J.+Bilskyauthor=S.+Weberauthor=T.+P.+Davisauthor=H.+I.+Yamamuraauthor=E.+Malatynskaauthor=S.+M.+Appleyardauthor=J.+Slaninovaauthor=A.+Misickaauthor=A.+W.+Lipkowskiauthor=V.+J.+Hrubyauthor=F.+Porreca&title=Antinociceptive+profile+of+biphalin%2C+a+dimeric+encephalin+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive profile of biphalin, a dimeric enkephalin analog</span></div><div class="casAuthors">Horan, Peter J.; Mattia, Antonia; Bilsky, Edward J.; Weber, Steven; Davis, Thomas P.; Yamamura, Henry I.; Malatynska, Ewa; Appleyard, Suzanne M.; Slaninova, Jirina; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1446-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The dimeric enkephalin biphalin (Tyr-D-Ala-Gly-Phe-NH)2 was evaluated in mice using antinociceptive, gastrointestinal and phys. dependence paradigms and compared with that of morphine (ref. μ agonist) and etorphine (ultrapotent opioid agonist).  Intracerebroventricular biphalin was 6.7- and 257-fold more potent than etorphine or morphine in eliciting antinociception.  When administered i.t., biphalin produced only a 60% maximal antinociceptive effect in the tail-flick test even when given at doses up to 3 orders of magnitude higher than those effective i.c.v.; morphine was equipotent in this assay when given i.c.v. or i.t.  Both morphine and biphalin were equipotent after i.p. administration.  In spite of its antinociceptive effectiveness after i.p. administration, only a small fraction of [125I]biphalin penetrated to the brain (0.051%, at 20 min).  After i.c.v. administration, biphalin antinociception was antagonized by receptor selective doses of β-funaltrexamine (μ antagonist), naloxonazine (μ1 antagonist), ICI 174,864 (δ antagonist) and [D-Ala2,Cys4]deltorphin (δ2 antagonist), but not by [D-Ala2,Leu5,Cys6]enkephalin (δ1 antagonist) or nor-binaltorphimine (κ antagonist), whereas etorphine antinociception was antagonized only by β-funaltrexamine and naloxonazine.  Intracerebroventricular biphalin inhibited gastrointestinal propulsion at doses 8-fold higher than those producing i.c.v. antinociception; i.c.v. morphine showed a similar antinociceptive and gastrointestinal propulsion A50.  I.p. biphalin, but not i.p. morphine, showed little, if any, phys. dependence, but both biphalin and morphine produced phys. dependence when equiantinociceptive doses were infused i.c.v.  These results demonstrate an unusual profile for biphalin which suggests a potentially novel mechanism which may involve, in part, the putative opioid receptor complex of phys. or functionally interacting μ and δ2 opioid receptors.  Biphalin may thus represent the first in a series of such compds. which may lead to therapeutic advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA7Qt9LGJN_bVg90H21EOLACvtfcHk0ljMjFho57OmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2ns7Y%253D&md5=6a4f697df154c0059e847bdef01e2d84</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DP.%2BJ.%26aulast%3DMattia%26aufirst%3DA.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DMalatynska%26aufirst%3DE.%26aulast%3DAppleyard%26aufirst%3DS.%2BM.%26aulast%3DSlaninova%26aufirst%3DJ.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DAntinociceptive%2520profile%2520of%2520biphalin%252C%2520a%2520dimeric%2520encephalin%2520analog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D265%26spage%3D1446%26epage%3D1454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feliciani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciatore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.2174/1389557511307010011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.2174%2F1389557511307010011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=11-33&author=F.+Felicianiauthor=F.+Pinnenauthor=A.+Stefanucciauthor=R.+Costanteauthor=I.+Cacciatoreauthor=G.+Lucenteauthor=A.+Mollica&title=Structure-activity+relationships+of+biphalin+analogs+and+their+biological+evaluation+on+opioid+receptors&doi=10.2174%2F1389557511307010011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1389557511307010011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511307010011%26sid%3Dliteratum%253Aachs%26aulast%3DFeliciani%26aufirst%3DF.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DCacciatore%26aufirst%3DI.%26aulast%3DLucente%26aufirst%3DG.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DStructure-activity%2520relationships%2520of%2520biphalin%2520analogs%2520and%2520their%2520biological%2520evaluation%2520on%2520opioid%2520receptors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D13%26spage%3D11%26epage%3D33%26doi%3D10.2174%2F1389557511307010011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochynska-Czyz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacharczuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujalska-Zadrozny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain-A comparison with morphine</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2016.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2Fj.ejps.2016.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=27094782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVyjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=39-49&author=A.+Lesniakauthor=M.+Bochynska-Czyzauthor=M.+Sacharczukauthor=S.+Benhyeauthor=A.+Misickaauthor=M.+Bujalska-Zadroznyauthor=A.+W.+Lipkowski&title=Biphalin+preferentially+recruits+peripheral+opioid+receptors+to+facilitate+analgesia+in+a+mouse+model+of+cancer+pain-A+comparison+with+morphine&doi=10.1016%2Fj.ejps.2016.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine</span></div><div class="casAuthors">Lesniak, Anna; Bochynska-Czyz, Marta; Sacharczuk, Mariusz; Benhye, Sandor; Misicka, Aleksandra; Bujalska-Zadrozny, Magdalena; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-49</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The search for new drugs for cancer pain management has been a long-standing goal in basic and clin. research.  Classical opioid drugs exert their primary antinociceptive effect upon activating opioid receptors located in the central nervous system.  A substantial body of evidence points to the relevance of peripheral opioid receptors as potential targets for cancer pain treatment.  Peptides showing limited blood-brain-barrier permeability promote peripheral analgesia in many pain models.  In the present study we examd. the peripheral and central analgesic effect of i.v. administered biphalin - a dimeric opioid peptide in a mouse skin cancer pain model, developed by an intraplantar inoculation of B16F0 melanoma cells.  The effect of biphalin was compared with morphine - a golden std. in cancer pain management.  Biphalin produced profound, dose-dependent and naloxone sensitive spinal analgesia.  Addnl., the effect in the tumor-bearing paw was largely mediated by peripheral opioid receptors, as it was readily attenuated by the blood-brain-barrier-restricted opioid receptor antagonist - naloxone methiodide.  On the contrary, morphine facilitated its analgesic effect primarily by activating spinal opioid receptors.  Both drugs induced tolerance in B16F0 - implanted paws after chronic treatment, however biphalin as opposed to morphine, showed little decrease in its activity at the spinal level.  Our results indicate that biphalin may be considered a future alternative drug in cancer pain treatment due to an enhanced local analgesic activity as well as lower tolerance liability compared with morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_k0xLyMzrIbVg90H21EOLACvtfcHk0liPW_twZTShsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVyjsLo%253D&md5=5b6b588dda0ffac74b9b388864b85630</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DLesniak%26aufirst%3DA.%26aulast%3DBochynska-Czyz%26aufirst%3DM.%26aulast%3DSacharczuk%26aufirst%3DM.%26aulast%3DBenhye%26aufirst%3DS.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DBujalska-Zadrozny%26aufirst%3DM.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DBiphalin%2520preferentially%2520recruits%2520peripheral%2520opioid%2520receptors%2520to%2520facilitate%2520analgesia%2520in%2520a%2520mouse%2520model%2520of%2520cancer%2520pain-A%2520comparison%2520with%2520morphine%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D89%26spage%3D39%26epage%3D49%26doi%3D10.1016%2Fj.ejps.2016.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1002/psc.2465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fpsc.2465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=23136069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eiurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=233-239&author=A.+Mollicaauthor=R.+Costanteauthor=A.+Stefanucciauthor=F.+Pinnenauthor=G.+Lucenteauthor=S.+Fidanzaauthor=S.+Pieretti&title=Antinociceptive+profile+of+potent+opioid+peptide+AM94%2C+a+fluorinated+analogue+of+biphalin+with+non-hydrazine+linker&doi=10.1002%2Fpsc.2465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker</span></div><div class="casAuthors">Mollica, Adriano; Costante, Roberto; Stefanucci, Azzurra; Pinnen, Francesco; Lucente, Gino; Fidanza, Stefano; Pieretti, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">233-239</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">AM94 is a fluorinated analog of biphalin with non-hydrazine linker that has an in vitro affinity for μ-opioid and δ-opioid receptors tenfold higher than biphalin.  Furthermore, in vivo evaluation in rats showed that AM94 has in hot plate test - after both intracerebroventricular and i.v. administrations - a greater and more durable efficacy than biphalin.  Here, the antinociceptive profile of AM94 is further evaluated by following two different administration routes, intrathecal and s.c., and two different animal species, rats and mice.  The analgesic potency of AM94 is compared with that of both the parent peptide biphalin and morphine.  Results show that in rats (tail flick test) and in mice (formalin test), AM94 has a higher and more durable analgesic effect than biphalin after intrathecal and s.c. administrations.  Conformational properties of biphalin and AM94 were also investigated by variable-temp. 1H NMR and energy minimization.  Copyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsduIHCd6H1rVg90H21EOLACvtfcHk0lhWXjmc_Ct1iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eiurzF&md5=6cdaa54fc8146f4b246e66a0dfcf8296</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fpsc.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.2465%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DLucente%26aufirst%3DG.%26aulast%3DFidanza%26aufirst%3DS.%26aulast%3DPieretti%26aufirst%3DS.%26atitle%3DAntinociceptive%2520profile%2520of%2520potent%2520opioid%2520peptide%2520AM94%252C%2520a%2520fluorinated%2520analogue%2520of%2520biphalin%2520with%2520non-hydrazine%2520linker%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2013%26volume%3D19%26spage%3D233%26epage%3D239%26doi%3D10.1002%2Fpsc.2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Potent biphalin analogs with μ/δ mixed opioid activity: <i>In vivo</i> and <i>In vitro</i> biological evaluation</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1002/ardp.201300380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fardp.201300380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=24798820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislChtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2014&pages=305-312&author=R.+Costanteauthor=A.+Stefanucciauthor=F.+Pinnenauthor=A.+Mollica&title=Potent+biphalin+analogs+with+%CE%BC%2F%CE%B4+mixed+opioid+activity%3A+In+vivo+and+In+vitro+biological+evaluation&doi=10.1002%2Fardp.201300380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Biphalin Analogs with μ/δ Mixed Opioid Activity: In Vivo and In Vitro Biological Evaluation</span></div><div class="casAuthors">Costante, Roberto; Pinnen, Francesco; Stefanucci, Azzurra; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Biphalin [(Tyr-Ala-Gly-Phe-NH-)2] is an octapeptide with mixed μ/δ opioid activity.  Its structure is based on two identical enkephalin-like portions linked "tail-to-tail" by a hydrazine bridge.  This study presents the synthesis and in vitro and in vivo bioassays of two biphalin analogs that do not present the toxicity connected with the presence of the hydrazine moiety and are able to elicit a higher antinociceptive effect than biphalin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTI0RkfV53rVg90H21EOLACvtfcHk0lhWXjmc_Ct1iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislChtrk%253D&md5=8d7622542dbbf79a07e4bc7f9ac39b03</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fardp.201300380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201300380%26sid%3Dliteratum%253Aachs%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DPotent%2520biphalin%2520analogs%2520with%2520%25CE%25BC%252F%25CE%25B4%2520mixed%2520opioid%2520activity%253A%2520In%2520vivo%2520and%2520In%2520vitro%2520biological%2520evaluation%26jtitle%3DArch.%2520Pharm.%26date%3D2014%26volume%3D347%26spage%3D305%26epage%3D312%26doi%3D10.1002%2Fardp.201300380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Biological active analogues of the opioid peptide biphalin: Mixed hM<sup>3</sup>-peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3419</span>– <span class="NLM_lpage">3423</span>, <span class="refDoi"> DOI: 10.1021/jm301456c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301456c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2ntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3419-3423&author=A.+Mollicaauthor=F.+Pinnenauthor=R.+Costanteauthor=M.+Locatelliauthor=A.+Stefanucciauthor=S.+Pierettiauthor=P.+Davisauthor=J.+Laiauthor=D.+Rankinauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Biological+active+analogues+of+the+opioid+peptide+biphalin%3A+Mixed+hM3-peptides&doi=10.1021%2Fjm301456c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Active Analogues of the Opioid Peptide Biphalin: Mixed α/β3-Peptides</span></div><div class="casAuthors">Mollica, Adriano; Pinnen, Francesco; Costante, Roberto; Locatelli, Marcello; Stefanucci, Azzurra; Pieretti, Stefano; Davis, Peg; Lai, Josephine; Rankin, David; Porreca, Frank; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3419-3423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural residues of the dimeric opioid peptide biphalin [(H-Tyr-D-Ala-Gly-Phe-NH)2-] were replaced by the corresponding homo-β3-amino acids.  Peptide 1 [(H-Tyr-D-Ala-Gly-hβ3Phe-NH)2-] contg. hβ3Phe in place of Phe showed good μ- and δ-receptor affinities (Kiδ = 0.72 nM; Kiμ = 1.1 nM) and antinociceptive activity in vivo together with an increased enzymic stability in human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6k4wr1xOsrVg90H21EOLACvtfcHk0lhWXjmc_Ct1iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2ntLs%253D&md5=a06ba74ccf8759ec7115af5bebf4dfba</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm301456c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301456c%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DLocatelli%26aufirst%3DM.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DRankin%26aufirst%3DD.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DBiological%2520active%2520analogues%2520of%2520the%2520opioid%2520peptide%2520biphalin%253A%2520Mixed%2520hM3-peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3419%26epage%3D3423%26doi%3D10.1021%2Fjm301456c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotenuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limatola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsodi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samavati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zador, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyhe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Novel cyclic biphalin analogue with improved antinociceptive properties</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1021/ml500241n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500241n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1032-1036&author=A.+Mollicaauthor=A.+Carotenutoauthor=E.+Novellinoauthor=A.+Limatolaauthor=R.+Costanteauthor=F.+Pinnenauthor=A.+Stefanucciauthor=S.+Pierettiauthor=A.+Borsodiauthor=R.+Samavatiauthor=F.+Zadorauthor=S.+Benyheauthor=P.+Davisauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Novel+cyclic+biphalin+analogue+with+improved+antinociceptive+properties&doi=10.1021%2Fml500241n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cyclic Biphalin Analogue with Improved Antinociceptive Properties</span></div><div class="casAuthors">Mollica, Adriano; Carotenuto, Alfonso; Novellino, Ettore; Limatola, Antonio; Costante, Roberto; Pinnen, Francesco; Stefanucci, Azzurra; Pieretti, Stefano; Borsodi, Anna; Samavati, Reza; Zador, Ferenc; Benyhe, Sandor; Davis, Peg; Porreca, Frank; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1032-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel opioid analogs have been designed by substituting the native D-Ala residues in position 2,2' of biphalin with two residues of D-penicillamine or L-penicillamine and by forming a disulfide bond between the thiol groups.  The so-obtained compd. 9 contg. D-penicillamines showed excellent μ/δ mixed receptor affinities (K i δ = 5.2 nM; K i μ = 1.9 nM), together with an efficacious capacity to trigger the second messenger and a very good in vivo antinociceptive activity, whereas product 10 was scarcely active.  An explanation of the two different pharmacol. behaviors of products 9 and 10 was found by studying their conformational properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcpAB9Zk-1bVg90H21EOLACvtfcHk0lirLAU7SspW8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ&md5=5bb0b213b04bddfed5f835c4cf307f5b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fml500241n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500241n%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLimatola%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DSamavati%26aufirst%3DR.%26aulast%3DZador%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DNovel%2520cyclic%2520biphalin%2520analogue%2520with%2520improved%2520antinociceptive%2520properties%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1032%26epage%3D1036%26doi%3D10.1021%2Fml500241n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minosi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szűcs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdei, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zádor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyhe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Opioid receptor activity and analgesic potency of DPDPE peptide analogues containing a xylene bridge</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Oiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=449-454&author=A.+Stefanucciauthor=E.+Novellinoauthor=S.+Mirzaieauthor=G.+Macedonioauthor=S.+Pierettiauthor=P.+Minosiauthor=E.+Sz%C5%B1csauthor=A.+I.+Erdeiauthor=F.+Z%C3%A1dorauthor=S.+Benyheauthor=A.+Mollica&title=Opioid+receptor+activity+and+analgesic+potency+of+DPDPE+peptide+analogues+containing+a+xylene+bridge&doi=10.1021%2Facsmedchemlett.7b00044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge</span></div><div class="casAuthors">Stefanucci, Azzurra; Novellino, Ettore; Mirzaie, Sako; Macedonio, Giorgia; Pieretti, Stefano; Minosi, Paola; Szucs, Edina; Erdei, Anna I.; Zador, Ferenc; Benyhe, Sandor; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-454</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abstr.: D-Pen2,D-Pen5 enkephalin (DPDPE) is one of the most selective synthetic peptide agonist targeting the δ-opioid receptor.  Three cyclic analogs of DPDPE contg. a xylene bridge in place of disulfide bond have been synthesized and fully characterized as opioid receptors agonists.  The in vitro activity was investigated showing a good affinity of 7a-c for μ and δ-receptors.  In vivo biol. assays revealed that 7b is the most potent analog with the ability to maintain high level of analgesia from 15 to 60 min following intracerebroventricular (i.c.v.) administration, whereas DPDPE was slight-ly active until 45 min. 7b induced long lasting analgesia also after s.c. administration, whereas DPDPE was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCwJGizEcNCbVg90H21EOLACvtfcHk0liBS0ShEGuwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Oiu70%253D&md5=8c4e70edc7248eb226dc41d63043cf57</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00044%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMirzaie%26aufirst%3DS.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DMinosi%26aufirst%3DP.%26aulast%3DSz%25C5%25B1cs%26aufirst%3DE.%26aulast%3DErdei%26aufirst%3DA.%2BI.%26aulast%3DZ%25C3%25A1dor%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DOpioid%2520receptor%2520activity%2520and%2520analgesic%2520potency%2520of%2520DPDPE%2520peptide%2520analogues%2520containing%2520a%2520xylene%2520bridge%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D449%26epage%3D454%26doi%3D10.1021%2Facsmedchemlett.7b00044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotenuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzoli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szűcs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdei, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zádor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyhe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Cyclic biphalin analogues incorporating a xylene bridge: Synthesis, characterization, and biological profile</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">858</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00210</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00210" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFGitbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=858-863&author=A.+Stefanucciauthor=A.+Carotenutoauthor=G.+Macedonioauthor=E.+Novellinoauthor=S.+Pierettiauthor=F.+Marzoliauthor=E.+Sz%C5%B1csauthor=A.+I.+Erdeiauthor=F.+Z%C3%A1dorauthor=S.+Benyheauthor=A.+Mollica&title=Cyclic+biphalin+analogues+incorporating+a+xylene+bridge%3A+Synthesis%2C+characterization%2C+and+biological+profile&doi=10.1021%2Facsmedchemlett.7b00210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile</span></div><div class="casAuthors">Stefanucci, Azzurra; Carotenuto, Alfonso; Macedonio, Giorgia; Novellino, Ettore; Pieretti, Stefano; Marzoli, Francesca; Szucs, Edina; Erdei, Anna I.; Zador, Ferenc; Benyhe, Sandor; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">858-863</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work we enhanced the ring lipophilicity of biphalin introducing a xylene moiety, thus obtaining three cyclic regioisomers.  Novel compds. have similar in vitro activity as the parent compd. but one of these (I) shows a remarkable increase of in vivo antinociceptive effect.  Nociception tests have disclosed its significant high potency and the more prolonged effect in eliciting analgesia, higher than that of biphalin and of the disulfide bridge contg. analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRoFOSqF5Z3LVg90H21EOLACvtfcHk0liBS0ShEGuwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFGitbvF&md5=c7d2183ccc9f22920e8b915ebb449ca6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00210%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DMarzoli%26aufirst%3DF.%26aulast%3DSz%25C5%25B1cs%26aufirst%3DE.%26aulast%3DErdei%26aufirst%3DA.%2BI.%26aulast%3DZ%25C3%25A1dor%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DCyclic%2520biphalin%2520analogues%2520incorporating%2520a%2520xylene%2520bridge%253A%2520Synthesis%252C%2520characterization%252C%2520and%2520biological%2520profile%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D858%26epage%3D863%26doi%3D10.1021%2Facsmedchemlett.7b00210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luisi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.4155%2Ffmc-2016-0232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=28635314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=859-869&author=A.+Stefanucciauthor=W.+Leiauthor=V.+J.+Hrubyauthor=G.+Macedonioauthor=G.+Luisiauthor=S.+Carradoriauthor=J.+M.+Streicherauthor=A.+Mollica&title=Fluorescent-labeled+bioconjugates+of+the+opioid+peptides+biphalin+and+DPDPE+incorporating+fluorescein-maleimide+linkers&doi=10.4155%2Ffmc-2016-0232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers</span></div><div class="casAuthors">Stefanucci, Azzurra; Lei, Wei; Hruby, Victor J.; Macedonio, Giorgia; Luisi, Grazia; Carradori, Simone; Streicher, John M.; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">859-869</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: The conjugation of fluorescent labels to opioid peptides is an extremely challenging task, which needs to be overcome to create new classes of probes for biol. assays.  Materials & methods: Three opioid peptide analogs of biphalin and [D-Pen2,5]-Enkephalin (DPDPE) contg. a fluorescein-maleimide motif were synthesized.  Results & discussion: The biphalin analog 17 binds to opioid receptors with Ki μ = 530 ± 90 nM and Ki δ = 69.8 ± 16.4 nM.  We then tested the ability of the compds. to stimulate G-protein-coupling, 17 activated μ-receptor expressing cells (EC50 = 16.7 ± 6.7 nM, EMax = 76 ± 4%) as well as δ-receptor expressing cells (EC50 = 42 ± 10 nM, EMax = 34 ± 8%).  However, 17 was not able to fluorescently label receptor in live or fixed cells.  Conclusion: Our data suggest that the biphalin scaffold could be employed to develop fluorescent ligands with the appropriate fluorescent motif, and suggest a means for further probe development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAcsYO_SWLObVg90H21EOLACvtfcHk0liBS0ShEGuwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7%252FL&md5=1144fc9a420750b948faaf38ca2d9845</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0232%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DLuisi%26aufirst%3DG.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DFluorescent-labeled%2520bioconjugates%2520of%2520the%2520opioid%2520peptides%2520biphalin%2520and%2520DPDPE%2520incorporating%2520fluorescein-maleimide%2520linkers%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D859%26epage%3D869%26doi%3D10.4155%2Ffmc-2016-0232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remesic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic Opioid Peptides</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1303</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160427123005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.2174%2F0929867323666160427123005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=27117332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFags7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1288-1303&author=M.+Remesicauthor=Y.+S.+Leeauthor=V.+J.+Hruby&title=Cyclic+Opioid+Peptides&doi=10.2174%2F0929867323666160427123005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Opioid Peptides</span></div><div class="casAuthors">Remesic, Michael; Lee, Yeon Sun; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1288-1303</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">For decades the opioid receptors have been an attractive therapeutic target for the treatment of pain.  Since the first discovery of enkephalin, approx. a dozen endogenous opioid peptides have been known to produce opioid activity and analgesia, but their therapeutics have been limited mainly due to low blood brain barrier penetration and poor resistance to proteolytic degrdn.  One versatile approach to overcome these drawbacks is the cyclization of linear peptides to cyclic peptides with constrained topog. structure.  Compared to their linear parents, cyclic analogs exhibit better metabolic stability, lower offtarget toxicity, and improved bioavailability.  Extensive structure-activity relationship studies have uncovered promising compds. for the treatment of pain as well as further elucidate structural elements required for selective opioid receptor activity.  The benefits that come with employing cyclization can be further enhanced through the generation of polycyclic derivs.  Opioid ligands generally have a short peptide chain and thus the realm of polycyclic peptides has yet to be explored.  In this review, a brief history of designing ligands for the opioid receptors, including classic linear and cyclic ligands, is discussed along with recent approaches and successes of cyclic peptide ligands for the receptors.  Various scaffolds and approaches to improve bioavailability are elaborated and concluded with a discourse towards polycyclic peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqRd2N_Fx-LVg90H21EOLACvtfcHk0lhTw14s-HNvEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFags7w%253D&md5=3a1df6a45b331fa5d7c78f0c34eccfe9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160427123005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160427123005%26sid%3Dliteratum%253Aachs%26aulast%3DRemesic%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DCyclic%2520Opioid%2520Peptides%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1288%26epage%3D1303%26doi%3D10.2174%2F0929867323666160427123005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">The opioid peptide analogue biphalin induces less physical dependence than morphine</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S0024-3205(01)01194-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2FS0024-3205%2801%2901194-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=11508644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFans7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1023-1028&author=M.+Yamazakiauthor=T.+Suzukiauthor=M.+Naritaauthor=A.+W.+Lipkowski&title=The+opioid+peptide+analogue+biphalin+induces+less+physical+dependence+than+morphine&doi=10.1016%2FS0024-3205%2801%2901194-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The opioid peptide analogue biphalin induces less physical dependence than morphine</span></div><div class="casAuthors">Yamazaki, Mitsuaki; Suzuki, Tsutomu; Narita, Minoru; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1023-1028</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We compared the phys. dependence liability of biphalin, a dimeric enkephalin analog that possesses high antinociceptive activity, with that of morphine in equipotent i.v. doses.  Naloxone challenge produced severe withdrawal signs after a 5-day infusion of morphine but only minor withdrawal signs after a 5-day biphalin infusion.  In a cross-dependence study, biphalin did not suppress body wt. loss after morphine withdrawal, but successfully suppressed wt. loss after pentazocine withdrawal.  These data support consideration of biphalin as a new analgesic with a novel pharmacol. profile and min. dependence liability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0NwvUOb7iu7Vg90H21EOLACvtfcHk0lhTw14s-HNvEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFans7c%253D&md5=70d0faa9a611991665243355e0dedbe6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2801%2901194-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252801%252901194-8%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DThe%2520opioid%2520peptide%2520analogue%2520biphalin%2520induces%2520less%2520physical%2520dependence%2520than%2520morphine%26jtitle%3DLife%2520Sci.%26date%3D2001%26volume%3D69%26spage%3D1023%26epage%3D1028%26doi%3D10.1016%2FS0024-3205%2801%2901194-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbotham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1093/bja/aep129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1093%2Fbja%2Faep129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=19474215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVKjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2009&pages=38-49&author=N.+Dietisauthor=R.+Guerriniauthor=G.+Caloauthor=S.+Salvadoriauthor=D.+J.+Rowbothamauthor=D.+G.+Lambert&title=Simultaneous+targeting+of+multiple+opioid+receptors%3A+a+strategy+to+improve+side-effect+profile&doi=10.1093%2Fbja%2Faep129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile</span></div><div class="casAuthors">Dietis, N.; Guerrini, R.; Calo, G.; Salvadori, S.; Rowbotham, D. J.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-49</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">0007-0912</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Opioid receptors are currently classified as μ (mu: mOP), δ (delta: dOP), κ (kappa: kOP) with a fourth related non-classical opioid receptor for nociceptin/orphainin FQ, NOP.  Morphine is the current gold std. analgesic acting at MOP receptors but produces a range of variably troublesome side-effects, in particular tolerance.  There is now good lab. evidence to suggest that blocking DOP while activating MOP produces analgesia (or antinociception) without the development of tolerance.  Simultaneous targeting of MOP and DOP can be accomplished by: (i) co-administering two selective drugs, (ii) administering one non-selective drug, or (iii) designing a single drug that specifically targets both receptors; a bivalent ligand.  Bivalent ligands generally contain two active centers or pharmacophores that are variably sepd. by a chem. spacer and there are several interesting examples in the literature.  For example linking the MOP agonist oxymorphone to the DOP antagonist naltrindole produces a MOP/DOP bivalent ligand that should produce analgesia with reduced tolerance.  The type of response/selectivity produced depends on the pharmacophore combination (e.g. oxymorphone and naltrindole as above) and the space between them.  Prodn. and evaluation of bivalent ligands is an emerging field in drug design and for anesthesia, analgesics that are designed not to be highly selective morphine-like (MOP) ligands represents a new avenue for the prodn. of useful drugs for chronic (and in particular cancer) pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirDRA_J_oBbVg90H21EOLACvtfcHk0lgGPiJjtHZWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVKjsrw%253D&md5=11a940d3394458c4d4894a2b6149e3b4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbja%2Faep129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252Faep129%26sid%3Dliteratum%253Aachs%26aulast%3DDietis%26aufirst%3DN.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRowbotham%26aufirst%3DD.%2BJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DSimultaneous%2520targeting%2520of%2520multiple%2520opioid%2520receptors%253A%2520a%2520strategy%2520to%2520improve%2520side-effect%2520profile%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2009%26volume%3D103%26spage%3D38%26epage%3D49%26doi%3D10.1093%2Fbja%2Faep129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinnen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliciani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">New potent biphalin analogues containing <i>p</i>-fluoro-L-phenylalanine at the 4,4’ positions and non-hydrazine linker</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1503</span>– <span class="NLM_lpage">1511</span>, <span class="refDoi"> DOI: 10.1007/s00726-010-0760-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1007%2Fs00726-010-0760-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=20924622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFWqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=1503-1511&author=A.+Mollicaauthor=F.+Pinnenauthor=F.+Felicianiauthor=A.+Stefanucciauthor=G.+Lucenteauthor=P.+Davisauthor=F.+Porrecaauthor=S.+W.+Maauthor=J.+Laiauthor=V.+J.+Hruby&title=New+potent+biphalin+analogues+containing+p-fluoro-L-phenylalanine+at+the+4%2C4%E2%80%99+positions+and+non-hydrazine+linker&doi=10.1007%2Fs00726-010-0760-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New potent biphalin analogues containing p-fluoro-L-phenylalanine at the 4,4' positions and non-hydrazine linkers</span></div><div class="casAuthors">Mollica, Adriano; Pinnen, Francesco; Feliciani, Federica; Stefanucci, Azzurra; Lucente, Gino; Davis, Peg; Porreca, Frank; Ma, Shou-Wu; Lai, Josephine; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1503-1511</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">The authors report the synthesis and the biol. evaluation of two new analogs of the potent dimeric opioid peptide biphalin.  The performed modification is based on the replacement of two key structural elements of the native biphalin, namely: the hydrazine bridge which joins the two palindromic moieties and the phenylalanine residues at 4 and 4' positions of the backbone.  The two new analogs contain 1,2-phenylenediamine and piperazine, resp., in place of the hydrazidic linker and p-fluoro-l-phenylalanine residues at 4 and 4' positions.  Binding values are Kiμ = 0.51 nM and Kiδ 12.8 nM for the phenylenediamine analog; Kiμ = 0.09 nM and Kiμ = 0.11 nM for the piperazine analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEPaPuQD717Vg90H21EOLACvtfcHk0lgGPiJjtHZWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFWqtro%253D&md5=091d91c83ce439e96ec7ca78feb42904</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00726-010-0760-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-010-0760-7%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DFeliciani%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DLucente%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DNew%2520potent%2520biphalin%2520analogues%2520containing%2520p-fluoro-L-phenylalanine%2520at%2520the%25204%252C4%25E2%2580%2599%2520positions%2520and%2520non-hydrazine%2520linker%26jtitle%3DAmino%2520Acids%26date%3D2011%26volume%3D40%26spage%3D1503%26epage%3D1511%26doi%3D10.1007%2Fs00726-010-0760-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughtput artificial membrane permeability assay for blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughtput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0liZNkX6pMJxIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughtput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piekielna-Ciesielska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymaszkiewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielińska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecka, A.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF<sub>3</sub>-Phe-Asp]NH<sub>2</sub></span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1441839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1080%2F14756366.2018.1441839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=29513114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2nsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=560-566&author=J.+Piekielna-Ciesielskaauthor=A.+Mollicaauthor=S.+Pierettiauthor=J.+Fichnaauthor=A.+Szymaszkiewiczauthor=M.+Zieli%C5%84skaauthor=R.+Kordekauthor=A.+Janecka&title=Antinociceptive+potency+of+a+fluorinated+cyclopeptide+Dmt-c%5BD-Lys-Phe-p-CF3-Phe-Asp%5DNH2&doi=10.1080%2F14756366.2018.1441839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2</span></div><div class="casAuthors">Piekielna-Ciesielska, Justyna; Mollica, Adriano; Pieretti, Stefano; Fichna, Jakub; Szymaszkiewicz, Agata; Zielinska, Marta; Kordek, Radzislaw; Janecka, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">560-566</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Opioid peptides and opiate drugs such as morphine, mediate their analgesic effects, but also undesired side effects, mostly through activation of the mu opioid receptor.  However, delta- and kappa-opioid receptors can also contribute to the analgesic effects of opioids.  Recent findings showed that simultaneous activation of multiple opioid receptors may result in addnl. analgesia with fewer side effects.  Here, the authors evaluated the pharmacol. profile of the authors' formerly developed mixed mu/kappa-opioid receptor ligands, Dmt-c[D-Lys-Phe-Phe-Asp]NH2 (C-36) and Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2 (F-81).  The ability of these peptides to cross the blood-brain barrier was tested in the parallel artificial membrane permeability (PAMPA) assay.  On the basis of the hot-plate test in mice after central and peripheral administration, analog F-81 was selected for the anti-nociceptive and anti-inflammatory activity assessment after peripheral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoeyREwmweIrVg90H21EOLACvtfcHk0liZNkX6pMJxIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2nsrs%253D&md5=fc70836e8087830bf9adeef2069c96e6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1441839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1441839%26sid%3Dliteratum%253Aachs%26aulast%3DPiekielna-Ciesielska%26aufirst%3DJ.%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DFichna%26aufirst%3DJ.%26aulast%3DSzymaszkiewicz%26aufirst%3DA.%26aulast%3DZieli%25C5%2584ska%26aufirst%3DM.%26aulast%3DKordek%26aufirst%3DR.%26aulast%3DJanecka%26aufirst%3DA.%26atitle%3DAntinociceptive%2520potency%2520of%2520a%2520fluorinated%2520cyclopeptide%2520Dmt-c%255BD-Lys-Phe-p-CF3-Phe-Asp%255DNH2%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D560%26epage%3D566%26doi%3D10.1080%2F14756366.2018.1441839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinberg, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into t-opioid receptor activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nature14886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fnature14886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=26245379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=315-321&author=W.+Huangauthor=A.+Manglikauthor=A.+J.+Venkatakrishnanauthor=T.+Laeremansauthor=E.+N.+Feinbergauthor=A.+L.+Sanbornauthor=H.+E.+Katoauthor=K.+E.+Livingstonauthor=T.+S.+Thorsenauthor=R.+C.+Klingauthor=S.+Granierauthor=P.+Gmeinerauthor=S.+M.+Husbandsauthor=J.+R.+Traynorauthor=W.+I.+Weisauthor=J.+Steyaertauthor=R.+O.+Drorauthor=B.+K.+Kobilka&title=Structural+insights+into+t-opioid+receptor+activation&doi=10.1038%2Fnature14886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into μ-opioid receptor activation</span></div><div class="casAuthors">Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics.  To shed light on the structural basis for μOR activation, here we report a 2.1 Å X-ray crystal structure of the murine μOR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment Nb39 (nanobody 39).  The BU72-stabilized changes in the μOR binding pocket are subtle and differ from those obsd. for agonist-bound structures of the β2-adrenergic receptor (β2AR) and the M2 muscarinic receptor (M2R).  Comparison with active β2AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the μOR, and mol. dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad.  Addnl., an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFUN1wheV07Vg90H21EOLACvtfcHk0lhc5T95Q0W13g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM&md5=b9af3e1351b04539379532c127c02651</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature14886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14886%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DFeinberg%26aufirst%3DE.%2BN.%26aulast%3DSanborn%26aufirst%3DA.%2BL.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DLivingston%26aufirst%3DK.%2BE.%26aulast%3DThorsen%26aufirst%3DT.%2BS.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructural%2520insights%2520into%2520t-opioid%2520receptor%2520activation%26jtitle%3DNature%26date%3D2015%26volume%3D524%26spage%3D315%26epage%3D321%26doi%3D10.1038%2Fnature14886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemyn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yefanov, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberthuer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tourwe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">Structural basis for bifunctional peptide recognition at human e-opioid receptor</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fnsmb.2965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=25686086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=265-268&author=G.+Fenaltiauthor=N.+A.+Zatsepinauthor=C.+Bettiauthor=P.+Giguereauthor=G.+W.+Hanauthor=A.+Ishchenkoauthor=W.+Liuauthor=K.+Guillemynauthor=H.+Zhangauthor=D.+Jamesauthor=D.+Wangauthor=U.+Weierstallauthor=J.+C.+Spenceauthor=S.+Boutetauthor=M.+Messerschmidtauthor=G.+J.+Williamsauthor=C.+Gatiauthor=O.+M.+Yefanovauthor=T.+A.+Whiteauthor=D.+Oberthuerauthor=M.+Metzauthor=C.+H.+Yoonauthor=A.+Bartyauthor=H.+N.+Chapmanauthor=S.+Basuauthor=J.+Coeauthor=C.+E.+Conradauthor=R.+Frommeauthor=P.+Frommeauthor=D.+Tourweauthor=P.+W.+Schillerauthor=B.+L.+Rothauthor=S.+Balletauthor=V.+Katritchauthor=R.+C.+Stevensauthor=V.+Cherezov&title=Structural+basis+for+bifunctional+peptide+recognition+at+human+e-opioid+receptor&doi=10.1038%2Fnsmb.2965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for bifunctional peptide recognition at human δ-opioid receptor</span></div><div class="casAuthors">Fenalti, Gustavo; Zatsepin, Nadia A.; Betti, Cecilia; Giguere, Patrick; Han, Gye Won; Ishchenko, Andrii; Liu, Wei; Guillemyn, Karel; Zhang, Haitao; James, Daniel; Wang, Dingjie; Weierstall, Uwe; Spence, John C. H.; Boutet, Sebastien; Messerschmidt, Marc; Williams, Garth J.; Gati, Cornelius; Yefanov, Oleksandr M.; White, Thomas A.; Oberthuer, Dominik; Metz, Markus; Yoon, Chun Hong; Barty, Anton; Chapman, Henry N.; Basu, Shibom; Coe, Jesse; Conrad, Chelsie E.; Fromme, Raimund; Fromme, Petra; Tourwe, Dirk; Schiller, Peter W.; Roth, Bryan L.; Ballet, Steven; Katritch, Vsevolod; Stevens, Raymond C.; Cherezov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-268</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bifunctional μ- and δ-opioid receptor (OR) ligands are potential therapeutic alternatives, with diminished side effects, to alkaloid opiate analgesics.  We solved the structure of human δ-OR bound to the bifunctional δ-OR antagonist and μ-OR agonist tetrapeptide H-Dmt-Tic-Phe-Phe-NH2 (DIPP-NH2) by serial femtosecond crystallog., revealing a cis-peptide bond between H-Dmt and Tic.  The obsd. receptor-peptide interactions are crit. for understanding of the pharmacol. profiles of opioid peptides and for development of improved analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG47AjtGIDCbVg90H21EOLACvtfcHk0lhc5T95Q0W13g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSitLg%253D&md5=e16eca5584731b26d7176c6a5f5e099d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2965%26sid%3Dliteratum%253Aachs%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DGiguere%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGuillemyn%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DSpence%26aufirst%3DJ.%2BC.%26aulast%3DBoutet%26aufirst%3DS.%26aulast%3DMesserschmidt%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DYefanov%26aufirst%3DO.%2BM.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DOberthuer%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DM.%26aulast%3DYoon%26aufirst%3DC.%2BH.%26aulast%3DBarty%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DH.%2BN.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DConrad%26aufirst%3DC.%2BE.%26aulast%3DFromme%26aufirst%3DR.%26aulast%3DFromme%26aufirst%3DP.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DStructural%2520basis%2520for%2520bifunctional%2520peptide%2520recognition%2520at%2520human%2520e-opioid%2520receptor%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D265%26epage%3D268%26doi%3D10.1038%2Fnsmb.2965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span> <i>Schrödinger
Release 2015-2</i>; <span class="NLM_publisher-name">Glide, Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New
York, NY</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%0ARelease+2015-2%3B+Glide%2C+Schr%C3%B6dinger%2C%0ALLC%3A+New%0AYork%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%250ARelease%25202015-2%26pub%3DGlide%252C%2520Schr%25C3%25B6dinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+Glide%3A+Docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lg0e2rLZkowqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520Glide%253A%2520Docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaserer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidhammer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spetea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D.</span></span> <span> </span><span class="NLM_article-title">μ Opioid receptor: novel antagonists and structural modeling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21548</span>, <span class="refDoi"> DOI: 10.1038/srep21548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fsrep21548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=26888328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21548&author=T.+Kasererauthor=A.+Lanteroauthor=H.+Schmidhammerauthor=M.+Speteaauthor=D.+Schuster&title=%CE%BC+Opioid+receptor%3A+novel+antagonists+and+structural+modeling&doi=10.1038%2Fsrep21548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">μ Opioid receptor: novel antagonists and structural modeling</span></div><div class="casAuthors">Kaserer, Teresa; Lantero, Aquilino; Schmidhammer, Helmut; Spetea, Mariana; Schuster, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21548</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The μ opioid receptor (MOR) is a prominent member of the G protein-coupled receptor family and the mol. target of morphine and other opioid drugs.  Despite the long tradition of MOR-targeting drugs, still little is known about the ligand-receptor interactions and structure-function relationships underlying the distinct biol. effects upon receptor activation or inhibition.  With the resolved crystal structure of the β-funaltrexamine-MOR complex, we aimed at the discovery of novel agonists and antagonists using virtual screening tools, i.e. docking, pharmacophore- and shape-based modeling.  We suggest important mol. interactions, which active mols. share and distinguish agonists and antagonists.  These results allowed for the generation of theor. validated in silico workflows that were employed for prospective virtual screening.  Out of 18 virtual hits evaluated in in vitro pharmacol. assays, three displayed antagonist activity and the most active compd. significantly inhibited morphine-induced antinociception.  The new identified chemotypes hold promise for further development into neurochem. tools for studying the MOR or as potential therapeutic lead candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCoqM4r8HMKrVg90H21EOLACvtfcHk0lg0e2rLZkowqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislylu7w%253D&md5=0820b4d11e21168641444e8b77b02dbd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsrep21548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21548%26sid%3Dliteratum%253Aachs%26aulast%3DKaserer%26aufirst%3DT.%26aulast%3DLantero%26aufirst%3DA.%26aulast%3DSchmidhammer%26aufirst%3DH.%26aulast%3DSpetea%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DD.%26atitle%3D%25CE%25BC%2520Opioid%2520receptor%253A%2520novel%2520antagonists%2520and%2520structural%2520modeling%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21548%26doi%3D10.1038%2Fsrep21548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmito, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzoli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">5771</span>– <span class="NLM_lpage">5783</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-42289-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fs41598-019-42289-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=30962495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252Fjt1Wnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=5771-5783&author=A.+Stefanucciauthor=W.+Leiauthor=S.+Pierettiauthor=E.+Novellinoauthor=M.+P.+Dimmitoauthor=F.+Marzoliauthor=J.+M.+Streicherauthor=A.+Mollica&title=On+resin+click-chemistry-mediated+synthesis+of+novel+enkephalin+analogues+with+potent+anti-nociceptive+activity&doi=10.1038%2Fs41598-019-42289-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity</span></div><div class="casAuthors">Stefanucci Azzurra; Dimmito Marilisa Pia; Mollica Adriano; Lei Wei; Streicher John M; Pieretti Stefano; Marzoli Francesca; Novellino Ettore</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5771</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Here, we report the chemical synthesis of two DPDPE analogues 7a (NOVA1) and 7b (NOVA2).  This entailed the solid-phase synthesis of two enkephalin precursor chains followed by a Cu(I)-catalyzed azide-alkyne cycloaddition, with the aim of improving in vivo analgesic efficacy versus DPDPE.  NOVA2 showed good affinity and selectivity for the μ-opioid receptor (KI of 59.2 nM, EC50 of 12.9 nM, EMax of 87.3%), and long lasting anti-nociceptive effects in mice when compared to DPDPE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiJMLWBMvsfhJ5E29YNGvQfW6udTcc2ebDc0UJukgh1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252Fjt1Wnsw%253D%253D&md5=d6f22ae834eaba9b192af48b9747316b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-42289-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-42289-5%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDimmito%26aufirst%3DM.%2BP.%26aulast%3DMarzoli%26aufirst%3DF.%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DOn%2520resin%2520click-chemistry-mediated%2520synthesis%2520of%2520novel%2520enkephalin%2520analogues%2520with%2520potent%2520anti-nociceptive%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D5771%26epage%3D5783%26doi%3D10.1038%2Fs41598-019-42289-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wardhan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2074</span>, <span class="refDoi"> DOI: 10.12688/f1000research.12286.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.12688%2Ff1000research.12286.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=29225793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BC1MzgtVSisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=2065-2074&author=R.+Wardhanauthor=J.+Chelly&title=Recent+advances+in+acute+pain+management%3A+understanding+the+mechanisms+of+acute+pain%2C+the+prescription+of+opioids%2C+and+the+role+of+multimodal+pain+therapy&doi=10.12688%2Ff1000research.12286.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy</span></div><div class="casAuthors">Wardhan Richa; Chelly Jacques</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2065</span>
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    </div><div class="casAbstract">In this review, we discuss advances in acute pain management, including the recent report of the joint American Pain Society and American Academy of Pain Medicine task force on the classification of acute pain, the role of psychosocial factors, multimodal pain management, new non-opioid therapy, and the effect of the "opioid epidemic".  In this regard, we propose that a fundamental principle in acute pain management is identifying patients who are most at risk and providing an "opioid free anesthesia and postoperative analgesia".  This can be achieved by using a multimodal approach that includes regional anesthesia and minimizing the dose and the duration of opioid prescription.  This allows prescribing medications that work through different mechanisms.  We shall also look at the recent pharmacologic and treatment advances made in acute pain and regional anesthesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtqHpTbtJBjBcr74wzj5o5fW6udTcc2eZ_Du1f8Oosxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzgtVSisg%253D%253D&md5=e7144b119d651c7dd5d7a4de73eddf37</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.12286.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.12286.1%26sid%3Dliteratum%253Aachs%26aulast%3DWardhan%26aufirst%3DR.%26aulast%3DChelly%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520acute%2520pain%2520management%253A%2520understanding%2520the%2520mechanisms%2520of%2520acute%2520pain%252C%2520the%2520prescription%2520of%2520opioids%252C%2520and%2520the%2520role%2520of%2520multimodal%2520pain%2520therapy%26jtitle%3DF1000Research%26date%3D2017%26volume%3D6%26spage%3D2065%26epage%3D2074%26doi%3D10.12688%2Ff1000research.12286.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwaszkiewicz, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span> <span> </span><span class="NLM_article-title">Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.3389/fphar.2013.00132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.3389%2Ffphar.2013.00132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=24167491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADC%252BC2c7gs1Grsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=132-138&author=K.+S.+Iwaszkiewiczauthor=J.+J.+Schneiderauthor=S.+Hua&title=Targeting+peripheral+opioid+receptors+to+promote+analgesic+and+anti-inflammatory+actions&doi=10.3389%2Ffphar.2013.00132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions</span></div><div class="casAuthors">Iwaszkiewicz Katerina S; Schneider Jennifer J; Hua Susan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Mechanisms of endogenous pain control are significant.  Increasing studies have clearly produced evidence for the clinical usefulness of opioids in peripheral analgesia.  The immune system uses mechanisms of cell migration not only to fight pathogens but also to control pain and inflammation within injured tissue.  It has been demonstrated that peripheral inflammatory pain can be effectively controlled by an interaction of immune cell-derived opioid peptides with opioid receptors on peripheral sensory nerve terminals.  Experimental and clinical studies have clearly shown that activation of peripheral opioid receptors with exogenous opioid agonists and endogenous opioid peptides are able to produce significant analgesic and anti-inflammatory effects, without central opioid mediated side effects (e.g., respiratory depression, sedation, tolerance, dependence).  This article will focus on the role of opioids in peripheral inflammatory conditions and the clinical implications of targeting peripheral opioid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCrlFIPUywuzAyhZbj3lKdfW6udTcc2eZ_Du1f8Oosxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7gs1Grsg%253D%253D&md5=09f11622b05d78facc2643a4fb880f99</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00132%26sid%3Dliteratum%253Aachs%26aulast%3DIwaszkiewicz%26aufirst%3DK.%2BS.%26aulast%3DSchneider%26aufirst%3DJ.%2BJ.%26aulast%3DHua%26aufirst%3DS.%26atitle%3DTargeting%2520peripheral%2520opioid%2520receptors%2520to%2520promote%2520analgesic%2520and%2520anti-inflammatory%2520actions%26jtitle%3DFront.%2520Pharmacol.%26date%3D2013%26volume%3D4%26spage%3D132%26epage%3D138%26doi%3D10.3389%2Ffphar.2013.00132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotshteyn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turchin, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomonis, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broglè, K. C.</span></span> <span> </span><span class="NLM_article-title">DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.063560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1124%2Fjpet.103.063560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=15054116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVykt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=793-799&author=G.+T.+Whitesideauthor=J.+E.+Harrisonauthor=M.+S.+Pearsonauthor=Z.+Chenauthor=Y.+Rotshteynauthor=P.+I.+Turchinauthor=J.+D.+Pomonisauthor=L.+Markauthor=K.+Walkerauthor=K.+C.+Brogl%C3%A8&title=DiPOA+%28%5B8-%283%2C3-Diphenyl-propyl%29-4-oxo-1-phenyl-1%2C3%2C8-triazaspiro%5B4.5%5Ddec-3-yl%5D-acetic+Acid%29%2C+a+novel%2C+systemically+available%2C+and+peripherally+restricted+mu+opioid+agonist+with+antihyperalgesic+activity%3A+II.+In+vivo+pharmacological+characterization+in+the+rat&doi=10.1124%2Fjpet.103.063560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">DiPOA ([8-(3,3-diphenylpropyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat</span></div><div class="casAuthors">Whiteside, Garth T.; Harrison, James E.; Pearson, Michelle S.; Chen, Zhengming; Rotshteyn, Yakov; Turchin, Paul I.; Pomonis, James D.; Mark, Lilly; Walker, Katharine; Brogle, Kevin C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">793-799</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Mu opioid receptors are expressed throughout the central and peripheral nervous systems.  Peripheral inflammation leads to an increase in mu receptor present on the peripheral terminals of primary sensory neurons.  Activation of peripheral mu receptors produces potent antihyperalgesic effects in both humans and animals.  Here, we describe the in vivo pharmacol. properties of the structurally novel, highly potent, systemically available yet peripherally restricted mu opioid agonist, [8-(3,3-diphenylpropyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid (DiPOA).  DiPOA administered i.p. produced naltrexone-sensitive, dose-dependent reversal of Freund's complete adjuvant-induced inflammatory mech. hyperalgesia (1-10 mg/kg).  Maximum percent reversal (67%) was seen 1 h postadministration at 10 mg/kg (the highest dose studied).  DiPOA also proved antihyperalgesic in a model of postsurgical pain with a max. percent reversal of 85% 1 h postadministration at 30 mg/kg i.p. (the highest dose studied).  DiPOA administered i.p. had no effect in the tail flick assay of acute pain (0.1-10 mg/kg), produced no ataxia as measured by latency to fall from an accelerating rotarod (3-30 mg/kg), and was not antihyperalgesic in the Seltzer model of neuropathic pain (1-10 mg/kg).  This is the first report of a peripherally restricted, small-mol. mu opioid agonist that is nonsedating, antihyperalgesic, and effective against inflammatory and postsurgical pain when administered systemically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCIgpGdUguarVg90H21EOLACvtfcHk0lj68-Fy3sVKaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVykt74%253D&md5=c366a0425c235549967f4d86da17f586</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.063560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.063560%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DHarrison%26aufirst%3DJ.%2BE.%26aulast%3DPearson%26aufirst%3DM.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DRotshteyn%26aufirst%3DY.%26aulast%3DTurchin%26aufirst%3DP.%2BI.%26aulast%3DPomonis%26aufirst%3DJ.%2BD.%26aulast%3DMark%26aufirst%3DL.%26aulast%3DWalker%26aufirst%3DK.%26aulast%3DBrogl%25C3%25A8%26aufirst%3DK.%2BC.%26atitle%3DDiPOA%2520%2528%255B8-%25283%252C3-Diphenyl-propyl%2529-4-oxo-1-phenyl-1%252C3%252C8-triazaspiro%255B4.5%255Ddec-3-yl%255D-acetic%2520Acid%2529%252C%2520a%2520novel%252C%2520systemically%2520available%252C%2520and%2520peripherally%2520restricted%2520mu%2520opioid%2520agonist%2520with%2520antihyperalgesic%2520activity%253A%2520II.%2520In%2520vivo%2520pharmacological%2520characterization%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D793%26epage%3D799%26doi%3D10.1124%2Fjpet.103.063560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bileviciute-Ljungar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spetea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windisch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidhammer, H.</span></span> <span> </span><span class="NLM_article-title">Peripherally mediated antinociception of the m-opioid receptor agonist 2-[(4,5g-Epoxy-3-hydroxy-14βmethoxy-17-methylmorphinan-6βyl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.096032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1124%2Fjpet.105.096032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=16339394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVWmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=220-227&author=I.+Bileviciute-Ljungarauthor=M.+Speteaauthor=Y.+Guoauthor=J.+Sch%C3%BCtzauthor=P.+Windischauthor=H.+Schmidhammer&title=Peripherally+mediated+antinociception+of+the+m-opioid+receptor+agonist+2-%5B%284%2C5g-Epoxy-3-hydroxy-14%CE%B2methoxy-17-methylmorphinan-6%CE%B2yl%29amino%5Dacetic+acid+%28HS-731%29+after+subcutaneous+and+oral+administration+in+rats+with+carrageenan-induced+hindpaw+inflammation&doi=10.1124%2Fjpet.105.096032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally mediated antinociception of the μ-opioid receptor agonist 2-[(4,5α-epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation</span></div><div class="casAuthors">Bileviciute-Ljungar, Indre; Spetea, Mariana; Guo, Yan; Schutz, Johannes; Windisch, Petra; Schmidhammer, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Opioids induce analgesia by activating opioid receptors not only within the central nervous system but also on peripheral sensory neurons.  This study investigated peripherally mediated antinociception produced by the μ-opioid receptor agonist 2-[(4,5α-epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic acid (HS-731) after s.c. and oral administration in rats with carrageenan-induced hindpaw inflammation.  Antinociceptive effects after s.c. administration were assessed 3 h after intraplantar carrageenan injection and compared with those of centrally acting μ-opioid agonists 14-methoxymetopon and morphine.  Opioid agonists caused dose-dependent increases in inflamed paw withdrawal latencies to mech. and thermal stimulation.  The time course of action was different, in that HS-731 (20 μg/kg s.c.) produced significant long-lasting effects up to 4 h after administration, whereas 14-methoxymetopon (20 μg/kg) and morphine (2 mg/kg) reached their peak of action at 10 to 30 min, and their effect declined rapidly thereafter.  S.c. administration of the peripherally selective opioid antagonist naloxone methiodide inhibited antinociception elicited by HS-731 (20 μg/kg s.c.), whereas it was ineffective against 14-methoxymetopon (20 μg/kg s.c.).  Moreover, the antinociception produced by 100 μg/kg s.c. HS-731 was dose-dependently reversed by s.c. naloxone methiodide.  This indicates that HS-731 preferentially activates peripheral opioid receptors, whereas 14-methoxymetopon mediates analgesia via central mechanisms.  Orally administered HS-731 significantly reduced hyperalgesia in the inflamed paw induced by carrageenan, which was reversible by s.c. administered naloxone methiodide.  These results show that systemic (s.c. and oral) treatment with the μ-opioid agonist HS-731 produces potent and long-lasting antinociception through peripheral mechanisms in rats with carrageenan-induced hindpaw inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlV0UnJMuSLVg90H21EOLACvtfcHk0lgy9eTNwYwgrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVWmt7c%253D&md5=ed14cf0f039457fa728595cbdaa178f6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.096032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.096032%26sid%3Dliteratum%253Aachs%26aulast%3DBileviciute-Ljungar%26aufirst%3DI.%26aulast%3DSpetea%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DJ.%26aulast%3DWindisch%26aufirst%3DP.%26aulast%3DSchmidhammer%26aufirst%3DH.%26atitle%3DPeripherally%2520mediated%2520antinociception%2520of%2520the%2520m-opioid%2520receptor%2520agonist%25202-%255B%25284%252C5g-Epoxy-3-hydroxy-14%25CE%25B2methoxy-17-methylmorphinan-6%25CE%25B2yl%2529amino%255Dacetic%2520acid%2520%2528HS-731%2529%2520after%2520subcutaneous%2520and%2520oral%2520administration%2520in%2520rats%2520with%2520carrageenan-induced%2520hindpaw%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D220%26epage%3D227%26doi%3D10.1124%2Fjpet.105.096032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span> <span> </span><span class="NLM_article-title">Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1506</span>– <span class="NLM_lpage">1509</span>, <span class="refDoi"> DOI: 10.1248/cpb.47.1506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1248%2Fcpb.47.1506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10553648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK1MXmslCqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1999&pages=1506-1509&author=Y.+Sasakiauthor=T.+Sutoauthor=A.+Amboauthor=H.+Ouchiauthor=Y.+Yamamoto&title=Biological+properties+of+opioid+peptides+replacing+Tyr+at+position+1+by+2%2C6-dimethyl-Tyr&doi=10.1248%2Fcpb.47.1506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-tyrosine</span></div><div class="casAuthors">Sasaki, Yusuke; Suto, Takuya; Ambo, Akihiro; Ouchi, Hidekazu; Yamamoto, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1506-1509</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">To understand the effect of the replacement of Tyr residue at position 1 in opioid peptides by 2,6-dimethyl-Tyr (Dmt) on the biol. property, chiral (D or L) Dmt1 analogs of Leu-enkephalin (Enk) and Tyr-D-Arg-Phe-βAla-NH2 (YRFB) were synthesized and their enzymic stabilities, in vitro bioactivities and receptor binding affinities compared with those of parent peptides.  [L-Dmt1]Enk (1) exhibited 4-fold higher stability against aminopeptidase-M and possessed dramatically increased activities in guinea pig ileum (GPI) (187-fold) and mouse vas deferens (MVD) (131-fold) assays, and in rat brain receptor binding assays (356-fold at μ receptor and 46-fold at δ receptor) as compared to Enk.  [L-Dmt1]YRFB (3) also exhibited increased activities in GPI (46-fold) and MVD (177-fold) assays, and in the binding assays (69-fold at μ receptor and 341-fold at δ receptor) as compared to the parent peptide.  [D-Dmt1]Enk (2) and [D-Dmt1]YRFB (4) exhibited activities with diminished or lesser potency than the parent peptide in all assays.  These results indicate that there is a tendency for μ affinity to be enhanced more than δ affinity with introduction of L-Dmt into δ ligand peptide (Enk), and for δ affinity to be enhanced more than μ affinity in case of μ ligand peptide (YRFB), resulting in reduced receptor selectivities at the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkokfMI34avLVg90H21EOLACvtfcHk0lgy9eTNwYwgrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslCqt7s%253D&md5=4d6d864805d50ae7a56d8afed20ed4d7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1248%2Fcpb.47.1506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.47.1506%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DSuto%26aufirst%3DT.%26aulast%3DAmbo%26aufirst%3DA.%26aulast%3DOuchi%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26atitle%3DBiological%2520properties%2520of%2520opioid%2520peptides%2520replacing%2520Tyr%2520at%2520position%25201%2520by%25202%252C6-dimethyl-Tyr%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1999%26volume%3D47%26spage%3D1506%26epage%3D1509%26doi%3D10.1248%2Fcpb.47.1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pogozheva, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomize, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosberg, H. I.</span></span> <span> </span><span class="NLM_article-title">Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">612</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/S0006-3495(98)77552-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2FS0006-3495%2898%2977552-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=9675164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK1cXltFyitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=612-634&author=I.+D.+Pogozhevaauthor=A.+L.+Lomizeauthor=H.+I.+Mosberg&title=Opioid+receptor+three-dimensional+structures+from+distance+geometry+calculations+with+hydrogen+bonding+constraints&doi=10.1016%2FS0006-3495%2898%2977552-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints</span></div><div class="casAuthors">Pogozheva, Irina D.; Lomize, Andrei L.; Mosberg, Henry I.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">612-634</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">Three-dimensional structures of the transmembrane, seven α-helical domains and extracellular loops of δ, μ, and κ opioid receptors, were calcd. using the distance geometry algorithm, with hydrogen bonding constraints based on the previously developed general model of the transmembrane α-bundle for rhodopsin-like G-protein coupled receptors (Biophys. J. 1997. 70:1963).  Each calcd. opioid receptor structure has an extensive network of interhelical hydrogen bonds and a ligand-binding crevice that is partially covered by a β-hairpin formed by the second extracellular loop.  The binding cavities consist of an inner "conserved region" composed of 18 residues that are identical in δ, μ, and κ opioid receptors, and a peripheral "variable region," composed of 19 residues that are different in δ, μ, and κ subtypes and are responsible for the subtype specificity of various ligands.  Sixteen δ-, μ-, or κ-selective, conformationally constrained peptide and nonpeptide opioid agonists and antagonists and affinity labels were fit into the binding pockets of the opioid receptors.  All ligands considered have a similar spatial arrangement in the receptors, with the tyramine moiety of alkaloids or Tyr1 of opioid peptides interacting with conserved residues in the bottom of the pocket and the tyramine N+ and OH groups forming ionic interactions or H-bonds with a conserved aspartate from helix III and a conserved histidine from helix VI, resp.  The central, conformationally constrained fragments of the opioids (the disulfide-bridged cycles of the peptides and various ring structures in the nonpeptide ligands) are oriented approx. perpendicular to the tyramine and directed toward the extracellular surface.  The results obtained are qual. consistent with ligand affinities, crosslinking studies, and mutagenesis data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomsqriUZlUkLVg90H21EOLACvtfcHk0lhAwKMAURnp_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFyitr4%253D&md5=d676d455db7c5e99247284e4315c2a04</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977552-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977552-6%26sid%3Dliteratum%253Aachs%26aulast%3DPogozheva%26aufirst%3DI.%2BD.%26aulast%3DLomize%26aufirst%3DA.%2BL.%26aulast%3DMosberg%26aufirst%3DH.%2BI.%26atitle%3DOpioid%2520receptor%2520three-dimensional%2520structures%2520from%2520distance%2520geometry%2520calculations%2520with%2520hydrogen%2520bonding%2520constraints%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D75%26spage%3D612%26epage%3D634%26doi%3D10.1016%2FS0006-3495%2898%2977552-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidlack, J. M.</span></span> <span> </span><span class="NLM_article-title">Cyclazocine revisited</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1007/BF02532378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1007%2FBF02532378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=8947927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1Okurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=1369-1373&author=S.+Archerauthor=S.+D.+Glickauthor=J.+M.+Bidlack&title=Cyclazocine+revisited&doi=10.1007%2FBF02532378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclazocine revisited</span></div><div class="casAuthors">Archer, Sydney; Glick, Stanley D.; Bidlack, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1369-1373</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">Recently synthesized compds. which have long-term mu antagonist activity and short-term kappa agonist effects prevent self-administration of cocaine and morphine in rats.  Cyclazocine, a compd. synthesized in 1962 and studied in animals and man in the 1960's and in the early 1970's is a mu antagonist in rats and man and is a potent kappa agonist in both species.  It also prevents self-administration of cocaine and morphine in rats.  Although it produces unpleasant side effects in man, subjects become tolerant to these side effects but not to the antagonistic actions of the drug after prolonged administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLCN_lEZbabVg90H21EOLACvtfcHk0ljBqhAkP4mUQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1Okurg%253D&md5=3006d809a84276b480ebfc9247424a46</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02532378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02532378%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DGlick%26aufirst%3DS.%2BD.%26aulast%3DBidlack%26aufirst%3DJ.%2BM.%26atitle%3DCyclazocine%2520revisited%26jtitle%3DNeurochem.%2520Res.%26date%3D1996%26volume%3D21%26spage%3D1369%26epage%3D1373%26doi%3D10.1007%2FBF02532378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenard, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roerig, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portoghese, P. S.</span></span> <span> </span><span class="NLM_article-title">Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">19208</span>– <span class="NLM_lpage">19213</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506627102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1073%2Fpnas.0506627102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=16365317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XivV2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=19208-19213&author=D.+J.+Danielsauthor=N.+R.+Lenardauthor=C.+L.+Etienneauthor=P.+Y.+Lawauthor=S.+C.+Roerigauthor=P.+S.+Portoghese&title=Opioid-induced+tolerance+and+dependence+in+mice+is+modulated+by+the+distance+between+pharmacophores+in+a+bivalent+ligand+series&doi=10.1073%2Fpnas.0506627102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series</span></div><div class="casAuthors">Daniels, David J.; Lenard, Natalie R.; Etienne, Chris L.; Law, Ping-Yee; Roerig, Sandra C.; Portoghese, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">19208-19213</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Given the mounting evidence for involvement of δ opioid receptors in the tolerance and phys. dependence of μ opioid receptor agonists, the authors have investigated the possible phys. interaction between μ and δ opioid receptors by using bivalent ligands.  Based on reports of suppression of antinociceptive tolerance by the δ antagonist naltrindole (NTI), bivalent ligands [μ-δ agonist-antagonist (MDAN) series] that contain different length spacers, and pharmacophores derived from NTI and the μ agonist oxymorphone, have been synthesized and evaluated by intracerebroventricular (i.c.v.) administration in the tail-flick test in mice.  In acute i.c.v. studies, the bivalent ligands functioned as agonists with potencies ranging from 1.6- to 45-fold greater than morphine.  In contrast, the monovalent μ agonist analogs were substantially more potent than the MDAN congeners and were essentially equipotent with one another and oxymorphone.  Pretreatment with NTI decreased the ED50 values for MDAN-19 to a greater degree than for MDAN-16 but had no effect on MDAN-21.  Chronic i.c.v. studies revealed that MDAN ligands whose spacer was 16 atoms or longer produced less dependence than either morphine or μ monovalent control MA-19.  On the other hand, both phys. dependence and tolerance were suppressed at MDAN spacer lengths of 19 atoms or greater.  These data suggest that phys. interaction between the μ and δ opioid receptors modulates μ-mediated tolerance and dependence.  Because MDAN-21 was found to be 50-fold more potent than morphine by the i.v. route (i.v.), it offers a previously uncharacterized approach for the development of analgesics devoid of tolerance and dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonz5CFnYjrYrVg90H21EOLACvtfcHk0li9yW1D4SbWjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivV2nuw%253D%253D&md5=eaa04a16db78abe66a01eb1c16756c21</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506627102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506627102%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DD.%2BJ.%26aulast%3DLenard%26aufirst%3DN.%2BR.%26aulast%3DEtienne%26aufirst%3DC.%2BL.%26aulast%3DLaw%26aufirst%3DP.%2BY.%26aulast%3DRoerig%26aufirst%3DS.%2BC.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DOpioid-induced%2520tolerance%2520and%2520dependence%2520in%2520mice%2520is%2520modulated%2520by%2520the%2520distance%2520between%2520pharmacophores%2520in%2520a%2520bivalent%2520ligand%2520series%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D19208%26epage%3D19213%26doi%3D10.1073%2Fpnas.0506627102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilkenny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthill, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, D. G.</span></span> <span> </span><span class="NLM_article-title">Animal research: reporting in vivo experiments: the ARRIVE guidelines</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1579</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00872.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1111%2Fj.1476-5381.2010.00872.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=20649561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1577-1579&author=C.+Kilkennyauthor=W.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Animal+research%3A+reporting+in+vivo+experiments%3A+the+ARRIVE+guidelines&doi=10.1111%2Fj.1476-5381.2010.00872.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Animal research: Reporting in vivo experiments: the arrive guidelines</span></div><div class="casAuthors">Kilkenny, Carol; Browne, William; Cuthill, Innes C.; Emerson, Michael; Altman, Douglas G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1577-1579</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWTuV0uX4LbVg90H21EOLACvtfcHk0lguw6AHJffJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSqtLk%253D&md5=2812fe0670e4f613a0b0aa3da03e5e7c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00872.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00872.x%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DAnimal%2520research%253A%2520reporting%2520in%2520vivo%2520experiments%253A%2520the%2520ARRIVE%2520guidelines%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26spage%3D1577%26epage%3D1579%26doi%3D10.1111%2Fj.1476-5381.2010.00872.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilley, E.</span></span> <span> </span><span class="NLM_article-title">Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">3189</span>– <span class="NLM_lpage">3193</span>, <span class="refDoi"> DOI: 10.1111/bph.12955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1111%2Fbph.12955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=25964986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3189-3193&author=J.+C.+McGrathauthor=E.+Lilley&title=Implementing+guidelines+on+reporting+research+using+animals+%28ARRIVE+etc.%29%3A+new+requirements+for+publication+in+BJP&doi=10.1111%2Fbph.12955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP</span></div><div class="casAuthors">McGrath, John C.; Lilley, Elliot</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3189-3193</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The ARRIVE guidelines have been implemented in BJP for 4 years with the aim of increasing transparency in reporting expts. involving animals.  BJP has assessed our success in implementing them and concluded that we could do better.  This editorial discusses the issues and explains how we are changing our requirements for authors to report their findings in expts. involving animals.  This is one of a series of discussing updates to the BJP Linked Editorials : This Editorial is part of a series.  To view the other Editorials in this series, visit: ; ; and .  Video : To view the video on the ARRIVE guidelines, visit:.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-Be_pTHIX1rVg90H21EOLACvtfcHk0lj_Pt3LD_iEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rO&md5=8525b931d44bd6640a6649ad2f43f733</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fbph.12955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12955%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DJ.%2BC.%26aulast%3DLilley%26aufirst%3DE.%26atitle%3DImplementing%2520guidelines%2520on%2520reporting%2520research%2520using%2520animals%2520%2528ARRIVE%2520etc.%2529%253A%2520new%2520requirements%2520for%2520publication%2520in%2520BJP%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3189%26epage%3D3193%26doi%3D10.1111%2Fbph.12955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen A; Berge O G; Hunskaar S; Rosland J H; Hole K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eZ2igKrsmfztLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giembycz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacEwan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonnacott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, J. C.</span></span> <span> </span><span class="NLM_article-title">Experimental design and analysis and their reporting: new guidance for publication in BJP</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">3461</span>– <span class="NLM_lpage">3471</span>, <span class="refDoi"> DOI: 10.1111/bph.12856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1111%2Fbph.12856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=26114403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3461-3471&author=M.+J.+Curtisauthor=R.+A.+Bondauthor=D.+Spinaauthor=A.+Ahluwaliaauthor=S.+P.+Alexanderauthor=M.+A.+Giembyczauthor=A.+Gilchristauthor=D.+Hoyerauthor=P.+A.+Inselauthor=A.+A.+Izzoauthor=A.+J.+Lawrenceauthor=D.+J.+MacEwanauthor=L.+D.+Moonauthor=S.+Wonnacottauthor=A.+H.+Westonauthor=J.+C.+McGrath&title=Experimental+design+and+analysis+and+their+reporting%3A+new+guidance+for+publication+in+BJP&doi=10.1111%2Fbph.12856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental design and analysis and their reporting: new guidance for publication in BJP</span></div><div class="casAuthors">Curtis, Michael J.; Bond, Richard A.; Spina, Domenico; Ahluwalia, Amrita; Alexander, Stephen P. A.; Giembycz, Mark A.; Gilchrist, Annette; Hoyer, Daniel; Insel, Paul A.; Izzo, Angelo A.; Lawrence, Andrew J.; MacEwan, David J.; Moon, Lawrence D. F.; Wonnacott, Sue; Weston, Arthur H.; McGrath, John C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3461-3471</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Linked Editorials : This Editorial is part of a series.  To view the other Editorials in this series, visit: ; ; and.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Jd_c_V1H0rVg90H21EOLACvtfcHk0lixsUuMF-MrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurrJ&md5=766587bc5c1f7142ab57bf8f276fe12b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fbph.12856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12856%26sid%3Dliteratum%253Aachs%26aulast%3DCurtis%26aufirst%3DM.%2BJ.%26aulast%3DBond%26aufirst%3DR.%2BA.%26aulast%3DSpina%26aufirst%3DD.%26aulast%3DAhluwalia%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DS.%2BP.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26aulast%3DGilchrist%26aufirst%3DA.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DInsel%26aufirst%3DP.%2BA.%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DLawrence%26aufirst%3DA.%2BJ.%26aulast%3DMacEwan%26aufirst%3DD.%2BJ.%26aulast%3DMoon%26aufirst%3DL.%2BD.%26aulast%3DWonnacott%26aufirst%3DS.%26aulast%3DWeston%26aufirst%3DA.%2BH.%26aulast%3DMcGrath%26aufirst%3DJ.%2BC.%26atitle%3DExperimental%2520design%2520and%2520analysis%2520and%2520their%2520reporting%253A%2520new%2520guidance%2520for%2520publication%2520in%2520BJP%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3461%26epage%3D3471%26doi%3D10.1111%2Fbph.12856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLane, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergquist, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cormier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsky, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span> <span> </span><span class="NLM_article-title">Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1016%2Fj.lfs.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=28723417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WqsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2017&pages=1-7&author=V.+D.+McLaneauthor=I.+Bergquistauthor=J.+Cormierauthor=D.+J.+Barlowauthor=K.+L.+Houseknechtauthor=E.+J.+Bilskyauthor=L.+Cao&title=Long-term+morphine+delivery+via+slow+release+morphine+pellets+or+osmotic+pumps%3A+Plasma+concentration%2C+analgesia%2C+and+naloxone-precipitated+withdrawal&doi=10.1016%2Fj.lfs.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal</span></div><div class="casAuthors">McLane, Virginia D.; Bergquist, Ivy; Cormier, James; Barlow, Deborah J.; Houseknecht, Karen L.; Bilsky, Edward J.; Cao, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Slow-release morphine sulfate pellets and osmotic pumps are common routes of chronic morphine delivery in mouse models, but direct comparisons of these drug delivery systems are lacking.  In this study, we assessed the efficacy of slow-release pellets vs. osmotic pumps in delivering morphine to adult mice.  Male C57BL/6NCr mice (8 wk old) were implanted s.c. with slow-release pellets (25 mg morphine sulfate) or osmotic pumps (64 mg/mL, 1.0 μL/h).  Plasma morphine concns. were quantified via LC-MS/MS, analgesic efficacy was detd. by tail flick assay, and dependence was assessed with naloxone-pptd. withdrawal behaviors (jumping) and physiol. effects (excretion, wt. loss).  Morphine pellets delivered significantly higher plasma drug concns. compared to osmotic pumps, which were limited by the soly. of the morphine sulfate and pump vol./flow rate.  Within 96 h post-implantation, plasma morphine concns. were indistinguishable in pellet vs. pump-treated samples.  While osmotic pump did not have an antinociceptive effect in the tail flick assay, pumps and pellets induced comparable dependence symptoms (naloxone-pptd. jumping behavior) from 24-72 h post-implantation.  In this study, we compared slow-release morphine pellets to osmotic minipumps for morphine delivery in mice.  We found that osmotic pumps and s.c. morphine sulfate pellets yielded significantly different pharmacokinetics over a 7-day period, and as a result significantly different antinociceptive efficacy.  Nonetheless, both delivery methods induced dependence as measured by naloxone-pptd. withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMVEKRpARU77Vg90H21EOLACvtfcHk0lgqPy8V27fpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WqsrrP&md5=8211027f5149fc9ce0eb659c4856d4f3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DMcLane%26aufirst%3DV.%2BD.%26aulast%3DBergquist%26aufirst%3DI.%26aulast%3DCormier%26aufirst%3DJ.%26aulast%3DBarlow%26aufirst%3DD.%2BJ.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DCao%26aufirst%3DL.%26atitle%3DLong-term%2520morphine%2520delivery%2520via%2520slow%2520release%2520morphine%2520pellets%2520or%2520osmotic%2520pumps%253A%2520Plasma%2520concentration%252C%2520analgesia%252C%2520and%2520naloxone-precipitated%2520withdrawal%26jtitle%3DLife%2520Sci.%26date%3D2017%26volume%3D185%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.lfs.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascarella, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westkaemper, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human kappa-opioid receptor in complex with JDTic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1038/nature10939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1038%2Fnature10939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=22437504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVegt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=327-332&author=H.+Wuauthor=D.+Wackerauthor=M.+Mileniauthor=V.+Katritchauthor=G.+W.+Hanauthor=E.+Vardyauthor=W.+Liuauthor=A.+A.+Thompsonauthor=X.+P.+Huangauthor=F.+I.+Carrollauthor=S.+W.+Mascarellaauthor=R.+B.+Westkaemperauthor=P.+D.+Mosierauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+kappa-opioid+receptor+in+complex+with+JDTic&doi=10.1038%2Fnature10939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human κ-opioid receptor in complex with JDTic</span></div><div class="casAuthors">Wu, Huixian; Wacker, Daniel; Mileni, Mauro; Katritch, Vsevolod; Han, Gye Won; Vardy, Eyal; Liu, Wei; Thompson, Aaron A.; Huang, Xi-Ping; Carroll, F. Ivy; Mascarella, S. Wayne; Westkaemper, Richard B.; Mosier, Philip D.; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">327-332</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiol. processes, including the regulation of pain, respiratory drive, mood, and -in the case of κ-opioid receptor (κ-OR)- dysphoria and psychotomimesis.  Here we report the crystal structure of the human κ-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 Å resoln.  The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human κ-OR.  Modeling of other important κ-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5'-guanidinonaltrindole, and the diterpene agonist salvinorin A analog RB-64, reveals both common and distinct features for binding these diverse chemotypes.  Anal. of site-directed mutagenesis and ligand structure-activity relationships confirms the interactions obsd. in the crystal structure, thereby providing a mol. explanation for κ-OR subtype selectivity, and essential insights for the design of compds. with new pharmacol. properties targeting the human κ-OR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpARTr4eE_zZbVg90H21EOLACvtfcHk0lg3y5w_qxNHpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVegt7k%253D&md5=c54dd24df9065ed3b1a51420e74e2542</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnature10939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10939%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DWestkaemper%26aufirst%3DR.%2BB.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520kappa-opioid%2520receptor%2520in%2520complex%2520with%2520JDTic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D327%26epage%3D332%26doi%3D10.1038%2Fnature10939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A force field providing broad coverage of drug-like small molecules and proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lg3y5w_qxNHpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, N.</span></span> <span> </span><span class="NLM_article-title">ChemDraw Ultra 10.0</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">13649</span>– <span class="NLM_lpage">13650</span>, <span class="refDoi"> DOI: 10.1021/ja0697875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0697875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=13649-13650&author=N.+Mills&title=ChemDraw+Ultra+10.0&doi=10.1021%2Fja0697875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">ChemDraw Ultra 10.0</span></div><div class="casAuthors">Mills, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13649-13650</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSDwZrNGK3c7Vg90H21EOLACvtfcHk0lhNX62BwN2eOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFequr8%253D&md5=994150d3069bed3f48d411c429b54a78</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja0697875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0697875%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DN.%26atitle%3DChemDraw%2520Ultra%252010.0%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D13649%26epage%3D13650%26doi%3D10.1021%2Fja0697875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">2794</span>– <span class="NLM_lpage">2812</span>, <span class="refDoi"> DOI: 10.1002/prot.23106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fprot.23106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=21905107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFehsLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=2794-2812&author=J.+Liauthor=R.+Abelauthor=K.+Zhuauthor=Y.+Caoauthor=S.+Zhaoauthor=R.+A.+Friesner&title=The+VSGB+2.0+model%3A+a+next+generation+energy+model+for+high+resolution+protein+structure+modeling&doi=10.1002%2Fprot.23106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling</span></div><div class="casAuthors">Li, Jianing; Abel, Robert; Zhu, Kai; Cao, Yixiang; Zhao, Suwen; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2794-2812</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A novel energy model (VSGB 2.0) for high resoln. protein structure modeling is described, which features an optimized implicit solvent model as well as physics-based corrections for hydrogen bonding, π-π interactions, self-contact interactions, and hydrophobic interactions.  Parameters of the VSGB 2.0 model were fit to a crystallog. database of 2239 single side chain and 100 11-13 residue loop predictions.  Combined with an advanced method of sampling and a robust algorithm for protonation state assignment, the VSGB 2.0 model was validated by predicting 115 super long loops up to 20 residues.  Despite the dramatically increasing difficulty in reconstructing longer loops, a high accuracy was achieved: all of the lowest energy conformations have global backbone RMSDs better than 2.0 Å from the native conformations.  Av. global backbone RMSDs of the predictions are 0.51, 0.63, 0.70, 0.62, 0.80, 1.41, and 1.59 Å for 14, 15, 16, 17, 18, 19, and 20 residue loop predictions, resp.  When these results are cor. for possible statistical bias as explained in the text, the av. global backbone RMSDs are 0.61, 0.71, 0.86, 0.62, 1.06, 1.67, and 1.59 Å.  Given the precision and robustness of the calcns., the authors believe that the VSGB 2.0 model is suitable to tackle "real" problems, such as biol. function modeling and structure-based drug discovery.  Proteins 2011; © 2011 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXSQ9URQR6obVg90H21EOLACvtfcHk0liSgl0t9AC38A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFehsLfK&md5=cb63aef455d13520c8ed94b99eae2287</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fprot.23106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.23106%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DThe%2520VSGB%25202.0%2520model%253A%2520a%2520next%2520generation%2520energy%2520model%2520for%2520high%2520resolution%2520protein%2520structure%2520modeling%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2011%26volume%3D79%26spage%3D2794%26epage%3D2812%26doi%3D10.1002%2Fprot.23106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span> <span> </span><span class="NLM_article-title">Accurate prediction of the relative potencies of members of a series of kinase inhibitors using Molecular Docking and MM-GBSA Scoring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4808</span>, <span class="refDoi"> DOI: 10.1021/jm060522a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060522a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4805-4808&author=P.+D.+Lyneauthor=M.+L.+Lambauthor=J.+C.+Saeh&title=Accurate+prediction+of+the+relative+potencies+of+members+of+a+series+of+kinase+inhibitors+using+Molecular+Docking+and+MM-GBSA+Scoring&doi=10.1021%2Fjm060522a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA Scoring</span></div><div class="casAuthors">Lyne, Paul D.; Lamb, Michelle L.; Saeh, Jamal C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4805-4808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability of mol. docking, using the program Glide and an MM-GBSA postdocking scoring protocol, to correctly rank a no. of congeneric kinase inhibitors was assessed.  The approach was successful for the cases considered and suggests that this may be useful for the design of inhibitors in the lead optimization phase of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVyYUu0E1ua7Vg90H21EOLACvtfcHk0liSgl0t9AC38A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFGjs7s%253D&md5=ea44ed5036a1569d191481bf10c74889</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060522a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060522a%26sid%3Dliteratum%253Aachs%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26atitle%3DAccurate%2520prediction%2520of%2520the%2520relative%2520potencies%2520of%2520members%2520of%2520a%2520series%2520of%2520kinase%2520inhibitors%2520using%2520Molecular%2520Docking%2520and%2520MM-GBSA%2520Scoring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4805%26epage%3D4808%26doi%3D10.1021%2Fjm060522a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ucurum, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotiadis, D.</span></span> <span> </span><span class="NLM_article-title">Engineering a chemical switch into the light-driven proton pump proteorhodopsin by cysteine mutagenesis and thiol modification</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8846</span>– <span class="NLM_lpage">8849</span>, <span class="refDoi"> DOI: 10.1002/anie.201601537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=10.1002%2Fanie.201601537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=8846-8849&author=D.+Harderauthor=S.+Hirschiauthor=Z.+Ucurumauthor=R.+Goersauthor=W.+Meierauthor=D.+J.+M%C3%BCllerauthor=D.+Fotiadis&title=Engineering+a+chemical+switch+into+the+light-driven+proton+pump+proteorhodopsin+by+cysteine+mutagenesis+and+thiol+modification&doi=10.1002%2Fanie.201601537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering a Chemical Switch into the Light-driven Proton Pump Proteorhodopsin by Cysteine Mutagenesis and Thiol Modification</span></div><div class="casAuthors">Harder, Daniel; Hirschi, Stephan; Ucurum, Zoehre; Goers, Roland; Meier, Wolfgang; Mueller, Daniel J.; Fotiadis, Dimitrios</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">8846-8849</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">For applications in synthetic biol., for example, the bottom-up assembly of biomol. nanofactories, modules of specific and controllable functionalities are essential.  Of fundamental importance in such systems are energizing modules, which are able to establish an electrochem. gradient across a vesicular membrane as an energy source for powering other modules.  Light-driven proton pumps like proteorhodopsin (PR) are excellent candidates for efficient energy conversion.  We have extended the versatility of PR by implementing an on/off switch based on reversible chem. modification of a site-specifically introduced cysteine residue.  The position of this cysteine residue in PR was identified by structure-based cysteine mutagenesis combined with a proton-pumping assay using E. coli cells overexpressing PR and PR proteoliposomes.  The identified PR mutant represents the first light-driven proton pump that can be chem. switched on/off depending on the requirements of the mol. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqghhyONGTbPrVg90H21EOLACvtfcHk0ljRebOHszaOyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWrs74%253D&md5=cfe0be5674fdb2d9a8be029bccf0dddb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601537%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DD.%26aulast%3DHirschi%26aufirst%3DS.%26aulast%3DUcurum%26aufirst%3DZ.%26aulast%3DGoers%26aufirst%3DR.%26aulast%3DMeier%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BJ.%26aulast%3DFotiadis%26aufirst%3DD.%26atitle%3DEngineering%2520a%2520chemical%2520switch%2520into%2520the%2520light-driven%2520proton%2520pump%2520proteorhodopsin%2520by%2520cysteine%2520mutagenesis%2520and%2520thiol%2520modification%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D8846%26epage%3D8849%26doi%3D10.1002%2Fanie.201601537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M','PDB','5C1M'); return false;">PDB: 5C1M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWD','PDB','4RWD'); return false;">PDB: 4RWD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJH','PDB','4DJH'); return false;">PDB: 4DJH</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84403"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01963?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01963</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_001.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_005.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_006.pdb">PDB</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR spectra of final compounds, analytical RP-HPLC traces, UPLC traces, HRMS, plasma stability curves, BBB-PAMPA procedure (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_008.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_001.pdb">jm9b01963_si_001.pdb (360.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_002.pdb">jm9b01963_si_002.pdb (352.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_003.pdb">jm9b01963_si_003.pdb (362.59 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_004.pdb">jm9b01963_si_004.pdb (356.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_005.pdb">jm9b01963_si_005.pdb (355.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_006.pdb">jm9b01963_si_006.pdb (363.01 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_007.pdf">jm9b01963_si_007.pdf (1.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01963/suppl_file/jm9b01963_si_008.csv">jm9b01963_si_008.csv (2.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01963%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01963" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679988350edb3dbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
